#version: 0.2
Ġ a
i n
o n
Ġ t
e r
a t
o l
r e
o r
h e
e n
Ġ s
l i
Ġ p
i on
Ġ c
Ġ o
e s
r o
Ġ f
i s
Ġt he
i c
Ġa n
e d
a l
i t
l e
Ġ in
Ġ m
Ġo f
Ġ d
a n
a r
Ġ P
Ġan d
c t
at ion
in g
Ġ w
ol li
Ġ b
en t
Ġ K
Ġ C
ĠK olli
e t
Ġ T
Ġf or
u l
i d
Ġ 1
a s
Ġt o
a b
Ġ I
Ġ S
u s
o m
Ġ A
Ġ (
Ġ is
Ġ re
a m
e l
Ġp ro
Ġ e
Ġ 2
u r
i l
Ġ g
u t
o s
Ġ 3
u m
i g
Ġ h
0 0
l y
Ġ n
Ġ D
ab le
Ġ O
u ct
y l
Ġc on
Ġ F
r a
at e
u re
o w
c e
ic al
d uct
p h
it h
Ġ B
Ġ M
Ġs t
Ġ or
i li
u p
Ġ 5
Ġ E
er s
o t
Ġt h
Ġ 4
i v
m ul
Ġb e
d on
ĠT he
u b
Ġa re
t y
om p
Ġa s
ĠKolli don
Ġ v
Ġw ith
t ic
i f
u n
s ol
Ġ R
e c
Ġs ol
c o
Ġ 6
r i
Ġa c
Ġ W
t s
p p
q u
Ġa l
s t
o d
re s
ol y
Ġ on
Ġc omp
Ġ l
a g
Ġ 0
Ġ us
Ġpro duct
ion s
i m
Ġd is
ig h
et h
a ct
p er
at er
a c
a in
or m
E S
es t
ation s
e g
i z
Ġa pp
ent s
es s
re d
A S
ili ty
Ġ k
T I
as e
e m
f orm
Ġc o
en d
ĠI n
ph or
li c
Ġ L
f en
Ġe x
i b
h ar
re am
ro fen
Ġ3 0
it y
a x
O N
r an
up rofen
t h
Ġ 8
t er
iv e
in e
ra d
e ct
Ġfor mul
i al
ĠKolli phor
Ġa t
Ġc an
AS F
m a
ĠO R
e ar
Ġs p
er e
ĠB ASF
Ġcon t
Ġ G
Ġt able
en s
Ġp oly
Ġ H
ro m
Ġ5 0
i r
Ġ N
an t
d er
Ġ li
i es
i um
Ġac id
a p
l as
ut ion
sol v
Ġ y
ĠP E
Ġb y
Ġd r
Ġ 7
Ġfor m
o ur
Ġth at
o c
a il
el l
A R
form ation
Ġ 9
f er
v id
ĠP ro
y d
ĠI N
e v
Ġw h
at ed
Ġ2 0
Ġ it
Ġ U
) .
Ġf rom
u g
res s
Ġw e
en e
E R
ag e
m er
I N
ab ility
er m
p t
is t
eth yl
ĠPE G
Ġp ar
d ing
o g
c ream
TI ON
igh t
ar d
c h
Ġw ater
Ġn ot
at ing
am e
Ġapp lic
las tic
Ġsol ub
b uprofen
Ġk g
l ow
Ġ V
o x
w ax
har ma
p ro
ĠP R
an d
Ġus ed
mul s
Ġg rad
Ġ2 5
Ġin formation
an ce
ĠO F
at ure
r ate
Ġ un
ĠKolli solv
ul ar
Ġ4 00
v er
Ġa d
ly c
E D
on e
or y
i p
Ġm g
tic le
d it
O R
c ess
os t
Ġf il
I T
ĠS t
if ic
ĠKolli cream
f f
r ation
Ġs u
Ġ1 0
a v
ĠC L
Ġpro per
Ġm a
h ol
Ġp er
Ġm in
Ġd es
ĠI buprofen
ĠT h
li g
is c
red i
g redi
T A
Ġwe ight
2 5
le ase
Ġ1 2
ĠD ES
ĠKolli wax
o us
Ġs iz
ĠT able
r y
t ies
in t
Ġt em
IN G
c ent
p os
Ġan y
Ġd i
per ature
Ġo b
Ġ1 5
Ġtem perature
un t
u d
Ġm an
C T
as t
Ġin c
Ġs h
ut ical
Ġh igh
co hol
c om
al u
th er
el y
am p
Ġn ame
ĠU S
Ġgrad es
Ġa ct
ce utical
Ġo il
ili z
Ġs us
H A
um b
co at
p ical
Ġ1 00
Ġa v
Ġy our
a f
at ory
at a
I G
Ġe muls
h yd
Ġp h
ĠP h
Ġpro cess
ĠR eg
Ġp re
Ġ6 0
i x
ĠM A
Ġ r
o f
) ,
ĠIN F
ĠPR O
Ġtable t
m ent
ĠF or
isc os
ic h
Ġa b
ĠC S
if i
Ġformul ations
he n
ĠPro duct
en ce
Ġav ail
Ġcon cent
s ul
Ġtable ts
Ġre qu
Ġ4 0
harma ceutical
ff ect
Ġpoly mer
Ġproper ties
a d
id e
Ġd et
Ġn umb
ĠF ig
s p
Ġp ow
ĠKolli coat
ig n
P I
sol ution
Ġformul ation
ra y
k in
p ens
o re
ol og
iscos ity
c ri
of t
Ġavail able
Ġ [
ol ec
Ġpro vid
o v
5 5
Ġ le
he m
Ġm ix
od ium
Ġm on
ec ific
Ġd if
olec ular
Ġin d
Ġd oc
Ġob lig
an ol
Ġcon s
Ġcont ain
Ġcon dit
Ġs up
Ġ -
ĠA N
ĠP lastic
Ġ1 8
Ġl ow
Ġ ib
ĠS ol
res ent
im e
Ġsus pens
Ġa m
Ġp o
it e
it ion
ub le
us t
Ġth is
Ġ im
Ġb ot
Ġsiz e
Ġdoc um
M S
et y
a li
i le
Ġc ap
Ġin gredi
Ġoblig ation
M A
f act
Ġs he
Ġib uprofen
y s
u al
ac k
ro x
pt ion
amp le
k g
Ġ &
Ġa g
Ġs ub
Ġs oft
Ġfil m
Ġw as
Ġc h
ĠT H
l u
Ġin t
TION S
Ġdocum ent
Ġp harmaceutical
ĠS p
Ġact ive
hem ical
h n
s e
ĠTh is
low ing
g el
Ġal l
ul atory
ĠA l
A N
c es
OR MA
ĠINF ORMA
ĠINFORMA TION
N S
Ġh as
Ġdr ug
Ġcondit ions
ĠP oly
Ġex c
Ġprovid ed
. ,
ĠD A
Ġo ther
ra ct
s o
k e
l ing
p ar
Ġre fer
sol uble
lyc er
af ety
g e
p ers
Ġco ating
i o
ĠC omp
ri b
t ing
Ġf ol
Ġg ran
Ġd o
us e
pro p
Ġsh ow
n t
at ive
or l
ec hn
Ġac c
f ter
t le
qu id
ost ear
Ġdif fer
Ġ up
Ġ8 0
Ġapplic ation
Ġpow der
ater ial
v ent
Ġt ime
Ġus e
Ġ7 0
ĠDES IG
ĠTH E
ĠDA TA
ĠDESIG NS
Ġd ata
m ar
r ol
Ġdis solution
Ġli quid
Ġproduct s
y r
ili c
Ġ J
Ġh ere
Ġv alu
ĠFig ure
Ġgran ul
Ġ qu
ES S
Ġwh ich
d e
re e
av e
Ġhere in
1 0
m end
r ic
Ġb in
ĠC ON
Ġ6 4
Ġp lastic
ut ions
Ġv iscosity
vid one
t ain
Ġs e
s or
Ġcomp ress
Ġsu it
al ly
ĠC o
Ġ9 0
Ġit s
 ®
Ġd e
A L
Ġw ere
act or
eg a
Ġdis t
end ial
Ġ ethyl
or t
Ġdes cri
h t
o od
l es
ure d
lyc ol
Ġdr um
o un
Ġsolub le
Ġdet erm
Ġc om
ĠE ur
ecific ation
r uct
u fact
, ,
Ġal cohol
Ġ50 25
R AN
Ġf at
ĠW AR
TI ES
Ġcont ent
Ġapplic ations
RAN TIES
ĠWAR RANTIES
Ġ <
ĠV A
t ure
Ġ en
ĠC et
ĠUS P
Ġm ed
ph ilic
Ġm olecular
Ġre p
R I
ali ty
Ġprocess ing
Ġbot tle
Ġh yd
int eg
Ġ he
Ġsol id
Ġ est
Ġm e
am et
Ġsp ray
5 0
in yl
or age
Ġdo es
os e
act er
ib le
Ġun der
Ġfol lowing
ĠI t
Ġsub st
il l
ĠD is
Ġma y
Ġdist rib
T H
Ġt est
er y
w e
Ġ1 9
Ġh ave
a ce
Ġinc re
com mend
U R
Ġc har
is h
Ġre commend
qu e
ethyl ene
o ut
Ġsu ch
I D
P R
Ġg lycol
Ġsoft gel
i ent
Ġs kin
Ġc ream
Ġe ffect
Ġman ufact
Ġshe et
li ev
Ġin soluble
00 0
ry st
r on
Ġ ro
Ġk olli
Ġpar ticle
li ed
ĠA r
ĠA PI
Ġus ing
iz ed
Ġform s
Ġv ery
Ġ =
it s
ĠP lease
Ġsolub iliz
ro s
ĠP S
Ġsol ution
Ġper form
as ed
ĠA c
ug h
ĠP AR
Ġfat ty
IT H
D ING
M P
p o
Ġ Q
Ġe e
ĠReg ulatory
Ġsup p
L L
al l
Ġst ear
Ġman y
ar y
ĠF OR
and ard
Ġnumb er
i ev
Ġ ran
Ġingredi ents
l in
ĠF ine
Ġcomp endial
Ġwh ite
and ling
ver y
sp ect
Ġsuspens ion
orl d
Ġchar acter
Ġph ase
ĠA s
4 0
Ġm od
iv id
Ġa fter
Ġb et
ut e
Ġcomp le
ĠL A
ĠFor mul
at es
Ġb l
os age
ĠI P
Ġconcent ration
ur ing
olog y
que ous
i a
i ents
in ed
Ġm m
ĠP ar
Ġre l
Ġdis pers
ĠAN Y
Ġexc ip
Ġdiffer ent
sor b
Ġcompress ion
m olli
c y
u e
Ġp ur
Ġm eth
ĠC AS
Ġal so
a y
Ġo ur
Ġre sul
h ib
Ġa queous
Ġf actor
Ġre g
N o
U CT
Ġon ly
ĠPR D
we en
UCT S
C RI
T E
os ition
ĠB E
ĠN O
ĠDES CRI
ĠPRO D
oun d
ivid ual
a red
v inyl
ĠPROD UCTS
y pical
Ġg ood
Ġbet ween
Ġs odium
ro g
Ġst orage
Ġacid s
echn ical
Ġd osage
ĠS afety
ical ly
ĠW h
ostear yl
r it
ro ugh
Ġto pical
ĠMA E
de hyd
m ega
Ġad d
re ct
Ġs y
Ġrequ i
o u
o ic
at ely
Ġm aterial
Ġac et
k ing
ĠC hemical
Ġbin ding
C L
Ġ eth
Ġb ene
ĠA pp
Ġ2 00
ĠE X
ifi er
Ġbene f
m ents
Ġsol utions
Ġapp rox
ens ity
ĠAl cohol
N TA
Ġor al
ĠW ater
Ġpar tic
e el
Ġm el
ĠBASF s
Ġdr y
Ġad dit
Ġmix ture
d u
o p
Ġg el
ĠR E
Ġrequ est
Ġind ividual
1 9
a use
r ig
ĠAr ticle
an ces
Ġth rough
Ġn on
v ed
Ġ olli
Ġc ur
il y
Ġn e
ic s
ra ph
Ġex t
Ġup on
ĠIP M
re a
ro duct
hyd rate
Ġc ryst
Ġm ax
ot h
rol id
% ]
al es
ĠIn formation
ĠIn gredi
Ġy ou
yr rolid
ĠFormul ation
S E
n ess
ĠS odium
Ġnumb ers
2 0
N F
er al
Ġran ge
Ġp ack
Ġin f
Ġ1 7
Ġrep resent
Ġpur pos
Ġbenef its
D I
ol e
re nt
Ġst ir
3 4
m in
Ġint o
m o
Ġd ensity
as f
Ġfil l
sul es
Ġdistrib ution
a en
i od
ĠP harma
Ġw ell
dehyd e
u id
an ts
IT Y
Ġcap sules
prop yl
PR ESS
Ġmanufact ured
ĠEX PRESS
4 4
Ġo ver
co unt
ag n
ĠCON DI
ĠCONDI TIONS
in al
es ts
is tic
Ġ30 55
lycer ol
Ġdrum s
yrrolid one
en cy
Ġdi rect
p oly
Ġp ress
Ġp resent
s u
Ġan t
as es
Ġex ample
ac h
og raph
l am
Ġp ri
ĠC on
ul l
Ġe v
ĠCet ostearyl
Ġsubst ances
a k
Ġ x
le ct
Ġre t
Ġg uid
Ġmed ium
Ġpartic ular
c ed
Ġth ere
Ġdis integ
Ġcons ist
Ġcomple x
p m
Ġs ur
Ġs ign
s ist
v e
Ġro om
p e
Ġdes ign
pos it
Ġsuit able
Ġfactor s
C U
ut es
ĠE E
Ġth an
Ġsp ecification
rea ding
P O
l o
ul d
om ers
Ġst andard
ub ric
Ġgrad e
I L
li z
Ġbe en
Ġl oc
Ġ[ %]
b asf
Ġin st
Ġg iv
Ġcon st
ĠE n
Ġgranul es
Ġest er
ĠAPI s
Ġcur rent
R PI
Ġs ales
Ġm ain
Ġm ore
Ġ2 4
ĠO D
Ġst ability
ĠPEG s
Ġguid ance
L I
on g
ĠS E
Ġre lease
Ġ5 00
Ġal dehyde
em b
Ġim p
. .
B IL
he d
he s
Ġ1 1
ĠI MP
ag ing
ĠSol ub
CL U
ĠIMP LI
ĠAN D
Ġcharacter istic
BIL ITY
ĠIMPLI ED
3 0
Ġ rate
Ġn o
ĠE x
ĠCS A
P A
Ġw ill
im ately
Ġsolub ility
pro duct
Ġvalu e
Ġvalu es
Ġbl end
Ġexcip ients
1 1
Ġv ar
Ġmon th
ĠQ u
aen oic
o uld
p end
ion al
Ġf a
Ġf ree
is ter
as s
Ġ3 00
Ġst able
Ġsiz es
TH ER
Ġt ests
Ġp H
ic k
Ġor ig
Ġdis solv
Ġadd ed
Ġloc al
. :
Ġc ol
Ġf ull
ar k
Ġbe liev
ell ow
par ation
Ġbeliev ed
ĠD C
Ġsp reading
Ġma ke
ĠTable t
Ġconst it
3 8
m l
p yrrolidone
r ing
ĠA n
ĠM ed
ĠPh ase
olog ical
Ġshow n
g an
v el
ĠI I
Ġapp lied
amet er
Ġh um
iv ely
ĠR e
Ġli po
ifi ed
Ġsuspens ions
ĠComp osition
Ġrepresent ative
F ig
e is
Ġc ar
al c
Ġme as
Ġmeth od
ol ox
Ġo mega
Ġthe y
ĠP H
Ġdescri ption
Ġdeterm ined
ĠQu ality
olox am
e e
ul k
ĠI l
Ġmin utes
Ġacc ur
Ġen h
hib it
B L
o red
li very
iz e
ver age
Ġemuls ions
Ġim pro
ĠWh ile
g es
es ium
ĠK IN
ab iliz
el le
ĠM CT
Ġcomp on
ĠSp ray
tain ed
Ġstear ate
rog ol
agn esium
) -
o vidone
t o
ox y
lam m
H T
v ents
Ġ ra
in s
Ġ8 5
erm e
Ġpo int
Ġingredi ent
ister ed
D E
E ur
Ġin spect
id es
molli ent
Ġpri or
C HA
N ESS
U AL
c c
m on
Ġa ir
Ġo d
ĠF IT
ĠM ER
ĠE PA
Ġl a
ĠIN CLU
Ġle vel
Ġ5025 9
Ġdispers ion
NTA BILITY
Ġvar i
ĠKIN D
CHA NTABILITY
ĠFIT NESS
ĠMER CHANTABILITY
L AR
R ING
V ID
c ell
g ally
Ġs lig
Ġthe ir
ĠP UR
ĠD i
ph ar
ĠB ec
ĠW ITH
TI CU
Ġy ellow
ĠPRO VID
Ġle gally
Ġplastic iz
ruct ure
ĠPAR TICU
Ġpack et
PO SE
Ġfa ith
Ġconstit ute
Ġaccur ate
ĠINCLU DING
Ġslig ht
ĠPUR POSE
ĠBec ause
ĠPROVID ED
ĠPARTICU LAR
6 0
Ġb el
Ġco unt
amet ers
ĠPharma co
phar ma
i or
er ated
ro p
Ġm emb
Ġb ased
Ġ4 5
Ġl ubric
ĠSp ecification
a re
Ġs afety
Ġf lu
Ġm ost
ĠO THER
Ġconcent r
Ġdeterm ine
liz ation
cell ence
w o
en et
ion ic
Ġ( +
ri es
erm an
Ġdrug s
sorb ate
Ġcount ries
X cellence
d is
f ore
Ġpro f
Ġh ard
ac rogol
Ġs ens
Ġe as
ĠW orld
ap ent
Ġde livery
Ġlipo philic
l ud
r ug
os apent
ĠG MS
Ġph ys
Ġ40 7
rig lycer
gan ic
Ġs iev
Ġm ic
Ġb ut
iz ation
lic ations
Ġr pm
D S
L S
o ist
Ġ et
Ġin ter
ĠA R
ce pt
pt ions
Ġmon ograph
Ġtest ing
Ġpresent ed
Ġret est
o am
r yl
Ġe qu
Ġv it
un ct
Ġex p
ev er
Ġper iod
T Y
j ect
Ġt wo
Ġp l
Ġthe se
ĠT ot
ĠS LS
Ġh om
ĠM aterial
Ġst ored
ĠReg Xcellence
Ġcontain ing
Ġsheet s
Ġsolubiliz er
ĠPar ticle
ĠTot al
c ial
n e
Ġt ypical
er os
he x
Ġp erme
Ġc ust
Ġm at
Ġv ers
Ġwith in
Ġsol vent
ĠL ud
ĠH andling
ific ant
Ġsup posit
Ġsign ificant
Ġmonth s
4 8
: /
e al
Ġa ffect
Ġa verage
Ġc ros
al m
Ġsol vents
Ġ6 00
Ġpre p
Ġsuit ability
eis mar
t p
Ġre ad
ĠD e
Ġform ation
mer cial
Ġcust omers
c m
t ect
Ġo x
Ġw hen
Ġ3 5
od ine
Ġpoly vinyl
ĠSt ear
amp les
Ġdet ail
Ġ18 8
Ġhyd ro
Ġcryst al
:/ /
4 7
A c
K olli
O U
Q RPI
s lin
v ant
Ġst ructure
rad es
Ġpoly ethylene
pos al
kin et
Ġch an
Ġdescri ptions
Ġpurpos e
Ġbel ow
oist ure
Ġcros slin
4 9
er t
le t
Ġ1 3
Ġpro p
Ġh t
ith er
Ġhigh er
Ġind ic
Ġqu ality
ĠSolub ility
erman y
kinet ics
s w
in ate
Ġt rad
Ġp ail
ĠS AL
Ġre du
if y
Ġincre ase
Ġsoftgel s
Ġht tp
S F
V P
Ġt ast
Ġan sw
ĠT ER
Ġfor ce
Ġh andling
ĠE muls
ĠE ITH
Ġco poly
ĠIn t
ĠG eismar
Ġun t
Ġcontain ed
Ġreg ulatory
Ġeth anol
Ġaddit ion
Ġansw ers
ĠEITH ER
9 7
E CT
G AR
P ER
P TIONS
S ID
a e
e w
f ace
Ġc le
Ġc hemical
ĠC P
ĠT HA
ĠI R
ĠS HA
Ġre liev
ĠR IG
Ġco ol
ĠIN TE
ER ED
ĠUS ED
ĠMA Y
ĠMA DE
ĠINF RING
ĠPRO PER
ov e
ĠCON SID
ĠPAR T
ĠFOR TH
ĠCAS E
ĠDESCRI B
ĠDESCRI PTIONS
Ġmel ting
ĠRE GAR
roduct ion
Ġdesign s
ĠSE T
Ġcompon ents
ĠWITH OU
ĠOTHER S
ĠWorld Ac
ĠAR E
Ġexp ress
ĠSAL E
ĠTER MS
Ġunt il
ECT UAL
ĠTHA T
ĠSHA LL
Ġreliev e
ĠRIG HT
ĠINFRING ING
ĠPROPER TY
ĠCONSID ERED
ĠREGAR DING
ĠWITHOU T
ĠWorldAc count
n al
t ed
y m
il d
ran s
Ġsp ec
ell ing
Ġam b
Ġpo vidone
Ġalcohol s
LL ECTUAL
Ġvari ous
ĠINTE LLECTUAL
ĠDESCRIB ED
ĠRIGHT S
1 5
b o
Ġs c
Ġd er
Ġd ev
Ġ1 6
Ġst abiliz
Ġwh ile
ĠCo ating
ĠIngredi ent
Ġpress ure
ĠInt roduction
8 0
ĠP VP
ĠO UR
ĠR H
Ġproduct ion
Ġpar ameters
Ġinc lu
ĠDis integ
Ġinspect ion
Ġinclu ding
m ac
at ur
an e
ĠT o
ĠD es
yl ene
Ġv ia
ron ov
Ġ3055 44
ĠPharmaco kinetics
riglycer ides
P h
l and
re at
cri ption
Ġag ent
ĠPoly sorbate
Ġ5025 3
Ġapprox imately
Ġmain ly
Ġmemb ran
Ġprep ared
) :
I S
h iev
m ers
m ost
Ġs af
Ġf ound
Ġw ax
Ġac hiev
Ġal most
ĠG lycerol
ip ress
Ġqu ant
Ġinst ruct
Ġsaf e
l odine
on st
Ġf low
ĠP ack
ĠA fter
Ġon e
Ġemuls ifier
Ġconcentr ations
Ġt echn
ĠT echnical
Ġre spect
ĠD rug
ĠR I
st ag
Ġdis posal
em ark
ib ility
ĠH ard
our nal
ifi ers
ĠJ ournal
Ġrecommend ed
Ġimp ort
ĠMed ium
Ġhom og
Ġinstruct ions
stag land
v ers
or s
ic ological
ĠD HA
ĠThe y
orl ess
Ġacc el
Ġcom mercial
lin ical
Ġmod el
Ġolli cream
Ġslight ly
Ġder iv
ĠDes cription
ĠRI BL
2 2
f ul
p hen
Ġ ent
Ġa r
Ġp elle
Ġm oisture
Ġb ar
ĠT ypical
ĠS A
ĠS up
Ġal low
st em
Ġpar t
ox ide
MS DS
Ġshow s
Ġresul ts
Ġant i
Ġphys ical
Ġaccel erated
c on
l us
y c
Ġf in
it ies
Ġd em
ĠA d
ĠD O
Ġst ar
Ġth ree
ĠW ith
Ġbot h
ĠAc id
Ġacet ate
Ġflu id
Ġamb ient
3 9
m m
at us
at ch
Ġf ish
Ġan al
Ġb ag
ts eal
Ġwh ere
Ġtemperature s
Ġab ove
mar tseal
Ġconsist ency
dis pers
L ab
Ġ um
Ġo cc
ĠC l
ĠC ream
Ġbe h
ĠN o
Ġacc or
Ġgranul ation
Ġsy nt
Ġread ily
l or
s ible
Ġ _
er ic
it ive
om ega
os a
Ġor ganic
ĠE L
ri ability
ĠW hen
ĠU n
Ġab out
Ġplasticiz er
ĠPack aging
Ġdem onst
2 1
8 5
e p
t en
at h
Ġs om
ĠT rad
am in
el op
ĠE th
iv es
Ġsp e
ox yl
yr ist
Ġse lect
Ġde pend
ros co
Ġdisinteg ran
ĠLud ipress
Ġdev elop
Ġimport ant
Ġm ust
ĠS he
ĠA mo
Ġ3 3
ĠL ys
las s
Ġag ents
Ġbin der
ĠSpray ing
ĠAmo unt
o id
r al
or ph
Ġwith out
res h
im um
Ġinc lud
Ġemuls ion
Ġest ers
ĠDis solution
Ġcream s
Ġrequi red
Ġgiv en
Ġmeas ured
oloxam er
z ole
Ġ >
Ġ ens
ion ized
ro sp
Ġd uring
ĠS martseal
Ġe very
Ġ2 2
ail ability
ĠPro p
av ailability
Ġdi ameter
Ġsh ould
Ġlow er
ust ry
io availability
all ine
Ġsy stem
enet ration
ĠDe ionized
Ġtrad emark
Ġcopoly mer
g ht
h a
m ic
p id
t e
Ġ %
Ġs ent
Ġc a
an s
as ing
Ġcomp ared
act ose
Ġli ght
ign ment
Ġcons ignment
Ġcom b
Ġsubst ance
Ġstir ring
Ġorig in
lamm atory
unct ion
Ġpelle ts
osa hex
2 6
P roduct
Ġt rans
en eral
Ġf ine
Ġof f
ĠP re
ĠC linical
am es
ur ther
ac id
Ġformul a
vid on
Ġsupp ly
Ġexpress ed
i i
o om
Ġ @
Ġ Z
Ġs mo
Ġto x
Ġre m
Ġg ermany
ow n
Ġst ud
ĠN ame
Ġconcent rate
ĠIngredi ents
Ġhum id
oom Lab
at in
Ġs o
Ġs ample
Ġp ract
ic osapent
Ġb u
ent ial
har mac
ip ment
Ġdi hydrate
Ġpre paration
Ġhe at
Ġev en
ĠEx ample
Ġod or
Ġlevel s
Ġmembran e
Ġbeh av
% .
1 8
t ual
Ġc it
Ġb ox
ul f
ĠB ulk
ĠM on
res er
ir tual
Ġob tained
ĠPoly mer
par ate
molli ents
Ġrequi re
Ġeth er
Ġsur face
ĠDi hydrate
Ġcle ar
bo ard
3 1
d ers
y g
z ym
Ġs em
Ġd ue
Ġb ro
id er
Ġpro tect
ri ed
Ġl ess
Ġ8 7
ĠV iscosity
Ġqu ick
Ġsupp lied
Ġsignificant ly
Ġcrystal lization
ify ing
ĠHard ness
Ġbehav ior
L B
f ol
l ess
u x
Ġp lease
Ġ1 4
ostear ate
Ġvers ion
Ġcrosslin king
Ġhumid ity
2 7
Ġm ol
Ġpoly mers
ĠH C
ĠH LB
Ġcons ider
ĠCon t
c ip
e ight
i red
t ab
w elling
Ġs m
Ġf ast
is e
Ġre le
ĠF riability
lic ation
Ġcont act
Ġpre vent
ĠAl l
ract ion
,, )
ĠCet yl
Ġhyd rox
Ġcomplex es
Ġperme ation
rosp ovidone
o unt
ol l
Ġs ame
ĠP harmaceutical
el d
Ġst atus
ot ri
Ġas s
Ġcomp ound
ES E
em ent
Ġapplic able
Ġam ount
prop anol
sor ption
rog en
7 0
a ke
g rades
l l
Ġp at
Ġc ell
Ġthe n
Ġm ild
ĠA t
Ġ2 6
il es
ĠM agnesium
igh ts
ma zole
Ġsp ecific
ĠN ov
Ġme et
Ġperform ance
Ġolli wax
Ġcar b
Ġ(+ )-
Ġhydro philic
ĠCl otri
Ġens ure
osahex aenoic
ĠZ oomLab
Ġcit rate
ĠClotri mazole
a ys
m ed
Ġf oam
ĠP F
ĠP G
Ġw id
Ġe mollients
Ġ2 1
ĠD ue
sol id
Ġcomp ar
ir st
ĠPro stagland
ĠSt andard
Ġdif f
ĠJ P
ace mic
Ġpurpos es
Ġthere fore
ĠDisinteg ration
ĠLys inate
O M
i eld
p ic
in f
at ively
or ies
Ġp harma
Ġc et
Ġo int
al e
Ġd ate
Ġe ither
ow ever
Ġst eel
ter n
Ġint end
Ġdiffer ence
Ġsur fact
Ġquick ly
3 5
3 7
r ated
w n
Ġt riglycerides
he tic
Ġw et
ul t
Ġ3 6
Ġh ad
Ġ9 6
Ġoil s
ĠReg istered
ĠSol id
Ġcom mon
Ġkolli phor
Ġexcip ient
Ġne ut
Ġev alu
Ġenh ance
Ġla w
Ġmonograph s
Ġocc ur
ĠShe et
Ġsm all
Ġintend ed
1 2
c i
k s
v i
Ġ +
Ġp ain
Ġp las
Ġin v
ĠC c
id ae
Ġh our
ĠThe se
ri x
Ġl ot
ear ance
Ġli ke
ell ent
ĠV irtual
ĠUS A
Ġag re
PR ESE
ĠAs sist
sorb ed
NTA TIONS
ĠRE PRESE
Ġimpro ve
Ġyellow ish
Ġhomog en
Ġplas ma
ĠREPRESE NTATIONS
% )
P ure
a Pure
e qu
Ġe ach
ur yl
ut yl
Ġn or
ĠD ata
ĠO mega
ĠM ax
ot e
ub lications
ri er
Ġus ual
ac ity
Ġ7 5
alu e
Ġexc ellent
ĠAc et
ronov aPure
icosapent aenoic
ulf ate
- (
T echnical
m ol
n ot
n ter
Ġc yc
ur b
ĠE mollient
Ġform er
ff ic
ĠTh ere
Ġch ain
Ġcoating s
Ġse parate
Ġgel atin
Ġinf lu
. -
S P
T able
a ff
c er
r at
y Product
is ed
Ġin hibit
Ġpro du
Ġst ron
Ġor der
Ġv ol
Ġco res
ter ature
Ġli terature
ĠPro cess
ist ration
Ġtablet ing
Ġcap acity
oun ts
Ġincre asing
Ġglycol s
Ġresul t
Ġdry ing
su es
ĠCon sist
Ġprof iles
Ġsupposit ory
Ġsom e
Ġsmo oth
Ġsem i
Ġstron g
r ast
y lic
y pe
Ġ if
Ġc ent
Ġf irst
ic e
ent hol
ĠS e
Ġre li
Ġ3 8
ĠR acemic
Ġapp ro
ĠL P
Ġcont rast
ĠH yd
rop ri
Ġwax y
Ġquant ity
Ġaccor ding
1 6
a lic
n own
y n
Ġs low
Ġs amples
Ġc ase
Ġf resh
Ġf unction
ĠKolli tab
ĠM acrogol
ĠW eight
Ġl ong
ag es
Ġapp ropri
Ġab ility
Ġind ustry
Ġfilm s
Ġdissolv ed
Ġchan ge
Ġderiv ed
Ġtox icological
Ġpract ically
Ġbox es
Ġrele vant
ĠMax omega
alic ylic
4 2
9 2
i an
m ethyl
Ġ Y
Ġc l
Ġf urther
Ġm u
ĠP harmac
ĠI ts
Ġcon vent
Ġsol e
ĠH owever
ĠN e
ress ion
Ġpre par
Ġr ich
ĠComp endial
Ġfol low
min istration
Ġorig inal
are nter
Ġdetail s
phen yl
zym e
Ġconvent ional
1 4
2 00
b ed
Ġ i
ic ture
Ġm acrogol
Ġm ult
ĠM olecular
ĠE ux
Ġcont rol
Ġ50 34
ap e
Ġ9 5
Ġma de
ry lic
ast or
Ġhigh ly
Ġmix er
Ġpo or
Ġcap su
so propyl
Ġsolid s
Ġ19 9
Ġperform ed
Ġenh an
pharma ceutical
Ġequ ipment
ĠStear ic
med i
Ġprepar ations
ĠEux yl
t al
Ġ ly
re n
Ġf ib
Ġm ass
Ġd eg
Ġd ried
ĠC or
Ġn ames
ĠO ral
iv al
Ġcomp li
Ġ8 00
ĠApp lication
Ġne ed
Ġ3055 47
Ġlubric ants
Ġeas y
Ġsiev e
Ġmat rix
yrist ate
O H
f or
f rom
f fer
m p
y st
in d
en er
Ġp e
Ġp os
Ġm agnesium
ĠP ovidone
ĠP ronovaPure
ĠO A
Ġv eg
un d
Ġ6 8
eth anol
per ties
ĠComp ression
Ġincre ased
Ġacet one
Ġcol orless
Ġprof ile
ĠNov ata
arenter al
Ġveg et
M E
W orld
m g
p a
Ġa id
er ol
Ġs et
Ġp un
Ġp ort
Ġof ten
ĠC h
ĠI sopropyl
ĠA eros
Ġe mollient
Ġ3 4
um mar
ĠM an
ĠM yProduct
ĠR et
Ġformul ated
ial ly
ĠTable ts
Ġemuls ifiers
Ġle ast
Ġam ounts
Ġkolli don
Ġresul ting
Ġext r
Ġext ract
Fig ure
dispers ion
rosco pic
fol io
ĠConsist ency
Ġfib er
Ġport folio
in ation
Ġt ri
ol ar
Ġc or
Ġc alc
le x
Ġn atur
ph ate
Ġv is
Ġal k
Ġ30 6
ĠN a
Ġr at
Ġch lor
ĠPoly ethylene
propyl ene
Ġdisinteg ration
Ġlubric ant
Ġvit ro
Ġrespect ively
Ġanal ges
Ġsynt hetic
Ġspe ed
Ġoff ers
e f
Ġf eel
ĠP ublications
ĠS ize
ĠG U
oc osahexaenoic
ĠPro perties
Ġab sorbed
Ġmix ed
Ġtest ed
ĠWh ite
ryl ate
Ġtechn ology
Ġstar ch
ĠTrad en
M enthol
y p
z z
Ġ j
Ġt is
er tain
li s
Ġp enetration
Ġp arenteral
Ġis o
ĠF orm
Ġcomp os
im ent
Ġsp ect
Ġfil ling
ĠSt eel
ht ml
Ġhe ating
Ġcryst alline
Ġhttp s
Ġtast e
ĠPre paration
Ġdiff raction
ĠPharmac ology
5 9
o b
re g
Ġs welling
Ġp ass
Ġc re
Ġo ut
it ation
Ġb ulk
ent ly
ĠT ri
am ine
up s
Ġth ick
Ġ6 7
est er
Ġk N
ear ate
ĠH e
Ġpow er
Ġmix ing
ĠSol vent
Ġrel ative
iod ine
Ġpolyvinyl pyrrolidone
reser v
Ġpat ients
Ġappropri ate
Ġcapsu le
Ġrat io
1 3
o ph
en ing
Ġp m
Ġp alm
Ġf ra
Ġb od
ĠS R
Ġre sp
Ġe pa
Ġ3 7
ĠB l
co yl
Ġcomp at
ac et
ac rylic
ain t
ĠG eneral
ap rate
oc aprate
erm ore
Ġact ion
se e
Ġ90 10
Ġdistrib utions
Ġsolubiliz ation
Ġpack aging
oloxam ers
ryl ocaprate
Ġhour s
Ġappro ved
Ġcalc ul
reserv ative
L Y
T he
g ed
l ed
Ġa ut
in es
Ġt reat
Ġs our
ĠP icture
Ġb est
ĠA S
Ġre st
el ess
ĠM ix
Ġv inyl
Ġk nown
ĠL ow
Ġ12 0
Ġshow ed
ĠCo coyl
Ġcharacter ization
Ġreg ul
ĠApp lications
Ġmel t
Ġinst ant
Ġgiv es
ĠStear yl
Ġdetail ed
Ġtast eless
Ġstabiliz e
Ġdemonst rated
Ġca us
Ġcompound s
Ġpoor ly
Ġveget able
Ġbod y
5 7
7 9
R OM
c ing
r am
Ġt ol
Ġof fer
ĠA b
ĠE ther
Ġ6 9
Ġl actose
ĠIn d
ĠH um
Ġwe ights
Ġse e
Ġ17 5
Ġparticular ly
hibit ed
lamm ation
Ġox ide
ĠEth yl
Ġdevelop ment
Ġfoam s
Ġwid ely
Ġinflu ence
ĠY our
Ġmu ch
ĠMyProduct World
ĠRet est
Ġtis sues
6 3
i er
l buprofen
o k
y ear
Ġf ail
Ġw ould
et ary
id ent
ĠS ee
om mend
ĠA m
ur al
ili s
ec ommend
act ions
ĠIn let
Ġ8 2
Ġli m
ene ous
erm at
muls ifier
Ġab sorption
Ġle ad
ruct ural
Ġrel atively
Ġcharacteristic s
Ġmethod s
Ġra pid
Ġsens ory
Ġsens itive
Ġmic ro
Ġent eric
Ġdisintegran t
ĠPG s
Ġneut ra
Ġprodu ced
ĠAeros il
Ġresp on
2 8
4 5
j or
m olecular
p re
s alicylic
Ġ .
er n
Ġm ark
Ġd el
ĠP oloxamer
ĠT alc
Ġto co
um e
yl salicylic
ph erol
ec re
co ating
ĠIn f
Ġ9 7
ER E
Ġdes ired
Ġshe ll
po e
Ġsupp le
hib ition
Ġext ent
Ġstir red
Ġindic ation
Ġrem ain
Ġconsider ed
Ġcarb on
Ġenhance ment
vi ew
ME N
Ġanalges ic
Ġrest ric
Ġrespon sible
Ġtoco pherol
A I
A CT
I A
a pp
h an
i os
o vidon
t ion
ol s
en ces
Ġf aint
an n
Ġw rit
ĠC rospovidone
ĠT ox
Ġpro m
ig ment
ĠD IS
ĠF actor
ĠF ROM
if ies
Ġco vers
ĠH ERE
ant i
AR AN
Ġ9 00
ĠSt ructural
Ġsus tained
Ġshe ar
TE ES
CL AI
ĠApp rox
Ġmax imum
ĠEXPRESS LY
ĠEmuls ifier
Ġspec ified
orph ous
Ġoint ments
Ġsurfact ants
Ġlaw s
ĠGU ARAN
Ġfra ud
Ġdel ay
MEN T
ĠDIS CLAI
ĠGUARAN TEES
ĠDISCLAI MS
E C
E E
d i
Ġ end
Ġt echnical
Ġc ertain
is m
it is
Ġm isc
Ġw ide
ul a
ut ed
Ġn ec
ĠF oam
ĠE ffect
st ract
od el
Ġcomp r
Ġl o
est ig
ess ary
ĠSt ud
ific ation
iliz ation
Ġemuls ifying
Ġmon o
Ġam ong
Ġse al
ĠQ RPI
Ġfill ed
Ġdesign ed
Ġimp act
Ġimpro ved
Ġeas ily
Ġpl ace
Ġstud y
yg roscopic
ĠHC O
Ġvol ume
Ġnec essary
5 2
8 7
G MP
_ _
c ryst
g th
r in
Ġ ident
on d
er ved
Ġs ummar
Ġp ot
Ġc ases
Ġc astor
Ġf l
Ġin hibition
Ġd ha
Ġd ays
ul ose
ab ly
us ion
Ġre ac
Ġg ro
Ġh ist
ĠB ioavailability
ĠM ar
Ġst ic
ty pe
Ġli ability
ard board
ch ain
Ġ25 0
ĠSt orage
Ġab stract
Ġcontain s
Ġcondit ion
Ġmanufact uring
Ġmeth anol
Ġla uryl
Ġequ ival
Ġcool ing
Ġachiev ed
Ġbar rier
Ġselect ed
Ġbu ffer
Ġinv estig
Ġly s
Ġiso propanol
ĠBl end
2 9
l a
t able
u ary
w orld
Ġ es
en ed
Ġm et
Ġb atch
ĠC ar
ĠT G
ĠT est
Ġto tal
ĠS oft
Ġre s
ur th
Ġg reat
ĠO rig
ĠF urth
ĠB in
Ġst ep
up lus
ĠW F
Ġon to
ag ram
ac count
est inal
iz ing
ĠU s
Ġmin im
Ġdi etary
umb er
Ġpow ders
Ġliquid s
Ġcompress ed
Ġgel s
Ġhum an
Ġ50259 49
Ġsupposit ories
Ġredu ce
Ġallow s
Ġcell ulose
inf lammatory
ren gth
world account
ĠFurth ermore
b ased
e ur
g ra
r um
r ich
s ue
t ake
Ġ ut
Ġp pm
it amin
ĠS yn
Ġe ffic
Ġ2 8
um in
ĠO ct
ĠB io
ĠM eth
Ġ5 7
Ġco ated
Ġpar aff
ard s
ĠSt ability
Ġdi agram
ĠCS S
Ġmon ostearate
so b
Ġmed ian
Ġmeas ure
Ġhard ness
ĠAd ministration
ĠEL P
Ġdisintegran ts
Ġcomb ination
Ġpos sible
lis hed
Ġsupple ments
ĠApprox imately
ĠEffect s
Ġstic king
ĠOrig in
Ġparaff in
% ,
. ?
. ),
I buprofen
M C
b e
b r
f e
o per
p or
Ġ iodine
Ġs er
Ġp oloxamer
Ġo wn
is on
is es
Ġm orph
ĠC ardboard
as ter
Ġto w
ut ics
Ġh and
ĠB rit
Ġst rength
Ġbe c
ĠR ecommend
co us
Ġal umin
Ġad vant
Ġprocess es
ĠSol uplus
tain ing
RI BL
Ġran ges
ĠPar ts
ĠApp earance
ĠEn anti
Ġdissolv es
Ġra w
Ġperme ability
ĠProstagland ins
Ġcet ostearyl
Ġmorph ology
ĠBrit ish
ĠEnanti omers
S t
U SP
b al
c hes
e y
l an
n f
z ed
Ġ ed
re ater
Ġc lass
ed es
Ġw or
il ling
ot t
Ġim medi
prop an
Ġeffect ive
Ġsolubiliz ing
Ġaddit ional
oth er
ach ine
oxy ethylene
alm it
ĠUn der
Ġcyc lo
Ġinhibit ors
ĠTraden ame
Ġtow ards
0 8
1 00
5 00
7 5
E mulsifier
e ine
in er
on ic
at or
Ġs ug
Ġs ulfate
Ġf lex
it an
Ġm l
Ġd ated
Ġb ioavailability
ĠT urb
om at
Ġis sue
el s
Ġg lass
Ġ3 60
ig ure
ĠM in
ers edes
Ġth us
Ġac cess
Ġcomp osition
Ġus er
ĠG rades
hyd ro
ĠPoly vinyl
Ġro t
Ġkolli wax
Ġstear yl
Ġbl ood
Ġrequi res
Ġspec ial
ĠSup posit
Ġlot ions
Ġextr usion
reg istered
Ġtreat ment
4 000
M F
i ot
Ġs ed
Ġp ost
Ġo pt
ĠP hen
ĠP ovidon
Ġb ed
as er
ab or
am ily
ĠD P
ĠF at
ĠE v
Ġl aser
im p
act ion
orm al
Ġapp ly
ect ion
Ġ10 2
ous ly
Ġ15 0
Ġ100 0
Ġprovid e
Ġcons equ
Ġam orphous
Ġpo vidon
Ġag ain
Ġsub ject
gel s
Ġrefer ence
ostear y
we ight
Ġmel ted
Ġpri mar
Ġ300 34
Ġdissolv e
Kolli don
Ġcool ed
Ġflow ability
ĠProp ylene
ĠMon ostearate
rogen ated
Ġenhan cer
Ġfeel ing
Ġcre ate
Ġmark et
propan oic
. )
. ;
8 6
C E
c or
h er
i ation
Ġ ir
Ġ ide
Ġ 000
en zyme
Ġs ev
Ġp et
Ġp olar
Ġf amily
ic t
Ġb io
ĠT g
Ġg lycerol
Ġh ot
Ġcon c
ĠF ish
ĠM odel
st er
im es
ib iot
Ġ30 5
ran t
rad ation
Ġma jor
Ġpolymer ization
Ġse en
ort ed
Ġhe ad
Ġ19 0
Ġkolli solv
Ġstear ic
ced ure
Ġconsist ing
ĠEn d
ject ion
Ġ50253 25
Ġprotect ed
Ġmeet s
Ġagre ement
Ġdeg radation
yst earate
Ġnatur al
Ġvis cous
zz le
Ġequival ent
Ġlys inate
Ġbec ause
ĠRecommend ed
ĠTurb ula
Ġide al
Ġpet rol
6 2
B C
O r
S C
f lowing
Ġ X
Ġ ~
Ġa p
er ape
Ġp ronov
al ine
Ġb o
Ġb ack
ĠC om
Ġfor ces
Ġ2 3
ig ments
ĠD ist
ĠO n
ĠB oth
ĠM yristate
if f
Ġ6 5
Ġl ar
ĠL actose
Ġex cept
ap ure
Ġform ing
Ġun d
Ġpharmaceutical s
ĠSp ecific
rib ution
ĠCo enzyme
Ġeffect s
Ġinf lammatory
Ġblend ed
Ġplasticiz ers
eros ol
48 7
Ġachiev e
Ġquant ities
ĠTrad e
Ġfiber board
ĠHe at
Ġregul ation
ermat itis
Ġseal ed
Ġpronov apure
ĠDist ribution
7 8
9 5
c osapent
k ed
r il
v alue
Ġ el
Ġa e
Ġa erosol
er ance
at um
re lease
li min
Ġp le
ic ov
Ġd id
Ġd rop
ĠS icov
Ġe le
il m
Ġn um
Ġn ormal
ĠD ry
ĠO ver
ra ch
Ġst ress
Ġ5 5
co poe
Ġdis c
Ġco con
ĠL CE
Ġex per
Ġacid ic
Ġform ed
ox id
Ġad hes
Ġmin imum
ĠTh io
Ġ12 2
Ġav oid
Ġde f
Ġsolubiliz ers
Ġdispers ions
Ġne ither
Ġfill s
mon th
Ġsiev ed
Ġtypical ly
Ġprop ylene
vers ible
ĠSup ersedes
Ġanti oxid
Ġspe ak
ĠAssist ant
ĠMan ufact
ecre cy
ĠTox icological
Ġdelay ed
ĠStud ies
Ġreac hed
ĠPovidon es
Ġpetrol atum
ĠSicov it
Ġcocon ut
0 6
E icosapentaenoic
P C
T U
b ran
c end
l sob
t ely
Ġ /
Ġp ale
Ġf re
al s
ĠP oloxamers
ĠP reservative
ĠC ap
ĠT riglycerides
ĠI g
ĠA v
Ġre cept
os phate
Ġ3 2
Ġ3 38
ra red
ĠB ro
ĠM ic
up ert
Ġ4 2
un g
ec ially
Ġl buprofen
Ġex hib
th rit
th ases
ĠH S
Ġli st
Ġli pid
Ġy ear
Ġ9 9
Ġdes cend
Ġdi oxide
Ġcontain er
Ġint eg
Ġ19 97
Ġmanufact ure
Ġmod ified
Ġcomple tely
Ġpartic les
oxy ethanol
Ġ50259 48
Ġflu x
Ġinter actions
Ġmat ter
Ġox id
ors ch
phen ols
Ġar ticle
Ġsynt hes
Ġcompar ison
Ġreli ability
ĠNe upert
Ġfollow s
Ġpass ed
Ġcompat ibility
ĠHum an
Ġrapid ly
Ġremain ing
app ed
ĠSyn thases
oper oxide
ĠEnd operoxide
ĠThio ester
lsob utyl
Ġexhib its
thrit is
Ġdescend ing
8 9
9 6
N a
P a
P ar
T ype
b ing
u li
w ay
ol ol
Ġp ub
ion ed
Ġc hem
Ġc ause
ĠC A
ĠC ol
ĠT R
ĠS kin
us p
ĠA g
Ġe vid
Ġe limin
Ġbe com
ĠR ic
ec anol
ĠW H
Ġex amples
Ġcont in
ĠH igh
ap or
Ġ7 00
Ġad ding
ĠSt abiliz
ĠTH IS
Ġethyl ene
Ġhyd ration
po vidone
ĠFormul ations
Ġrel ating
19 8
Ġcur ve
Ġant ibiot
Ġsign ifies
ĠDi ameter
Ġperiod s
Ġhydro ph
Kolli phor
ĠNo zzle
Ġinclud e
Ġcomb ined
Ġtrans ition
Ġstud ies
Ġbro ad
ĠCont ent
Ġspecific ations
tern ative
Ġoccur s
ĠProcess ing
ener ally
Ġrestric t
Ġgro ups
copoe ia
Ġantioxid ant
Ġyear s
Ġsynthes ized
Ġpub lished
0 5
9 4
g lycerol
u ene
Ġ :
Ġt alc
Ġs yr
Ġp an
Ġp ure
Ġp red
Ġo p
is ts
is hed
Ġthe m
Ġb ip
ĠK orsch
ĠC ros
as ant
ĠS ci
ĠS ulfate
Ġg ast
Ġg reater
ĠD E
ĠF e
ph a
ĠM el
Ġ4 50
iv o
ĠW et
qu ently
Ġl iner
im il
ens ion
Ġ10 5
Ġmin eral
ĠTh erape
Ġhe l
Ġ= =
rit ical
dehyd es
Ġblend er
ĠIl l
Ġpl ate
ne um
ĠDisinteg rant
atur ated
yrist yl
Ġdepend s
Ġrem ov
ield s
Ġpe ak
Ġvinyl pyrrolidone
Ġlead s
Ġopt im
ĠPhen oxyethanol
Ġsev eral
7 97
C O
S ol
a z
d od
l s
n er
o form
p ecially
s c
w t
in ations
Ġt end
Ġt ract
at ile
at ives
Ġs ilic
Ġs imil
Ġp a
Ġp yrrolidone
Ġc e
Ġb as
ĠS u
ĠA ir
am ins
yl dod
ĠF ilm
ĠM ore
ers on
Ġ4 9
iv ity
Ġdis or
Ġapp earance
Ġk in
ĠL a
Ġpoly oxyl
ĠU se
ist ry
ip o
ĠSt ir
Ġob s
ast e
Ġr he
ĠCS L
Ġ5025 38
Ġmed ia
Ġme ans
Ġmaterial s
ak er
ĠEn ter
Ġblend ing
Ġcompon ent
Ġod orless
Ġvit amins
Ġcrystal s
Ġredu ces
ĠEmuls ifiers
Ġhomog eneous
ĠEth anol
Ġnor way
ĠAcet ylsalicylic
methyl propyl
Ġchlor oform
ob ic
ann ing
Ġes pecially
ĠMeth acrylic
Ġmeasure ments
Ġimmedi ately
yldod ecanol
4 6
5 3
U L
f t
g le
l at
m illing
p ant
v ing
w ise
y be
Ġ er
or r
li ke
Ġp reser
Ġp erson
Ġf lowing
Ġf aster
Ġd ose
ar ate
ĠP almit
Ġw ay
Ġb i
et er
et ail
ĠT ime
Ġe ar
Ġg enet
os is
Ġ3 1
Ġn eg
Ġn ature
Ġcon f
ce ed
Ġst rat
Ġst iff
ĠE mul
Ġ4 8
Ġbe aker
Ġv ivo
ĠR ed
ĠR oll
Ġac cept
Ġco re
ĠL ast
ĠL ubric
ĠG ermany
Ġpoly vidone
Ġpoly phenols
Ġ50 5
ir ing
our ces
ĠPro tect
Ġ20 19
pt ane
alu es
Ġph ases
hen ol
Ġcontain ers
ition al
Ġcap rylocaprate
Ġother wise
par t
Ġdescri bed
Ġen gra
ĠCet osteary
Ġkolli coat
ole ate
Ġpresent ation
Ġ50259 50
Ġsiev ing
ject s
Ġsc re
Ġ50253 50
Ġsystem s
ĠPre p
Ġso ybe
Ġbu il
Ġrequire ments
cip itation
ĠAssist ants
.- %]
Ġ5034 797
Ġcor neum
ĠNa OH
ĠTri ethyl
pre cipitation
Ġprom ote
Ġlo ad
Ġident ity
ĠCar b
Ġut iliz
ĠOct yldodecanol
Ġsed iment
ĠX L
Ġrecept or
Ġelimin ated
Ġsimil ar
Ġobs erved
Ġpreser ved
Ġgenet ically
Ġstrat um
ĠEmul gel
Ġsoybe an
/ -
2 40
3 6
I U
R S
c l
e x
h or
i e
m eth
m pt
v ated
y zed
Ġ z
Ġ rad
Ġt ak
Ġt yp
Ġs or
Ġs ec
Ġp eg
Ġf inal
is ing
it es
it ed
Ġd ermatitis
ar m
ĠP ract
ĠP igment
ĠI cosapent
Ġis su
Ġre f
Ġe lect
Ġg en
Ġg ain
Ġg ive
Ġ3 40
ĠO ne
Ġcon duct
ĠB atch
Ġ5 50
Ġare a
if orm
ĠR ich
Ġac count
Ġus a
Ġk ey
ĠL ab
Ġex hibited
ran olol
Ġform ers
ell ose
ĠTable ting
Ġr ates
iscos ities
Ġprovid es
ĠPoly oxyl
ort ion
Ġen zyme
Ġhe ptane
Ġee e
Ġsy mpt
Ġaddit ives
lo bal
ĠSE M
Ġvit amin
Ġprop ell
Ġfin ished
ĠCream s
Ġinclud es
te in
Ġlot s
Ġinhibit or
Ġslow ly
Ġcompli ance
ethanol amine
Ġspect rum
Ġpower ful
Ġaut omat
Ġcaus ed
Ġneutra lization
Ġmono hydrate
Ġpot ential
ĠUs ing
Ġeffic ient
Ġsug ar
itan ium
Ġlar ge
Ġele vated
Ġdisc re
Ġdef ined
ĠEnter ic
ĠPalmit ate
Ġneg lig
Ġtak en
Ġtyp es
Ġconduct ed
G E
P E
c ap
d ate
d ance
e muls
f y
i re
i mul
t ra
t ime
w w
w ays
y t
y nt
Ġ )
in ts
Ġt g
at is
or ts
Ġs atis
Ġf e
Ġf ever
it ions
le ts
Ġm us
an uary
ar t
Ġb ase
ĠC O
om er
Ġre lied
Ġre jects
ur y
ut r
ĠO le
ĠO il
ĠF it
ĠF ree
iv en
Ġbe fore
ĠR ot
ĠR ole
Ġal pha
Ġk ind
Ġk ern
ĠIn tern
ĠG ran
rom b
ir able
las h
oc k
ĠV alue
ĠV itamin
Ġun op
Ġun less
Ġdes irable
Ġany time
ud e
Ġpre fer
Ġoblig ations
ĠSol uble
Ġpo ints
Ġup date
ĠJ anuary
Ġsuit ed
Ġrep orted
Ġdistrib uted
Ġrecommend ations
ĠPar ameters
Ġaddit ive
Ġinf lammation
ĠAn y
Ġinspect ions
Ġchan ged
Ġredu ced
Ġent ire
ĠWith out
Ġaccor dance
ath er
Ġselect ion
Ġdepend ing
ĠMon ograph
Ġhydrox ystearate
Ġass oc
Ġsurfact ant
Ġinv ol
Ġusual ly
Ġchain s
yp oth
Ġlim itation
ĠSoft gels
ĠBin ding
ott i
ĠFat ty
Ġagain st
ĠManufact uring
Ġantibiot ics
Ġbip lan
Ġrad ical
Ġautomat ically
Ġdiscre tion
Ġsatis fy
Ġkern el
Ġunop ened
) )
- )-
. ).
4 3
D MF
G eral
c les
c hed
f ield
i que
j ury
k es
l f
m y
m en
p enetration
r ating
w ater
w ell
y re
z Geral
Ġ ess
in der
on ding
er ous
al am
Ġd am
ĠP er
ation al
ĠT ol
ĠT ype
ul phate
ĠS c
om s
Ġ( -)-
Ġre duct
Ġre tain
ur n
Ġg eneral
um at
Ġh al
Ġh ypoth
ĠF resh
Ġ4 22
mul ation
Ġsol ute
Ġal ternative
ter ios
Ġcan not
rom at
ĠN ote
Ġ7 2
Ġ20 21
Ġnot ed
ĠV as
Ġproper ty
ĠTh romb
Ġ12 00
Ġsus tain
Ġsus pend
Ġcons ists
Ġsup er
Ġch all
lu e
Ġexc lud
Ġrep orts
Ġunder take
ill in
Ġincre ases
ĠAr terios
ĠQ UAL
Ġmod e
pend ent
ĠMed ical
eros is
Ġox yg
Ġcrosslin ked
con taining
Ġstar ting
Ġfluid ized
oid al
Ġhydrox ide
Ġevalu ations
ci otti
Ġcent er
Ġreli ef
Ġlong er
Ġ199 0
Ġdeg ree
Ġcompli es
Ġneed ed
Ġchlor ide
Ġoffer ed
ok field
Ġfail ure
ĠInf lammation
ygroscopic ity
Ġinvestig ation
Ġhand led
Ġnum erous
bran ding
ĠCap rylocaprate
ĠRic ciotti
Ġhydroph obic
ĠTherape utics
Ġhel p
Ġbas ic
Ġkin ins
ĠLa uryl
cl erosis
Ġsympt oms
Ġmus cles
ĠFit zGeral
ĠIntern ational
yre tic
Ġess ential
alam us
Ġreduct ion
Ġhypoth alamus
ĠThromb osis
Ġsustain able
Ġsuspend ed
Ġchall en
ĠArterios clerosis
ĠQUAL ITY
Ġoxyg en
ĠFitzGeral d
1 7
9 3
A DE
B Y
D ES
E MENT
F RING
N G
N EC
R IT
d ae
e idae
f am
g er
g idae
p resent
t est
v p
v ement
w or
w ful
on duct
Ġt ap
er els
at al
re present
or ganic
or por
Ġs ard
Ġp imp
Ġp vp
ro und
is represent
ic el
Ġan ch
it rogen
Ġin jury
Ġm ent
Ġm ir
Ġm ack
Ġm isrepresent
Ġd one
an gidae
Ġb asf
ĠK oll
ĠC H
ul ent
Ġ1 30
ĠS TA
om ach
om eter
ĠA RI
ĠA LL
Ġpro hibited
Ġg ra
ĠD ocosahexaenoic
ĠF ACT
ure s
ĠB Y
Ġst omach
ili es
up eidae
Ġ4 6
ty pical
ĠR el
ĠR ES
ĠW RIT
Ġal ways
ac ed
TI SF
TI NG
Ġco ar
ĠL IA
th alm
ine ar
ĠOR AL
Ġcont ract
ĠG lycol
ĠG ert
Ġ50 3
Ġ50 26
ĠN ON
ĠN umber
ap on
Ġ7 7
ĠU l
IN FRING
Ġun la
Ġun iform
OR Y
Ġma king
Ġma kes
isc ible
Ġinc orpor
Ġsh ape
com br
ov ies
Ġdocument ation
Ġgranul ator
ĠCON NEC
Ġde ath
AL ING
Ġme an
UR SE
Ġmod er
ĠLA W
TE N
ĠEX CLU
Ġover view
Ġthere from
Ġconsist ent
CU MENT
Ġfull est
Ġmic elle
Ġ13 7
Ġindic ates
Ġexpress ly
Ġsc ale
Ġar ising
ĠSA TISF
Ġfin ally
ĠDO CUMENT
lor ide
ĠUn less
Ġensure s
Ġwid th
ĠUSA GE
Ġagre ed
ĠHyd rox
Ġpun itive
Ġalk aline
ĠInd ustry
ACT ORY
Ġwrit ing
Ġwrit ten
ĠHERE IN
ĠHERE BY
Ġfraud ulent
Ġmisc onduct
Ġplace bo
Ġalumin ium
Ġcyclo hex
Ġconsequ ential
Ġpovidon um
Ġbo ok
ĠOver view
TU TE
Par ticle
uli dae
ĠTR ADE
Ġbecom e
ĠWH E
ĠDE ALING
ĠMel ting
Ġsilic a
ipo philic
UL TING
pant henol
Ġperson al
Ġissu ance
ĠCO URSE
Ġdam ages
Ġexclud e
fam ilies
Ġsard ines
Ġpimp les
Ġanch ovies
Ġmack erels
Ġmisrepresent ation
ĠSTA TUTE
ĠARI S
ĠRES ULTING
ĠWRIT TEN
ĠGert eis
INFRING EMENT
Ġunla wful
combr idae
ĠCONNEC TION
ĠEXCLU DES
ĠSATISF ACTORY
5 8
9 8
A d
C hemical
b y
g et
l ate
o il
o ugh
v es
v ir
x panthenol
Ġ Ġ
in k
Ġt et
er g
ol id
ol ated
ro int
ro philic
Ġf our
ic lo
it ol
it ude
Ġin organic
Ġm agn
Ġd om
ĠK OH
ĠC har
et erm
ĠT apped
ab ol
ĠI S
ĠA nt
Ġre versible
Ġ2 80
os ph
ĠF in
ĠB C
ĠE qu
ĠR es
Ġal dehydes
res p
Ġcomp act
Ġus age
eth er
iz er
form ing
fen ac
Ġ7 4
Ġ20 11
Ġ25 00
dit ion
Ġdi ethyl
ĠPh ys
ĠProduct ion
ĠSol utions
Ġup per
acter istic
Ġ19 8
Ġmixture s
Ġstir r
poly mer
Ġ11 2
ĠSolub iliz
Ġcol d
Ġhard ly
unct ional
Ġread y
ert ified
Ġ50253 26
Ġdevelop ed
Ġwet ting
Ġneut ral
ĠThere fore
Ġmacrogol glycerol
medi ate
Ġneed s
ĠCh ain
Ġcompos itions
Ġthick ening
Ġsour ce
Ġ900 3
Ġcompr ised
cryst alline
Ġsummar y
Ġprimar y
Ġap is
Ġdrop lets
Ġfre quently
ĠAv icel
Ġchem istry
ĠLubric ants
Ġneglig ence
Ġbiplan ar
ĠLIA BILITY
ĠWHE THER
ĠARIS ING
vir on
roint estinal
iclo fenac
ĠChar acteristic
ĠCharacteristic s
, )
7 11
D ocosahexaenoic
F or
H ot
I E
g ing
g ether
h ip
k N
l ace
m pro
r oly
s aturated
t in
u le
v al
Ġ igure
in a
at ors
re m
re ad
en af
Ġs and
li es
Ġp res
Ġp igments
Ġc are
Ġc GMP
Ġf ew
Ġm as
Ġm yristate
ĠP PO
et ic
et imes
et wor
ĠT rans
Ġto gether
ab en
ab ilis
ĠS ur
om e
ĠA ct
Ġpro b
Ġ2 7
Ġg raph
Ġh ygroscopic
Ġn itrogen
Ġn etwor
ĠD SC
ĠF urther
ĠB i
ĠB lue
ĠM yristyl
Ġst imul
Ġ5 3
Ġ5 000
ot ox
ot hen
omp at
Ġv s
if lash
un e
sol utions
ec han
Ġac rylate
Ġcomp actor
ac y
ations hip
Ġapp lies
form ed
Ġpoly oxyethylene
ĠN ew
ard enaf
Ġad ministration
Ġpolymer ized
ys is
Ġag g
Ġint estinal
ĠComp os
Ġen cap
Ġen viron
Ġhyd rogenated
Ġhe al
ill ed
ron ic
Ġdispers ed
ak es
lect ed
lo id
lo ud
Ġcol loid
Ġcar rier
Ġsens it
Ġmic rosco
Ġwax es
lus ion
Ġbag s
Ġdemonst rate
Ġsom etimes
Ġdepend ent
fol d
Ġcyc le
Ġstrong er
Ġnatur ally
oph ilis
Ġcalcul ate
ĠFoam s
Ġcompr ises
Ġhist amine
Ġabstract s
Ġminim ize
Ġser ve
Ġadvant age
ĠEv alu
Ġ30034 97
Ġadhes ive
Ġavoid ed
Ġcontin u
Ġsyr ups
lat t
etail ed
Ġbuil ding
Ġhal f
Ġmoder ate
ĠEqu ipment
ardenaf il
Ġencap sul
0 3
> ,
R e
T o
g in
i philic
l ine
m al
m ing
r iv
s ec
Ġ u
in c
Ġt re
Ġt ar
Ġt riglycer
Ġs ite
Ġp harmac
Ġp oloxamers
Ġc ritical
es h
Ġf o
al le
Ġm ethylene
Ġm achine
Ġd il
Ġd ig
Ġd ec
Ġd own
an ing
ĠK ol
ĠT echn
ĠT riv
Ġto o
Ġto p
ĠI BC
ĠS ub
el f
Ġpro t
Ġe jection
Ġg o
Ġn utr
ph iphilic
Ġ5 70
ub ility
Ġare as
if ically
sol ute
ri ev
Ġl abor
Ġex ist
ĠG MP
ĠG latt
ens itive
ĠH ygroscopicity
ir ming
der ing
der mal
ĠPE O
ĠSt ep
Ġper ties
Ġmin i
pos e
Ġsh ared
pical s
Ġph osphate
Ġr h
Ġam phiphilic
Ġdocum ents
,, ,
Ġmed ical
Ġspray ed
Ġspray ing
Ġunder ne
Ġro b
Ġmeth acrylic
Ġext rem
Ġret riev
Ġgiv ing
emb er
ĠSolub ilization
Ġwill ful
ĠAn other
ĠRe li
ĠRe lease
Ġmembran es
Ġinclud ed
ĠProp ranolol
ii i
Ġbro wn
Ġpat ient
Ġhomogen ize
aff eine
Ġj u
Ġcompos ed
Ġcompat ible
Ġcarbon ate
di rect
Ġadvant ages
Ġflex ible
ĠPolyvinyl pyrrolidone
ĠSupposit ories
ĠOn ce
Ġlist ed
Ġconf irming
ĠRot ary
my pharma
ĠKoll li
thalm ic
Ġincorpor ated
ĠSolubiliz er
ĠCompos ite
Ġtar get
Ġtriglycer ide
ĠTriv ial
Ġlabor atory
Ġunderne ath
Ġretriev ed
- [
1 000
3 3
6 5
6 6
A pp
C l
E x
G s
U O
c a
c ular
g en
i wax
l os
m iscible
n umber
o ate
r up
â Ģ
Ġt erm
Ġt ension
at ches
he a
Ġs ecrecy
Ġp hen
Ġp reservative
Ġp igment
Ġp rin
Ġc s
ro b
ro w
Ġf ive
Ġan other
al lization
Ġm ethyl
ĠP un
et te
ĠT a
ĠT itanium
ĠS welling
us h
Ġe ur
Ġe ase
Ġ2 000
Ġg eneous
um arate
Ġn m
ĠO r
ĠO ur
yl line
Ġcon cer
ĠM e
ĠM achine
Ġ5 1
Ġ5 4000
Ġ4 4000
Ġv ary
st e
im er
act s
Ġco ver
Ġco precipitation
ĠL ight
Ġ50 37
Ġ50 57
Ġdr ink
oc ol
ĠPro cedure
Ġ20 6
Ġ20 16
Ġwe ak
Ġpar ts
Ġun saturated
ff eine
Ġper cent
25 0
Ġemuls ified
Ġr ub
Ġab le
olog ically
Ġmon omer
Ġdoc osahexaenoic
Ġshe lf
Ġag e
Ġsub se
ĠAl dehyde
ĠJ une
10 1
ĠCo polymer
Ġ5025 34
Ġest ab
ĠAc rylate
Ġacet ylsalicylic
Ġbenef it
SE M
Ġ17 1
Ġrepresent ed
Ġrepresent atives
Ġant ip
Ġstandard s
Ġno zz
ĠRe fer
Ġra ce
rop ic
Ġmemb er
Ġeas ier
Ġhom o
Ġchan ges
Ġrespect ive
ĠAd dition
Ġfluid s
Ġ33 50
Ġca ffeine
27 8
ĠSolid s
Ġcommon ly
Ġevalu ated
Ġ+ /-
ĠAcet yl
Ġ5034 8
ĠCor n
Ġtri ethyl
oph ylline
Ġtol uene
Ġend otox
table t
Ġres ources
Ġ57 25
Ġflex ibility
Ġrot ary
ĠSupposit ory
ĠSpecific ations
Ġple asing
ĠPrep are
Ġutiliz es
Ġelect ron
ĠGran ul
Ġassoc iation
Ġcoar se
abol ism
Ġcompact ed
abilis ation
Ġheal th
Ġmicrosco pe
Ġtre ated
alle l
ĠKol iwax
ĠTechn ology
Ġju ice
Ġprin cip
ĠPun ch
Ġconcer n
Ġ5057 42
Ġnozz les
4 1
9 0
9 55
C y
I O
O W
W F
a w
a rent
b ases
f ac
o ar
p y
p le
p ect
p ril
s et
s ensitive
u M
Ġ #
in ct
in oleate
Ġt ight
Ġt rit
at ter
re ted
he ther
en z
Ġs ites
li st
Ġp osition
Ġc ush
Ġf umarate
ic a
ic os
Ġan ionic
Ġin it
Ġm s
Ġm echan
Ġd ys
an ette
ĠP erme
Ġb ran
Ġb rit
Ġb ring
Ġb ios
ĠC ryst
et i
id ine
ĠS or
ĠS us
ĠS amples
ĠS ulphate
ĠA pril
Ġis olated
Ġre ach
Ġre dispers
Ġre action
Ġpro stagland
Ġe icosapentaenoic
Ġe mp
os tic
um p
Ġn ear
ĠD av
Ġ5 4
ĠE mp
ot hn
ĠR ev
ĠW IE
Ġal g
Ġal lowing
ag ed
im et
act ive
est ing
Ġapp ear
Ġco at
ĠIn c
ĠL anette
Ġ8 1
Ġ8 9
Ġpoly sorbate
ĠH P
ir ical
ant othen
Ġy et
ĠPro tein
ĠV alues
Ġper ox
isc la
Ġdi agn
Ġact ives
Ġemuls ify
Ġpre vents
Ġr ather
Ġ18 0
Ġch ir
Ġexc reted
ĠDA WF
Ġgran ular
Ġup take
Ġhe ated
ĠDis pers
Ġkolli cream
ĠAc cor
40 3
Ġbl ock
Ġthrough out
Ġx ylene
liz ed
hes is
oxy propylene
Ġpl aced
Ġvers us
Ġvers atile
ĠLud iflash
Ġprop ionic
ĠEmuls ifying
Ġfin d
Ġanal yzed
Ġwhere by
Ġ_ _
Ġsmo othn
zym es
Ġoint ment
Ġ36 6
Ġhomogen ized
Ġinflu ences
Ġfunction ality
Ġenhan ced
Ġmass es
Ġ68 955
Ġpun ch
Ġpun ches
Ġcor resp
Ġalk ali
Ġsour cing
Ġtol erance
Ġmisc ible
Ġfl av
Ġfl akes
table ts
ĠBin der
br uary
por ation
Ġalumin um
Ġed ition
Ġwor k
Ġwor king
ĠMin i
Ġir rit
ĠCom b
ĠCom mercial
rach loride
Ġevid ence
Ġop ened
ĠFe bruary
Ġremov ed
Ġce utical
orr hea
ĠPract ically
ynt hesis
Ġtet rachloride
ĠKollli phor
Ġtight ly
Ġtrit ur
Ġcush ioned
Ġbios ynthesis
ĠSus pens
ĠDav ies
ĠEmp irical
iscla imer
Ġdiagn ostic
ĠAccor ding
Ġsmoothn ess
1 10
7 00
A ID
A MP
B ASF
B enz
C h
C o
C rospovidone
I e
M ethyl
P Gs
T C
U S
b er
b one
i ety
k ely
m osph
p ly
s is
t ers
t rib
v ice
Ġ ionic
Ġa ux
Ġa rach
in let
er ability
at ior
Ġs al
Ġs per
li er
li ant
li fe
Ġp ane
Ġp atch
Ġc ast
Ġc loud
Ġo ste
Ġf ac
Ġf ields
ic ation
ed ing
Ġin her
Ġm il
Ġd ates
ĠP AMP
Ġb uprofen
ĠC it
ĠT e
ĠT ort
id onic
ab les
ĠI mpro
ĠS ust
Ġis sues
Ġre branding
Ġre pose
am ol
el a
Ġpro cedure
ur ance
Ġg elling
Ġ3 80
Ġ3 94
ig or
ĠD osage
ĠO TC
ĠF ood
ĠF ever
ĠF raction
ĠF acts
ce iv
ce utics
Ġst er
Ġ4 20
Ġ4 78
omp osition
Ġas pect
ĠR ap
ĠR ights
co ated
Ġ6 30
Ġ6 80
qu ent
res ents
Ġcomp lic
Ġl ase
im ate
ac c
ac he
ac rylate
ain s
rad e
Ġat mosph
ĠH ans
Ġli kely
Ġby product
Ġ9 8
Ġ9 86
Ġwe igh
ene acet
pt ide
ĠV iscosities
ĠSt atus
Ġper oxide
pos ition
unt il
Ġinc ub
Ġact ions
hyd rat
Ġr ic
Ġavail ability
Ġrequ ests
Ġlow est
Ġag ing
Ġch ronic
ĠSp reading
NS AID
ĠComp ar
prop ionic
de pendent
Ġdist urb
,, ,,
Ġrep resents
ĠDis position
Ġ19 7
Ġreg istered
Ġolli solv
Ġinf rared
Ġ17 8
Ġwell s
lect ion
ĠEn han
ong ing
ĠEx tra
Ġlipo ph
oxy gen
Ġra ise
Ġod our
Ġbel onging
pharma copoeia
pharma ceutics
Ġconcentr ates
dis solv
Ġprop ortion
Ġcopoly mers
Ġspec ifically
15 4
Ġsc ient
mac eti
Ġderiv ative
Ġar ises
Ġar thritis
ĠSup ply
lus ivity
ĠLys ine
ĠHC I
ĠCont ents
Ġass urance
Ġcell ular
Ġ26 4
Ġ26 5
ĠProstagland in
Ġoccur ring
equ ival
ĠHyd rogenated
ĠHyd rophilic
phenyl propionic
Ġ199 8
ĠCor poration
Ġpe ptide
Ġset up
Ġalk yl
ĠTraden ames
acet amol
Ġcalcul ated
ĠAb solute
ĠInd ividual
ĠHum ans
Ġfail ing
Ġshell s
Ġrestric ted
ĠMar tin
Ġgreat est
Ġstep s
ĠBio pharmaceutics
Ġcyclo oxygen
ĠEv en
Ġbio equival
ster oidal
Ġhead ache
Ġback bone
ril liant
ĠDry ing
Ġstress ed
ĠBro okfield
lsobutyl hydrat
lsobutyl phenylpropionic
ĠSci ences
Ġgast ric
Ġ== =
Sol ubility
Ġpa ired
Ġdisor dering
Ġrhe umat
Ġear lier
ĠLab el
Ġpropell er
ĠOle yl
Ġinvol ve
men orrhea
ĠTol erance
romat ograph
ĠVas cular
Ġdom ains
ĠRes erved
ĠBi ology
Ġstimul us
Ġsensit ize
Ġprot ocol
Ġrob ust
Ġantip yretic
oar thritis
Ġdys menorrhea
Ġbran ched
ĠRev ised
Ġchir al
Benz eneacet
Ch ain
Methyl propyl
Ġaux ili
Ġarach idonic
Ġpane list
Ġoste oarthritis
Ġinher ently
ĠPAMP A
ĠSust ain
ĠRap id
Ġcomplic ated
ĠHans en
Ġbyproduct s
NSAID s
Ġdisturb ances
ĠEnhan cing
Ġcyclooxygen ase
Ġbioequival ence
lsobutylhydrat ropic
Ġrheumat oid
Benzeneacet ic
) ).
6 8
9 9
A E
C C
D HA
E PA
P oly
V iscosity
b ic
c arm
d etailed
e h
j ust
k y
s ive
t on
Ġ âĢ
in ing
Ġt imes
ol d
re ement
he ar
he ated
Ġs ing
Ġs co
Ġs elf
li po
es ty
is k
Ġan c
al cohol
Ġin ject
Ġd ay
an k
ĠP ain
Ġw ound
ĠC astor
ĠS ecrecy
Ġre sist
Ġre cryst
ut let
ĠD oc
ĠO utlet
ĠB HT
ĠM g
ĠE S
ot a
Ġth in
ĠThe ophylline
ub e
Ġv on
Ġv igor
ĠR aw
Ġ6 6
st earate
Ġl inear
ĠL ipophilic
Ġex pos
Ġat om
Ġsp read
ĠG lycer
ĠG PC
ĠH A
ap an
Ġwh ose
Ġ20 20
Ġ20 14
Ġun ple
Ġad just
Ġoil y
Ġpre cip
Ġtablet ting
ali d
ack ing
Ġch ap
Ġch romatograph
ĠComp lex
Ġgranul ated
Ġcompress ible
Ġcompress ibility
Ġfat s
Ġhyd rogen
Ġsupp ort
ĠAs s
du ced
op ol
rig ger
Ġne w
20 9
ee p
Ġinter face
ĠDe xpanthenol
Kolli solv
Ġtrad itional
Ġsc anning
Ġstabiliz er
Ġstabiliz ers
ĠAt om
Ġcompar able
Ġpharma copoeia
Ġcet yl
Ġhomogen ous
equ ate
ffic ient
yn am
Ġmult itude
Ġpos s
acet in
Ġaut hor
ĠAS D
Ġoffer ing
ĠMar ch
Ġgreat ly
hydro us
Ġpolar ity
Ġple asant
ĠAg reement
ĠSu it
Ġaccept ed
Ġsec ond
PE G
Ġhelp s
ĠHydrox yl
ĠPhys ical
Ġdig est
App lication
Ġvary ing
Ġpercent age
Ġbrit tle
ĠHP MC
Ġflav our
ĠSuspens ion
carm ellose
Ġsing le
lipo philic
Ġunple asant
Ġprecip it
rigger ed
) ;
- )
- ,
. (
4 40
S up
T BC
U l
c ers
d ry
d ay
g lycol
h ite
l ov
o pt
o ured
s hear
v en
w hite
y to
z ing
Ġ rom
Ġa round
Ġt ran
re hen
he st
en ness
Ġs har
Ġp f
Ġp r
Ġp s
Ġp ear
Ġc rospovidone
Ġc ertified
Ġo ption
Ġf riability
Ġan hydrous
it ic
Ġin s
Ġin ner
Ġm ould
Ġd ens
Ġd ecre
ĠP res
ĠP har
ĠP igments
ent ion
ĠC affeine
as on
Ġto day
ĠS ch
ĠS ummar
Ġg lycer
Ġg mp
Ġg lobal
Ġg los
Ġ3 9
um ul
ig hest
Ġh ighest
Ġn am
ĠD isclaimer
ĠO ran
ĠF unction
ow der
ĠM ost
ĠM ass
Ġor gan
iv itamin
Ġbe ing
Ġbe verage
Ġv isc
Ġv ardenafil
if fer
Ġ6 50
Ġal ter
Ġl odine
Ġ0 5
Ġco ater
Ġco povidone
ĠL i
Ġex hibit
Ġ8 4
Ġcont ents
ĠG el
ĠG elling
Ġpoly glycol
Ġ50 209
Ġli t
Ġli es
Ġy ields
ĠPro of
ev enness
Ġ20 13
ard less
ĠV er
Ġun its
Ġun evenness
Ġad sorption
ĠSt ates
Ġ10 1
cent ration
Ġinc ompat
olog ies
Ġpo p
Ġint ake
Ġdocument ed
Ġde li
Ġdeterm ination
Ġhyd roly
ĠDis posal
Ġmod ern
Ġrel ated
Ġdispers ing
vinyl pyrrolidone
Ġapprox imate
Ġmax im
ole ic
Ġdisinteg rating
ĠEx per
Ġcol or
Ġconstit u
Ġimpro vement
ĠPharmaco poe
Ġinter mediate
Ġtechn ologies
Ġstar ters
ĠUn ited
Ġ22 000
Ġprotect ion
70 1
Ġcarb oxy
solid s
pic illin
Ġstrong ly
Ġ5034 79
Ġtri ethanolamine
Ġ67 701
Ġregul ations
Ġcaus tic
Ġut ilization
Ġpost ers
Ġprimar ily
Ġ30034 96
Ġ305 31
ĠCol oured
Ġevid ent
ĠCros carmellose
Ġgast rointestinal
Ġengra ving
Ġscre ening
ĠSc anning
Ġment ioned
ĠRel ative
Ġuniform ity
Ġmas king
Ġagg reg
Ġcontinu ously
Ġ50348 14
Ġprincip les
Ġtritur ated
Ġmil ky
Ġscient ific
ĠâĢ ĵ
Ġvigor ously
ĠGPC G
Ġchap ter
Ġtran sp
rehen sive
Ġshar p
Ġpear ls
Ġmould s
Ġdens ities
ĠSummar y
Ġglos s
ĠOran ge
Ġvisc ometer
0 1
7 2
8 2
A cc
C MC
E P
F T
I nf
O ED
P ro
Q R
b el
b itol
d rug
g t
h o
i en
k nown
m L
m s
o ct
r u
t acking
v iscosity
y ellow
Ġa i
in ess
on es
Ġt e
er o
re as
he ad
Ġs eg
Ġs atur
Ġs alicylic
Ġs ection
Ġp ublications
Ġc is
Ġc av
Ġc uring
es ired
ro st
is olid
ic le
Ġan gle
Ġm ole
Ġd ict
ar ies
ar ding
ĠP lace
Ġw hether
Ġb it
Ġb rea
ĠC all
ĠC ota
ĠC EP
et ra
ĠT od
Ġ1 48
ĠI f
ĠS o
ĠA P
am ide
el ine
Ġ2 40
Ġg enerally
00 6
ĠD ec
ĠD iffer
ĠO S
Ġcon form
ĠF inal
ce ption
ph yl
ĠM a
ĠE T
Ġ4 3
iv ers
Ġv i
Ġv apor
Ġv eh
Ġ6 2
Ġ6 000
ĠW ax
st ant
Ġcomp rehensive
Ġl l
ĠIn soluble
ĠL et
Ġ30 4
Ġ8 50
Ġformul ating
Ġcont rib
ĠG erm
ĠG OED
ĠH ot
ĠN om
Ġy ield
Ġdr iven
Ġ7 3
Ġ9 1
ĠPro duced
Ġ20 8
Ġ20 22
ug e
ard ed
Ġun ique
Ġun ivers
Ġad min
ific ations
av or
av ing
Ġma e
umb ers
hyd rox
Ġab s
Ġpolymer ic
Ġdet ection
cri bing
Ġib c
Ġim ages
,, ),
ĠDis solv
Ġrecommend s
Ġpur ification
Ġmeth acrylate
Ġacet yl
19 0
19 79
Ġover head
Ġcomplex ity
pe ia
ass ium
ĠMon o
Ġsem isolid
Ġconsider ably
ĠCont in
tern atively
ĠSheet s
Ġappro val
Ġcl os
Ġvis ible
Ġcompos ite
ĠTri ethanolamine
ĠAb sorption
Ġmicro crystalline
di ol
di ameter
St orage
ott om
Ġund esired
Ġadhes ion
Ġoxid ize
Ġpred ic
Ġoptim ized
ĠCarb opol
Ġgen erated
Ġprefer red
Ġsuper ior
ĠAnt i
Ġstirr ers
For mulation
ĠSur g
ĠEvalu ation
Ġencapsul ation
Ġnutr itional
ump ing
Ġalg al
ĠCit ric
acc har
Ġatmosph eric
Ġric inoleate
dissolv ed
Ġauxili aries
Ġresist ance
ĠGlycer yl
Ġchromatograph y
Ġauthor ity
ĠSuit able
dry ing
Ġdecre ases
ĠPres cribing
Ġdeli ver
Ġconstitu ent
QR P
Ġsatur ation
Ġcav ity
ĠTod ay
Ġconform s
Ġveh icle
ĠWax es
4 39
7 3
7 62
A PI
B HT
E O
H yd
P actor
Q G
S m
U b
a ding
b ut
c rogol
c atal
d ocosahexaenoic
e k
e ed
e icosapentaenoic
f a
g ast
g lobal
h de
i ological
l od
l onic
m ain
n n
o hde
p yrrolid
p olar
r ity
r ates
s sc
t ically
w aste
x EO
y e
 °
Ġ *
Ġ ur
in ic
in ce
in ci
Ġt ration
Ġt rin
at etra
ol uene
or ical
en c
Ġs a
Ġs combridae
Ġp ent
Ġp as
Ġp ore
Ġo a
Ġf ul
Ġf ric
Ġf unct
Ġf igure
Ġf ssc
ic es
it t
Ġin a
Ġm o
Ġm olec
ar b
ĠK N
ĠK et
ĠK eep
ĠC N
ĠC an
ĠC uring
ĠC OM
ul ations
Ġ1 40
ĠS h
ĠS i
ĠS er
ĠS ample
ĠS combridae
om in
Ġ( =
Ġis oth
Ġre cent
Ġre mar
Ġe mer
Ġ2 25
Ġ2 30
os her
um ing
Ġh ow
ĠD ensity
ĠD eterm
ĠD iclofenac
ĠO ph
ĠB et
ili ties
Ġ5 16
ĠE umul
ot tle
Ġbe vel
Ġas sist
Ġv ag
Ġv alid
tic les
ĠR emark
pp e
pp ed
Ġcomp action
Ġus es
im al
Ġco uld
ĠIn stant
ĠL ut
Ġex ception
Ġ8 000
ear yl
ĠG lass
ens ile
ĠH a
ĠH ist
Ġy m
oc ic
Ġ9 3
yd rate
Ġwe e
Ġnot es
Ġun it
ĠSt ored
Ġsu c
unt ry
unt ary
Ġman aging
af let
Ġph il
ĠReg ister
ĠReg ulations
Ġpre m
ment ary
olog ic
Ġle aflet
ali zed
Ġsoft ness
Ġch oic
lu cent
Ġall erg
Ġdo uble
Ġshow ing
Ġgranul ators
ĠCo untry
Ġrep e
Ġspray s
Ġ19 30
Ġcream iness
Ġro ugh
ĠAr ticles
ĠAc c
Ġstear ine
Ġcharacter ized
Ġbet ter
ĠPar acetamol
Ġrel ationship
sorb ates
Ġacet ylene
19 7
Ġmax omega
ales cent
Ġ17 0
aen ocic
Ġover all
ĠCon centration
Ġev apor
Ġconst ant
ĠEn gra
11 14
Ġvar ies
Ġfree zing
Ġhum ect
ĠRe ppe
Ġcar angidae
ĠPharmaco peia
Ġinter fac
Ġachiev ing
Ġtechn ique
ĠAd d
Ġanal ysis
ĠCl upeidae
oxyl ated
Ġselect ive
rosco py
Ġtrans formed
Ġtrans lucent
Ġprotect s
Ġ14 50
cip ients
Ġhydrox yt
Ġass ess
ĠStandard s
Ġdiff ers
Ġwet ted
Ġevalu ate
Ġsmall er
Ġvol untary
Ġcent r
ĠSe parate
Ġcl ose
Ġcl upeidae
Ġcl umping
Ġfollow ed
Ġmult ivitamin
Ġly ophilis
Ġ68 439
Ġextr ud
ef jor
iment al
Ġthick ener
Ġ67 762
Ġpalm itic
Ġlim it
ĠInf rared
Ġremain ed
ĠTox ic
ism s
Ġsummar izing
ĠMar crogol
ĠCar angidae
ĠUs age
fe eding
Ġclass ified
Ġsug g
omat ic
Ġconsequ ence
Ġmarket s
cor bic
Ġconc en
Ġconc ave
Ġ305 6
Ġinteg rity
ĠStabiliz ers
Ġtalc um
Ġremov able
Ġoptim izing
Ġdisor ders
Ġear ly
ceed s
Ġengra ulidae
Ġscre en
Ġload ed
Ġz ero
Ġsec ures
Ġref lected
Ġfe ature
ĠMonograph s
ĠPer oxide
Ġchallen ging
Ġcyclohex anol
Ġcyclohex ane
Ġsand efjor
Ġpres ence
Ġnetwor ks
Ġpharmac ological
Ġdil ute
Ġgo ed
ĠReli ef
ĠMe et
Ġsubse quent
Ġinit ial
Ġperox eal
Ġcorresp onding
Co povidone
Ġcloud y
Ġaspect s
CC P
ĠHA CCP
ynam ic
Ġins ert
Ġorgan ization
Ġlit tle
Ġincompat ible
Ġaggreg ates
bel ohde
reas y
Ġseg ments
ĠGerm aben
acchar in
Sm PC
Ub belohde
but anol
gast ric
main ly
Ġtrin ydrate
Ġpent ane
Ġful ly
Ġfric tion
Ġfunct ions
Ġisoth erm
Ġemer ged
ĠEumul gin
Ġbevel ed
ĠHist orical
Ġchoic e
ĠEngra ulidae
Ġinterfac ial
Ġhydroxyt oluene
Ġlyophilis ates
Ġsandefjor d
% /
% ),
, -
, ).
0 9
1 31
2 25
3 19
5 6
6 9
8 55
A v
B r
M w
O D
P QG
W eight
a king
b ar
c k
c os
d a
e mulsifier
f ree
g enerally
h y
i as
i ence
l ag
m etic
n g
s ing
s ts
s uming
u ro
v alues
w et
Ġ ,
Ġ Î
Ġ ene
Ġ ..
Ġ oll
in o
in ol
Ġt en
Ġt urb
Ġt apped
Ġt inct
at ic
or ough
he tically
Ġs ure
Ġs ide
Ġs ulf
Ġp enet
Ġc he
Ġc rosp
Ġc atal
Ġo pp
Ġf oc
Ġf avor
ic o
ic illin
ic rob
Ġan imal
al d
le ms
Ġm ill
Ġm esh
Ġd iclofenac
ar i
ĠP e
ĠP ion
ĠP owder
Ġb ound
Ġb ases
Ġb ath
Ġb atches
ĠC U
ĠC e
ĠC hem
ĠT A
ĠT ube
id ence
id ne
ĠI SP
ĠS D
ĠS y
ĠS accharin
us es
ĠA er
ĠA mer
ĠA sp
Ġre dispersion
Ġ2 9
Ġ2 20
Ġ2 85
ut ic
ut ane
Ġh is
Ġh ar
Ġh am
Ġh aving
ĠD V
ĠO p
ĠF ull
ra u
ph osphate
ĠB D
ĠB e
ĠM al
ĠM ac
ĠM oisture
up ies
Ġ5 2
ĠE ffic
ĠE ster
Ġth erm
Ġth ose
Ġ4 60
Ġv iscos
Ġv iscosities
if unctional
ec k
Ġsol ic
oly mer
Ġon set
Ġ0 1
Ġdis rup
act ing
est ers
ĠIn jection
Ġformul ate
Ġsp an
ĠG uid
ĠG els
Ġpoly diol
Ġ50 48
Ġ50 49
Ġ50 42
ĠN ot
ant ity
Ġli sts
Ġ7 1
our less
oc hemical
ell es
ell ar
Ġwh ict
Ġ20 4
ug ht
Ġpar allel
og en
ĠV Y
Ġun ders
Ġad equate
ĠSt ructure
Ġproper ly
Ġsiz ed
ud ipress
Ġpre ca
Ġr un
Ġr ise
Ġr isk
Ġtablet ability
sul f
Ġam ino
Ġim age
Ġint ens
ĠPoly sorbates
Ġdiffer ences
Ġvalu able
Ġgranul ate
Ġen erg
iev e
Ġmod ule
Ġcomple ting
Ġbl ank
ĠIP EC
ĠPar t
Ġdry er
20 19
aen oate
ong ation
ĠMed ic
ĠRe p
cc inic
rug ated
Ġmic ron
Ġet c
Ġinter pre
Ġpl ot
47 2
Kolli wax
Ġindic ate
Ġindic ations
Ġindic ated
Ġredu cing
Ġcle aning
Ġsc atter
ĠTo picals
Ġ50253 53
Ġtechn ica
vers ion
Ġcommercial ly
Ġpelle t
con suming
Ġfin es
ĠAd hes
Ġocc upies
Ġdemonst rates
Ġens uring
ĠProp ortion
Ġtrans dermal
Ġpract ice
Ġbu ild
Ġeven ly
Ġbro w
Ġbro ught
Ġhydrox yl
Ġmeet ing
inf ek
Ġagre em
Ġincreasing ly
Ġfresh ly
Ġappropri ately
Ġmult i
ĠCor rugated
for mulation
Ġiso propyl
ĠForm er
Ġspect ra
79 6
ermat ology
Ġneutra lized
45 1
Ġprom ot
ĠStud y
Ġsummar ized
Ġreac hes
Ġinvestig ations
Ġmet abolism
Ġeffic acy
Ġimmedi ate
Ġrot ation
Ġoxid ation
ĠAg ent
Ġpred ict
az ol
Ġbi ological
ceed ing
Ġstiff ness
ex cept
Ġz ur
Ġpropell ant
ww w
Ġchallen ge
Ġgra ft
eterm ined
ĠFin ally
ĠAct ive
Ġprob ably
Ġprob lems
Ġenviron ment
Ġcolloid s
Ġextrem ely
Ġtarget ed
Ġterm s
Ġestab lished
Ġrace mic
ĠGranul es
ĠSor ption
Ġirrit ation
Ġsal t
Ġrecryst allization
ĠAss ay
Ġposs ibility
ĠASD s
Ġ50209 10
Ġhydroly sis
ĠExper imental
Ġ30531 22
Ġbrea k
hydrox y
ĠDissolv e
arb on
ĠAcc ela
uro pe
Ġturb id
Ġcatal yst
Ġopp ort
Ġfoc uses
Ġdisrup t
ĠGuid eline
Ġunders t
Ġenerg y
0 2
0 10
1 40
1 80
2 3
2 37
3 31
3 37
5 40
5 21
5 472
6 7
6 87
8 8
B N
B U
B ottle
C il
C ra
C ie
D C
D i
D rum
F ull
G I
G lycerol
I sob
M odel
O A
P e
P ronovaPure
P almit
Q E
U IU
V er
V alue
W le
Y IG
a A
c roscopy
d ol
d ose
e fficient
f eel
g ha
h s
i ed
k to
l er
m ore
m ellose
n is
o co
o ks
p ent
s ha
s ources
s ieve
t ive
t ration
v ance
v ula
w ig
w ith
y ond
y ophilis
¼ m
â Ħ
Ġ 00
Ġ ip
Ġa very
in n
on am
Ġt r
Ġt an
Ġt un
Ġt ail
Ġt ype
er bal
at ty
at rix
ol o
or th
or atory
en ers
en ne
Ġs w
Ġs ph
Ġp ap
Ġp aste
Ġc ular
Ġc all
Ġo m
Ġo vula
ro ma
ro crystalline
Ġf ood
Ġf OM
Ġf ung
is ob
ic an
ic ity
ed ip
al ed
al al
al ance
al rau
it on
Ġm ag
Ġm yristyl
an ks
Ġw al
Ġw ind
ĠK ey
ĠK osher
ĠK Br
ĠC ell
ĠC ety
ĠC ritical
ĠT amp
ĠT ests
ĠT ex
ĠT riggered
ĠS N
ĠS ter
ĠS oc
ĠS mo
ĠS han
ĠA B
ĠA round
Ġ( (
Ġ( %)
Ġre ve
Ġre taining
am ali
Ġpro of
Ġpro ven
Ġ2 34
ur inol
ut ior
Ġ3 50
Ġ3 20
Ġh owever
Ġh und
Ġh inder
Ġh erbal
ly erol
Ġn if
Ġn yst
ĠD r
ĠD ermatology
ĠO kto
ĠF ran
ĠB y
ĠB utyl
ĠM O
ĠM et
ĠM ain
ĠM olar
ĠM Pa
ĠM esh
ĠM IO
Ġst abilisation
Ġ5 10
Ġ5 40
Ġ5 22
Ġ5 52
Ġth ermore
Ġbe yond
ĠThe n
ub les
Ġv ent
Ġv irtual
if uge
co ho
ri m
Ġac yc
Ġac ertain
ĠW e
Ġal fa
Ġal coho
Ġl O
Ġl en
ag ul
Ġ0 4
im en
im ens
Ġdis app
eth y
red s
Ġk idne
TI S
TI Ul
Ġco efficient
Ġco agul
ĠIn ter
ĠL D
ĠL yophilis
Ġex cess
Ġex pens
ib ilities
Ġ30 8
Ġ30 25
Ġ30 27
Ġ30 403
ran ts
th ium
ect ions
Ġformul ators
ear ch
ĠG ap
ĠG reater
ĠG row
ĠG lyerol
ĠH erman
ĠH alal
Ġ50 28
Ġ50 796
ir ly
Ġli thium
Ġdr u
Ġ7 75
ail able
Ġ20 63
ĠU V
ĠU Wle
pt ember
Ġnot ably
ĠV ari
ox icillin
ular ity
Ġfil ter
ĠSt rea
ĠSt abilisation
Ġ10 7
Ġmin or
ĠTh rough
ĠTh ick
ĠTh anks
25 451
Ġany more
Ġob tain
Ġact iv
Ġph ot
ĠReg ardless
Ġpre heated
Ġrequ iring
ad ec
sp olymer
Ġmix ers
Ġmon og
Ġind e
Ġind ivid
Ġam mon
Ġam oxicillin
ali ties
Ġcap rylic
ĠSp ring
ĠSp eed
ĠAl ternatively
Ġexc lusion
par aben
Ġrefer red
lycer ides
Ġdo ubles
vent il
Ġqu ali
ric es
Ġbin d
Ġplastic s
Ġdeterm inations
Ġcom es
Ġcom illing
Ġmed ic
Ġest im
Ġcream ier
ĠAc ryl
Ġsupp orted
Ġstear in
ĠAs corbic
40 4
Ġmod ifier
Ġmod ify
Ġmod ifications
Ġcomple te
Ġcomple mentary
Ġpur ity
Ġreg arding
Ġ200 5
Ġ200 7
op urinol
op rim
Ġrequest ed
SE C
Ġinf o
Ġinf ections
Ġ17 7
Ġfill er
Ġfill ers
Ġant acid
ach ute
lam ellar
Ġret ention
Ġconsist ed
Ġcomplex ation
Ġcomplex atior
lo y
ĠEn zymes
Ġmain tain
ĠSE C
Ġ500 22
ĠEx hibit
Ġblend s
ĠQu antity
Ġfa irly
38 8
38 75
Ġcar ried
Ġcar mellose
Ġimpro ves
Ġ50259 500
Ġ50259 521
60 18
60 388
Ġlubric ation
Ġphys ically
Ġmat rices
ĠLud wig
Ġprep are
Ġpolyvinyl pyrrolid
47 99
Ġcrosslin k
Ġindic ating
ĠEmuls ions
97 29
Ġ16 5
Ġ16 66
ĠTo pical
Ġ305544 92
Ġderiv atives
ĠTypical ly
Ġfin ish
39 63
Lab oratory
Ġ_ __
Ġdemonst rating
21 7
ĠProp ane
Ġcomb ine
18 9
Ġprotect ant
ĠHC l
Ġrele ased
ĠAll opurinol
ĠPharmaceutical s
Ġass ay
Ġcarb oxyl
Ġcompar ing
Ġpharma co
Ġcet osteary
35 3
vi Or
utyl phenyl
Ġresult inc
ĠSe ptember
42 49
ĠNe ut
Ġrich er
Ġrich ness
Ġi re
Ġmult ifunctional
Ġcontrol led
Ġcompli ant
Ġ305547 50
Ġ305547 19
Ġ305547 20
Ġ305547 21
Ġ305547 18
Ġ305547 52
Ġaid ed
ĠCh ina
ĠAeros ol
Ġ34 000
Ġextract s
Ġtri meth
Ġ306 60388
Ġ306 9729
Ġanalges ics
Ġj er
ĠMix ture
Ġcaus es
ĠAm ong
Ġlim ited
ovidon um
Ġ900 000
Ġmono hy
87 337
__ .
rin k
ond s
Ġpot assium
Ġfl at
Ġbuffer ed
ĠBlend er
Ġmet ric
Ġres sources
Ġminim ized
Ġ5025949 8
Ġ5025949 9
Ġ28 000
ĠOct adec
Ġmeasure ment
St earyl
Ġed ge
Ġed ges
Ġapply ing
Ġ305 25451
Or ls
Ġbo oks
Ġel abor
Ġnum eric
Ġexper t
Ġexper iment
month s
als art
ĠAv ailable
ĠMic rocrystalline
Ġcomparison s
ĠCol orless
Ġcontin ue
ĠStabiliz ation
ĠStabiliz ing
Ġsyr up
Ġtend ency
Ġpa iring
Ġrhe ological
Ġ502538 10
46 93
ĠRoll er
Ġaccept able
Ġ505 19
Ġ505 39
part ially
Ġ5025950 1
Ġ5025950 2
Ġ5025950 8
Ġ5025350 1
Ġ5025350 3
Ġ5025350 4
ĠPrep alrau
Ġ5034797 6
Ġ5034797 8
Ġ5034797 9
ĠCarb oxy
Ġsediment ation
Ġsor ption
Ġ550 87337
emuls ifiers
emuls ifying
yt ical
Ġkind s
Ġentire ly
Ġ1200 000
Ġtap s
Ġmir croscopy
ĠRel ationship
Ġ77 69
ĠUl t
ĠUl tra
Ġ137 189
58 12
ĠIS BN
Ġstirr er
ĠTrans dermal
Ġnetwor k
Ġ3003497 4
Ġ3003497 8
Re lease
To picals
Ġextrem e
Ex ample
Ex cipients
Ġphen yto
Ġ5037 237
Ġ5037 5472
Ġrub bing
Ġ502534 59
ĠAddition ally
Ġendotox in
Ġendotox ins
Ġ5725 4799
Ġ5725 4693
Ġconcern ed
Ġ505742 44
Ġ505742 45
ĠPerme ation
Ġbring ing
ĠCryst alline
Ġprostagland ins
Ġemp loy
Ġcoat ers
antothen ate
ĠDispers ion
Ġ366 53
ĠComb inations
Ġdiagnostic s
Ġster ilization
AE MA
ton ian
alcohol ic
Ġexpos ure
ĠComplex ation
Ġdigest ion
Ġflavour ing
Ġprecipit ate
lov ir
Ġpr ill
Ġglycer ide
Ġnam ely
Ġpop ularity
Ġmaxim ize
Ġ503479 50
Ġ3003496 7
Ġ5034814 3
Ġtransp arent
Ġgloss y
Ġte am
Ġdict ates
Ġbit ter
ĠMa YIG
ĠET D
Ġvi ew
Ġll Pe
ĠNom inal
Ġadmin istered
ĠContin ue
catal yzed
Ġur ine
atetra en
ĠSer um
ĠOph thalmic
Ġassist ant
Ġvalid ation
ĠLut rol
Ġcentr ifuge
ĠToxic ology
Ġ3056 3963
319 36
855 9
Av Orls
ĠÎ ¼m
Ġtinct ures
Ġsulf onam
Ġpenet rate
Ġcrosp ovidonum
ald rate
ĠSy stem
ĠAer omatic
ĠAmer ican
Ġhar der
Ġham per
ĠOp thalmic
ĠEffic acy
Ġ5048 6018
Ġ5049 8559
Ġpreca utions
Ġ5025353 2
Ġpellet ts
ĠAdhes ives
urope an
Ġunderst ood
Isob utane
Palmit io
Ver lag
gha i
sha fen
âĦ ¢
Ġtun ed
Ġsph er
Ġpap ers
Ġcall ed
ĠfOM TIUl
isob utylphenyl
edip ine
Ġmag aldrate
Ġwind ow
ĠTamp ing
ĠTex apon
ĠSmo oth
ĠShan ghai
Ġ234 12
Ġhund reds
Ġnif edipine
Ġnyst atin
ĠOkto ber
ĠButyl ated
ĠMIO QE
Ġ510 31936
Ġ552 3875
Ġthermore versible
Ġacyc lovir
Ġdisapp ear
Ġkidne ys
ĠLyophilis ing
Ġexpens ive
Ġ3025 5812
Ġ30403 404
ĠGrow ing
ĠHerman n
Ġ5028 4249
Ġ50796 353
Ġ775 4
ĠThick ener
Ġindivid u
ĠSpring er
ĠAcryl ates
Ġantacid s
Ġ50022 331
ĠExhibit ing
ĠLudwig shafen
Ġpolyvinylpyrrolid ones
Ġ___ __.
viOr l
Ġtrimeth oprim
Ġ3069729 9
Ġmonohy arate
alsart an
ĠPrepalrau viOrl
Ġphenyto in
Ġ5037237 8
ĠMaYIG enne
Ġsulfonam ides
ĠfOMTIUl AvOrls
Ġ5523875 8
! ?
. !?
0 7
1 49
7 7
8 1
8 48
: ?
? /
A ili
B ro
B lan
B rilliant
C in
C ream
C CU
E muls
E mollient
F rom
F atty
G os
G eneral
H andling
H SP
I V
L Cy
M an
M ild
M yProduct
M TU
N ote
P M
P SC
R eg
R acemic
R ecommend
S e
S kin
S oft
T ol
T erm
U n
U Ie
V al
V IS
W UIU
Y Tol
_ ,
a iv
a zole
b es
b ers
b ally
b its
b ottom
c hemical
c ibility
c ks
c lusivity
d imens
e ose
e Gos
f il
f ty
f ill
f ron
f ication
g ic
g erated
g rade
g reasy
h ts
h our
h ous
h Aili
i ative
i ologically
i ologic
j p
l b
l d
l abor
m is
m ate
m ann
m Pa
o U
o hor
p hed
p ie
p late
r d
r id
r ring
s ion
s uring
t he
t ation
t ific
t ment
t rol
t ured
t op
t ote
t ier
u ch
v a
w ic
w ide
w are
y x
z ation
Ġ ill
Ġ ipophilic
Ġ old
Ġa ff
Ġa roma
in ite
on or
on ym
Ġt c
Ġt ation
Ġt ax
Ġt ory
Ġt ake
Ġt itanium
er gel
er oidal
at s
at able
re test
or ic
or ding
or imet
he umat
en of
Ġs an
Ġs av
Ġs ix
Ġs aline
Ġs well
Ġs omposition
Ġp el
Ġp our
Ġp ension
Ġp yretic
ion ate
Ġc P
Ġc am
Ġc linical
Ġc umbers
Ġc idence
Ġo es
Ġo ptions
es e
ro ph
ro red
Ġf ery
is ian
Ġan ion
Ġan hs
al orimet
it out
it lam
it ites
it iative
le ier
le ft
Ġm ine
Ġm ach
Ġm oist
Ġd hAili
Ġd onor
an ding
an azol
ar ting
ĠP ON
ĠP IT
ĠP atch
ĠP ath
ĠP enetration
ĠP IU
ĠP atches
ĠP Ie
Ġw l
Ġw orld
Ġw itt
Ġb ic
Ġb ata
Ġb onding
Ġb ats
ĠC ur
ĠC ut
ĠC os
ĠC og
ĠC MC
ĠC ertified
ĠKolli ohor
ĠT ry
ĠT io
ĠT eel
ĠT wo
ĠT reat
ĠT OW
Ġfor ced
Ġ1 60
as ible
Ġto ols
ab bits
ĠI BU
ĠS P
ĠS ec
ĠS per
ĠS imp
ĠS ynt
ĠS ince
ĠS GI
us ner
ĠA ffect
ĠA ge
ĠA verage
ĠA IA
Ġre pro
Ġre actions
Ġre ceiv
Ġre ason
Ġre acting
am ot
am bers
Ġpro pos
Ġpro ud
Ġpro tein
Ġpro ceeds
Ġe a
Ġe que
Ġ2 39
ur se
ur ster
il les
Ġg ell
Ġg lo
ut ing
Ġ3 30
Ġ3 11
Ġ3 15
ig ating
Ġh arm
Ġn c
Ġn av
ĠD ev
ĠD MF
ĠD ermatitis
ĠD anazol
ĠO E
ĠO ther
ĠO cc
Ġcon ver
ĠF D
ĠF ow
ĠF rom
ĠF ore
ĠF aster
ĠF LCy
ĠF amot
ra phed
ow les
ow aiv
ĠB a
ĠB es
ĠB ut
ĠB ill
ĠB rilliant
ĠM emb
Ġst ra
Ġst ri
Ġst im
Ġst ated
Ġst rate
Ġst ruct
up ture
ĠE e
ĠE IN
ĠE molli
ĠE mollients
ers atile
ot ometer
Ġth orough
Ġ4 37
Ġ4 700
Ġv ial
Ġv ert
un ities
sol utior
ĠR c
ĠR em
ĠR ud
ĠR ather
ĠR heumat
ĠR abbits
Ġsol ely
co i
Ġ6 1
Ġ6 57
Ġac ron
ĠW iz
ĠW urster
qu ality
st ator
od e
Ġcomp ens
Ġcomp uted
Ġl h
Ġl ab
Ġl atory
ag gerated
Ġus p
im mediate
im icrob
Ġdis ad
Ġdis solutior
per formed
iz es
iz ers
Ġapp arent
em i
Ġco al
Ġco urse
Ġco coi
ĠIn sp
ĠIn itiative
lic les
lic ates
ĠL V
ĠL ear
ĠL ou
ĠL ives
ĠL inear
Ġex aggerated
ib rate
ran e
th ers
Ġ8 6
Ġ8 10
ial ysis
Ġat c
Ġat trib
Ġsp ace
Ġsp ind
ĠG l
ĠG r
ĠG ast
ĠG enerally
ĠG rade
ĠG illes
ens ive
ĠH SP
ir rit
ĠN onst
ĠN ames
ĠN orth
Ġli fe
ap i
ap tive
las ting
Ġ7 9
Ġ7 85
Ġform at
oc el
oc clusivity
ell a
vid es
ĠPro vides
Ġwh ales
Ġwh itout
Ġ20 1
ĠU p
ĠU dol
). :
og P
Ġnot e
ĠV IU
ĠV owles
ĠV ersatile
pro cess
Ġ25 9
ature ly
Ġun bran
Ġun dissolved
Ġ400 0
Ġad vice
IT TY
ĠSt rat
ĠSt arting
ĠKollicream s
Ġsu ffer
Ġma pped
Ġper ceiv
Ġmin ute
lig hts
Ġtem pre
Ġdi lection
Ġ15 687
com es
Ġprocess ability
Ġpre val
Ġr ole
Ġr ights
Ġr upture
hen ing
Ġ40 42
ad a
Ġle ave
Ġcontain e
Ġ- -
Ġ18 2
Ġ18 00
ĠSol utes
ust rated
Ġim part
ali zation
Ġcap ric
Ġcap tured
ys iologic
Ġsub tle
Ġsub mis
Ġsoft ening
Ġch ild
lu ence
Ġint ensity
ĠAl dehydes
ĠComp ound
rib utyl
prop y
prop ionate
Ġdiffer ing
ĠJ ose
ĠJ apan
ĠJ amali
de livery
10 34
10 38
10 94
Ġdist illed
Ġdescri bing
Ġdescri bes
,, .,
Ġen zymes
Ġrep licates
Ġ19 80
Ġchar t
Ġchar ac
Ġchar ge
Ġrecommend ation
PR D
ron yx
Ġro ute
ĠAr tific
Ġ= \
ĠAc cess
ĠAc Di
ĠFormul ating
ĠPar ameter
Ġdispers ive
Ġpur ged
ay er
Ġreg u
TE C
ĠWh itlam
du cibility
op rofen
rig erated
Ġext ensive
Ġinf lam
Ġinf inite
rent ly
Ġdirect ly
poly oxypropylene
lect ive
Ġret arded
Ġguid es
Ġsign s
posit ories
Ġstandard ized
liz e
Ġloc alization
ĠEn suring
ĠEx cept
11 11
11 39
11 33
Ġcol lected
Ġcol labor
ĠAn gle
Ġmeas uring
Ġmethod ology
Ġaccur ately
Ġra ised
Ġvari ance
Ġvari ety
ructure s
Ġmemb ers
Ġ45 31
Ġconcentr ated
Ġ(+ )
Ġ(+ /-
lud ed
Ġphys iologically
Ġinter rup
Ġinter active
Ġinter esting
ĠAR aA
Ġpl ay
Ġmat te
Ġsupposit or
Ġ35 89
Kolli cream
Kolli coat
vant age
Ġ13 52
Ġtrad e
Ġcle ave
Ġamb ien
Ġsc aled
Ġdev ice
Ġstabiliz es
Ġ305544 60
Ġ305544 39
Ġ305544 63
Ġ305544 62
Ġ305544 89
Ġ305544 43
Ġ305544 41
Ġachiev es
ĠPack age
ĠDrug s
stagland ins
Ġent ail
con trol
lus ive
Ġwhere as
Ġocc lusive
Ġbeh ave
eric a
ep a
Ġdepend ency
ĠShe ll
Ġinclud ec
Ġ22 8
Ġorigin ally
Ġtrans late
Ġpract ices
Ġmol ar
Ġconsider ation
Ġconsider able
ĠCont act
ĠCont rol
oll er
ĠNov el
Ġcompar tment
ĠProstagland ir
ĠProstagland ii
inf o
Ġoint men
Ġ36 9
Ġevalu ation
Ġevalu ating
Ġoccur red
vi AR
ĠAssist an
Ġhomogen izer
ĠAcet ate
.- >
Table ts
Ġorder ed
ĠConsist ent
Ġreli able
Ġ38 90
methyl propy
Ġmu cos
ĠPharmac olo
Ġi S
Ġmacrogol s
Ġ199 1
Ġ199 3
ĠCor p
Ġveget e
ĠCh ambers
ĠMan esty
ĠRet urn
Ġvis ion
ĠGU O
Ġj ust
lis h
ĠForm s
Ġspect roscopic
Ġspect roph
Ġpass age
Ġcre ating
Ġout performed
Ġout comes
ĠTri acetin
Ġthick eners
oph ysiologic
Ġcalcul ates
Ġsour ced
Ġtol erability
ĠAb sorbed
63 006
ĠAm ounts
28 2
ĠInf luence
IA UO
Ġprom ised
ĠFactor s
Ġ900 5
EC S
Ġlo ading
Ġident ical
Ġident ifies
Ġpot ent
Ġhist a
Ġhist oric
Ġcondition ed
Ġcondition ers
Ġequival ence
Ġinvestig ate
Ġlys ine
ĠBlend s
ĠSoft ware
Ġminim al
Ġ5025949 0
Ġ5025949 1
Ġ5025949 6
ĠSyn onym
be eck
Ġser ving
Ġser vice
St rat
Ġ360 2
ĠMin eral
Ġrot or
Ġsed imen
Ġsubject s
Ġconc luded
Ġ5025325 2
Ġ5025325 3
Ġ5025325 9
Ġap i
Ġback s
Ġund etermined
78 4
Ġdrop let
Ġfre ely
ĠBro wn
ĠBro cks
ĠMic elle
ĠMic rob
Ġ42 38
ung en
Ġinteg ration
Ġinteg rated
Ġ5025948 1
Ġ5025948 4
Ġ5025948 5
Ġ5025948 9
Par allel
ĠTR PM
Ġbecom es
ĠWH O
ĠHigh lights
198 1
Ġop alescent
ĠSci ence
ĠFe YTol
CO X
sc ale
Ġer ally
Ġer ization
Ġbi owaiv
Ġsimilar ity
meth od
ĠPract ice
ĠIcosapent ate
Ġref rigerated
Ġfe asible
art ame
ĠOle ate
)) ;
ĠTol erability
Ġretain s
urn s
Ġment ally
Ġmir rored
ĠCH I
Ġgra ined
Ġ503 63006
Ġ5026 440
Ġ5026 848
apon ification
Ġ137 282
ĠHydrox ystearate
Ad vance
Ad aptive
oil s
Ġmagn etic
ĠFin n
Ġ198 2
Ġ198 8
Ġ5025326 5
Ġ5025326 7
lace ment
Ġsand wic
ĠTrans fer
Ġcolloid al
ĠEvalu ate
Ġencapsul ates
Re branding
Ġu L
Ġpharmac ologically
Ġdil uted
Ġgo ing
ĠReli able
ĠOr ally
ĠOr ganic
Ġcover ed
Ġrub bed
Ġ502534 13
Ġestab lish
Ġrace mate
OW ITTY
ĠPerme ability
ĠCryst allization
Ġreach ing
Ġredispers ed
Ġprostagland in
Ġemp ty
Ġnear l
ĠComb ining
ĠCommercial ly
110 2
US A
Ġsper m
Ġsper maceti
Ġfac ility
ĠImpro ved
Ġweigh ing
Ġincub ation
Ġincub ated
ĠCompar atively
Ġlipoph ile
Ġlipoph iles
ĠSustain ability
ĠRapid ly
Poly ethylene
Ġsco red
Ġatom ised
Ġadjust ed
ĠMarch ant
Sup positories
opt ical
ĠPhar m
ĠSch leier
ĠMost ly
Ġalter ed
ĠVer beeck
ĠPharmacopoe ias
Acc ording
Inf lammatory
Pro staglandins
gt hening
oct anol
rost ructures
ĠSo ergel
ĠDec yl
ĠDiffer ent
Ġcontrib uting
Ġunivers al
ye ast
Ġpas ty
Ġmo iety
ĠKet oprofen
ĠCan ada
ĠSh ort
ĠDeterm inations
ĠBet ter
ĠHa usner
Ġwee ks
Ġprem aturely
Ġallerg ens
Ġrepe atable
Ġevapor ating
Ġhumect ants
Ġsugg esting
ĠCU e
ĠCe a
ĠAsp artame
ĠMac rostructures
Ġviscos itites
sulf ate
ĠPart ition
ĠMedic ines
ĠRep lacement
Ġmicron ized
Ġinterpre tation
Ġscatter ing
Ġbrow sing
infek tion
Ġpromot ers
Ġpredict ability
Ġopport unities
Ġtail or
Ġfung al
ĠCell s
ĠSter eose
ĠSoc iety
ĠFran z
ĠMet abolism
Ġvent ional
Ġlen gthening
ĠInter actions
Ġdru as
ĠVari able
Ġphot ograph
Ġmonog raphed
Ġinde pendent
ventil ated
Ġquali fication
Ġprepare c
Ġpharmaco kinetics
ĠNeut ronyx
Ġelabor ated
Ġexpert ise
ĠUlt imately
ĠUltra fil
Ġspher ical
Ġdisappear ing
Bro okfield
Blan k
CCU UIe
Emuls ifying
Mild ness
MyProduct World
MTU IAUO
PSC l
Recommend ation
Soft gels
Un like
Val oU
dimens ional
eGos o
fron t
hous e
tier ed
Ġill ustrated
enof ibrate
Ġsan ll
Ġsav es
Ġpel licles
Ġcumbers ome
isian a
Ġanhs ant
alorimet ry
Ġmach ines
ĠdhAili fty
ĠPON MTUIAUO
ĠPath ophysiologic
ĠPIU eGoso
ĠPIe ValoU
Ġworld wide
ĠCur rently
ĠCut out
ĠCos metic
ĠCog nis
ĠTreat ment
ĠTOW OWITTY
ĠSec ond
ĠSper maceti
ĠSimp le
ĠSynt hetic
ĠAffect ing
Ġrepro ducibility
Ġreceiv er
Ġpropos ed
Ġgell ed
Ġglo bally
Ġ311 21
Ġharm ful
Ġnav igating
ĠDev iation
ĠDMF s
ĠOcc lusivity
Ġconver ted
ĠFow ler
ĠFore front
ĠFamot idine
ĠBill erica
ĠMemb rane
Ġstri rring
Ġstim uli
Ġstrate gic
Ġstruct uring
ĠEIN ECS
ĠEmolli ence
Ġvert ically
ĠRem ove
ĠRud y
ĠRheumat ology
Ġacron ym
ĠWiz ard
Ġcompens ate
imicrob ial
Ġdisad vantage
ĠInsp iring
ĠLear n
ĠLou isiana
Ġspind le
ĠGast rointestinal
ĠGilles pie
irrit ating
ĠNonst eroidal
ĠVIU CCUUIe
process ed
Ġunbran ched
Ġsuffer ers
Ġperceiv ed
Ġtempre ature
Ġpreval ent
Ġsubmis sion
Ġchild ren
ĠJose ph
ĠArtific ial
ĠAcDi Sol
Ġinflam ma
Ġcollabor ation
Ġ(+/- )
Ġinterrup ted
ĠARaA viAR
control led
Ġmucos al
ĠPharmacolo ay
Ġspectroph otometer
ĠSynonym s
ĠFeYTol tote
Ġbiowaiv er
Ġ5026440 9
Ġ5026848 9
Advance ments
Ġsandwic hed
ĠStereose lective
ĠUltrafil tration
ĠPONMTUIAUO TIS
% ).
2 4
3 00
4 00
6 1
6 4
A A
A n
C on
C omposition
E T
E icosapent
F FT
I P
L C
N H
O O
S G
U U
V G
a em
a phyl
b itan
b enc
c ro
d ha
d ried
h i
i O
j unction
k yl
l ave
l omer
m ax
n o
n ow
o ose
r r
r ight
r illed
t a
u ation
u der
w ing
w able
x t
Ġ iod
Ġa est
Ġa romat
in ity
in lin
or ial
en eric
Ġs r
Ġs it
Ġs martseal
li benc
Ġf lus
ic id
ic ochemical
it us
le aning
Ġd erm
Ġd ust
Ġd ialysis
ar med
ar row
ĠP an
ĠP elle
ĠP antothen
ĠC a
ĠC er
et e
ĠT ap
ĠT aste
ĠT orr
ĠT ensile
ĠI mp
ĠS aponification
Ġre co
Ġe R
Ġe S
Ġe h
Ġe y
ur il
Ġg f
Ġg eismar
Ġ3 47
um ed
Ġh lb
Ġn ov
ĠD em
ĠD uring
ĠO ld
Ġcon junction
ĠF ib
ĠF irst
ĠF ind
ure th
ith in
ĠM ethyl
ĠM MA
ĠM FFT
Ġst age
Ġor ders
ili t
Ġ5 6
ĠE V
ĠE ee
ĠE icosapentaenoic
Ġ4 30
don ic
ty p
Ġv om
ĠR iton
ĠW t
ĠW SG
st anding
Ġl atter
Ġl udipress
Ġl ogP
Ġ0 2
act iv
Ġk Pa
Ġk now
em perature
ĠL u
Ġex act
th ough
Ġsp ring
ĠG eneric
ĠG libenc
ĠH ene
ĠH yg
Ġ50 30
ant ly
ant op
Ġ7 88
oc lave
ĠV ol
ĠV ardenafil
pro of
ED DS
ip id
cess ful
Ġ10 3
Ġ10 4
av ir
ĠTh us
Ġ15 00
Ġsh ort
com e
Ġemuls ification
ĠFor ce
Ġab sorb
ad es
pens ing
ĠSol ution
Ġam picillin
Ġsub coating
lu con
se o
ĠAl ternative
ĠAl kyl
ĠAl though
Ġde xpanthenol
AL A
Ġdist inct
Ġethyl esters
Ġcom e
Ġro und
Ġran ging
lin oleic
Ġbl oc
ia z
ĠPar achute
Ġeth oxylated
19 80
Ġnon ionic
20 63
Ġover come
Ġ3055 40
poly propylene
Ġpress ed
su ch
lam ide
ve x
ĠIl cosapent
Ġenh ances
cc us
rop rilled
dis integ
Ġphys ico
Ġmic roprilled
DS C
Ġvit al
49 9
Ġ13 5
Ġprop ranolol
Ġchemical ly
Ġstabiliz ed
ĠCoating s
Ġimport ance
ĠSup er
Ġallow ed
Ġallow ance
Ġpart ial
Ġanal ytical
dispers e
dispers ed
amin o
oid s
Ġ> .
Ġstud ied
Ġ14 6
Ġprevent ed
Ġcell s
ĠJP E
inf ection
ĠAcet one
Table t
Ġprodu ce
Ġi e
Ġenhan cers
for ce
for ated
ffer ves
Ġextr uder
Ġj apan
ob er
Ġout standing
Ġ67 5
ĠAS A
ĠAS S
ĠAm ide
ĠAm mon
ĠAm orphous
ĠAm picillin
ĠFoam ing
cryst als
Ġhist ory
ĠSoft gel
Ġres earch
iner alized
Ġmajor ity
Ġlar ger
Ġexper ience
Ġoxid izes
198 2
198 3
ĠCros spolymer
ĠDE AEMA
ĠSu ccinic
ĠSu cro
etail s
Ġbuil t
meth y
Ġsor bitan
Ġelect roly
ĠGran u
Ġassoc i
Ġmagn itude
ĠBC F
Ġdiethyl amino
ompat ibilities
ĠNew tonian
Ġagg lomer
Ġcontinu ous
ĠSub st
Ġnutr ition
Ġcs a
Ġweak ly
Ġsubse quently
ĠAcetyl trib
icos pent
icos atetraen
ĠSor bitol
Ġredispers e
ĠInc ompatibilities
ĠDispers ions
Ġfac ilit
ĠCompar ison
Ġsco pe
ĠDoc osapent
ĠAtom ization
ĠAtom izing
ĠLi ke
Ġclos ed
Ġmolec ule
Ġremar ks
Ġsuc cessful
ĠChem istry
hydroxy poly
ĠWe igh
Ġmedic inal
Ġestim ated
Ġemploy ing
Man esty
Reg Xcellence
Ġaff inity
Ġattrib utes
Ġaest hetically
Ġaromat ic
inlin er
Ġsit uation
uril sulfate
Ġnov ata
ĠDem ineralized
ĠFib re
ĠRiton avir
ĠGlibenc lamide
ĠHene icospent
antop ra
lucon ate
ĠIlcosapent ate
fferves cent
ĠSucro se
ĠAcetyltrib utyl
1 35
5 1
5 4
6 47
8 3
8 80
? .
A TBC
C affeine
D oc
H ME
I ESE
J E
L ipo
M U
M olecular
M oisture
P S
P IT
S T
S s
S IG
S DS
T G
Z IG
a V
a ing
b st
b inder
c omp
c ence
c ans
c lusion
d ine
f igure
f unctional
g lycerides
h ot
l ock
m n
m ass
n el
p H
p l
p ut
r int
s a
s ample
t ents
x ide
x ane
y ethylene
z ine
Ġ q
Ġ .,
Ġ icosapent
Ġa a
Ġa z
Ġa er
in y
on it
Ġt a
Ġt riggered
er c
at ro
or os
or ter
or ata
or gan
Ġs s
Ġs imp
Ġs aturated
Ġs ls
Ġp icture
Ġc ir
Ġc ep
Ġc alorimetry
Ġo thers
Ġf act
Ġf raction
Ġf da
Ġf ete
is ation
is ep
Ġan est
al mon
Ġm ents
Ġm Pa
Ġm bar
Ġd D
Ġd c
ĠP I
ĠP ot
ĠP IG
ĠP ia
Ġw t
Ġb a
Ġb ri
Ġb acter
Ġb ay
ĠC leaning
et ent
id ose
Ġ1 25
as tic
as king
ĠS U
ĠS X
ĠS ome
ĠS almon
ĠA part
am az
el ow
Ġpro ved
Ġe p
Ġe u
Ġe ae
Ġe ffervescent
Ġ2 10
Ġ2 18
ur ability
ur face
Ġg ener
ut ra
ut ri
ig ur
Ġn utri
ĠD etailed
ĠD iaz
ĠD etails
ĠO M
ĠO U
ĠO bst
ĠO xide
ĠF enofibrate
ate x
ph ase
ĠB alance
ĠB elow
ĠM I
ĠM atrix
Ġst ate
Ġst ill
Ġ5 9
ĠE uropean
Ġv et
Ġv alsartan
Ġwith ou
ĠW y
ĠW il
pp ing
pp erm
Ġal read
Ġcomp etent
Ġl od
Ġl so
Ġl atex
ag inal
im ents
Ġdis k
act ic
ac in
ain ing
Ġco ales
Ġco processed
ĠIn version
ĠL orata
Ġex ter
har d
Ġ30 44
Ġ30 59
th yl
Ġat t
ear y
ĠG yn
Ġpoly eth
ĠH R
ĠH eal
ĠN on
ĠN atro
Ġ7 6
AR T
Ġ9 4
Ġ20 18
Ġ20 12
pt ive
ch loride
pro tect
ver ed
Ġad sorb
Ġad sorbed
ip ic
Ġ12 7
ry cans
Ġsh aking
Ġsh orter
Ġact ivity
iliz ed
Ġph osph
ĠReg X
Ġr oller
Ġab und
Ġmon omers
ĠPlastic izer
ĠPlastic izers
Ġcap able
Ġch oose
Ġint est
yr id
Ġplastic ity
Ġse paration
Ġen able
ĠCet eary
Ġmed i
Ġrep ort
Ġhyd rate
Ġdistrib ute
Ġ19 49
out h
Ġcream bases
Ġeffect ively
ĠQ S
40 7
Ġpur ified
ay able
ĠWh ere
Ġacet ic
op hen
ĠRE N
19 87
Ġolli phor
Ġne xt
poly ethylene
su le
ĠCetostearyl alcohol
Ġx X
Ġsur fac
liz ing
Ġmain taining
ĠEx t
ĠEx ha
Ġdissolv ing
Ġvari ability
ĠDi rect
ĠDe livery
Ġox yethylene
49 5
Ġprop ort
Ġaddition ally
Ġcle an
Ġ16 1
Ġstabiliz ation
Ġ305544 35
Ġ305544 59
Ġ305544 87
Ġ305544 86
Ġ305544 58
Ġ50253 28
IS IESE
22 7
Ġpart ially
Ġfin ely
ĠAd opt
ĠUn it
ĠEth oxyl
Ġ22 7
osahex aenocic
Ġclear ly
ĠMacrogol glycerol
Ġmult idose
Ġ306 3
Ġj et
Ġthick ness
ĠMix ing
Ġsupple ment
ĠMeth ocel
hydro philic
Ġopt imum
Ġsubject ed
Ġsev en
Ġ5025325 6
Ġ5025325 7
iff in
Ġel ongation
Ġexper iments
Ġdef ect
ĠCol ourless
198 4
Ġpred omin
ĠMel t
ĠWet ting
ĠTherape utic
Ġhel d
az a
Ġ502538 56
Ġconf igur
Ġsor ayable
utr ition
iven ess
Ġ503 55
oil ing
Ġdom in
Ġ5025326 9
ĠSur face
Ġbrown ish
Ġinit ially
Ġmechan ical
Ġmechan isms
imet idine
Ġperox ides
Ġcorresp onds
US AN
ĠSustain ed
Ġexpos ed
Ġspread ability
Ġprecipit ates
ĠLi quid
Hyd ro
Hyd rophilic
omin ally
Ġexception al
Ġassess ing
Ġfavor able
Ġagreem en
arbon ate
oco ccus
Ġfilter ed
Ġjer rycans
mann itol
Ġbic arbonate
ĠBes ide
Ġstra ight
ĠGr iffin
AA ZIG
Con tents
Eicosapent aenocic
Ġflus hed
icid al
ĠPelle ts
ĠPantothen ic
ĠImp act
135 2
PS D
SIG ISIESE
oros ity
Ġanest hetic
Ġbri ef
ĠSalmon ella
amaz ep
utra lized
Ġnutri ents
pperm int
Ġalread y
Ġlso propanol
Ġcoales cence
ĠLorata dine
Ġexter nal
ĠGyn ec
ĠNatro sol
protect ed
Ġabund ant
Ġsurfac es
ĠExha ust
Ġ5025328 1
ĠAdopt ed
ĠEthoxyl ates
Ġpredomin antly
AAZIG A
SIGISIESE AAZIGA
, :
- %
0 4
1 20
1 44
1 60
3 2
6 50
6 63
7 1
7 6
B S
B es
B ulk
B inder
B ET
C I
C d
C r
C CO
E I
E N
E nter
G A
G R
H Cl
I n
I IG
I mpro
I Cl
J RS
K N
L aV
N N
N e
N ov
O Y
O tal
P as
P PO
P icture
P antothenate
S p
S ym
S welling
S emi
U E
V ICl
Y R
] ,
a ol
a res
b ioavailability
c f
c linical
c olated
c arbon
d es
d al
d le
d isc
e pt
f da
g ical
g ile
g ins
h al
h ow
h ere
i ig
i ri
i Cd
j pe
k able
k pa
l ain
l av
l my
m e
m an
m el
m yristate
o e
o i
o ethylene
p rint
p iCd
r s
r as
r usion
s er
s us
s os
s ence
s ales
s urface
t g
t ling
u ously
v isk
w in
w armed
z en
Ġ $
Ġ °
Ġa ry
Ġa CCO
in itis
in dependent
on as
on tal
Ġt i
Ġt ub
Ġt ac
Ġt eg
Ġt ann
Ġt rich
Ġt ube
Ġt ensile
Ġt ributyl
Ġt aining
at ri
at est
at ant
ol or
ol uble
ol ipid
re ce
or iz
or her
or aing
he lmy
Ġs ali
Ġs ave
Ġs ulphate
li t
Ġp ared
Ġp erman
Ġp antothenate
Ġp antopra
Ġc ul
Ġc os
Ġc ec
Ġc ert
Ġc acid
Ġo F
Ġo ct
Ġo per
Ġo mac
ro t
ro re
ro ved
Ġf ar
Ġf ield
Ġf unctional
Ġf rost
is co
is sc
ic ult
ed iment
al low
al ox
al dehyde
it ored
Ġin ad
Ġin version
Ġm L
Ġm es
Ġm enthol
Ġd im
Ġd ib
an tic
an gle
ĠP i
ĠP se
ĠP ages
ĠP arenteral
ĠP late
ĠP olid
ĠP inc
ĠP YR
Ġw ild
Ġw ww
Ġb urns
ĠC D
ĠC y
ĠC ore
ĠC alc
ĠC loud
ĠT im
ĠT emperature
Ġfor rr
ul es
Ġ1 38
ĠS m
ĠS on
ĠS AR
ĠS ug
ĠS eal
ĠS ha
ĠS EDDS
ĠS ediment
om en
om et
om eth
om enthol
om onas
ĠA ug
ĠA ten
ĠA VG
Ġ( )
Ġ( ~
Ġis oluble
am il
Ġpro phyl
Ġe pid
Ġe Bes
ur on
ur ities
il ute
Ġg luconate
Ġ3 000
Ġh oriz
ly piCd
Ġn ere
Ġn ominally
ĠD IN
ĠD rink
ĠD ilute
ĠO ily
ĠO wing
yl paraben
Ġcon ven
Ġcon vex
ĠF ill
ĠF lash
ĠF IO
ra con
ra ck
ra issc
ph atic
ith rom
ĠB ottom
ĠB oiling
ĠM ast
ĠM ay
ĠM ake
ĠM iscible
Ġst see
ili b
Ġ5 8
Ġ5 25
Ġ5 19
Ġ5 98
ĠE R
ĠE l
ĠE lect
ĠE icosatetraen
ers izer
ers uch
ot ient
ot print
Ġth erape
Ġ4 4
Ġbe er
Ġbe gin
Ġbe gins
Ġas h
Ġas cer
Ġv a
Ġv seo
if en
ĠR ating
ec yl
Ġsol d
ri um
ri etary
Ġac ne
ĠW ir
ĠW IN
ĠW hether
pp m
st ers
Ġon ce
Ġl ol
Ġl ine
Ġl ll
Ġl ump
Ġl atest
Ġ0 8
Ġ0 9
ess iO
AS A
form amide
Ġco ev
Ġco hes
ĠL ev
ĠL ime
ĠL oper
Ġex erc
Ġ30 1
Ġ30 2
Ġ30 57
Ġ30 499
ax is
Ġ8 8
Ġ8 25
Ġ8 19
ĠG TA
ĠG iven
ĠG Cl
ĠH em
ir med
ĠN A
ĠN E
ĠN ic
ĠN one
ĠN ee
ĠN ever
ĠN umbers
ĠN arrow
ĠN utrition
ap our
ap amil
Ġ7 60
Ġ7 68
oc anol
Ġ9 2
Ġwh y
Ġ20 17
ĠU rea
IN W
erm is
ethyl formamide
Ġpar acetamol
ch ure
Ġnot able
ĠV J
ĠV IN
ĠV orher
ĠV apour
Ġgrad ients
ver n
Ġad here
ip le
dit ions
ific ate
ff e
av y
Ġper forated
Ġper colated
Ġmin t
ĠTh i
Ġ12 4
Ġ15 1
Ġsh all
Ġsh ake
Ġact s
iliz e
Ġph yto
Ġprocess ed
Ġpre warmed
Ġr Otal
Ġtablet ed
Ġpolymer isation
Ġdet ect
kin ess
ore n
Ġle ft
Ġmon itored
Ġsup ern
Ġ18 1
Ġ18 5
Ġ18 7
Ġ18 9
Ġsuspens ior
Ġag it
Ġsub coat
ĠSp ec
se quent
ĠPoly phenols
par ately
prop rietary
Ġdiffer enc
Ġuse ful
rol ong
ĠJ e
ĠJ OY
Ġqu ite
Ġqu otient
Ġbin ders
Ġ64 0
Ġse parately
sor ptive
ĠCo ol
ĠCo ater
ĠCo povidone
® /
ht tp
Ġalcohol ic
Ġen ables
ĠCet iri
Ġmed iz
Ġmed ication
Ġhe xane
Ġsubst anti
ill us
we et
Ġeffect iveness
ĠPS D
Ġdispers e
Ġdispers ants
Ġdifferent iation
Ġreg ardless
Ġreg arded
Ġmel ts
ĠRE E
Ġindividual ly
rig ation
Ġnon proprietary
20 2
Ġinf lection
Ġ17 2
DI LY
44 00
poly mers
Ġant imicrobial
Ġant isep
ĠCon clusion
Ġev e
Ġthere by
lo hex
Ġ24 2
Ġ24 6
Ġ500 006
Ġimp urities
Ġ11 7
Ġno zzle
Ġvar us
pend ing
Ġcol ourless
Ġhum ans
Ġla VICl
Ġ50259 8
dis in
Ġsens ation
Ġmic elles
Ġexp lain
ne a
Ġaffect s
Ġprep ares
ĠDe pending
Ġhydro carbon
Ġ13 663
ĠEmuls ion
Ġdev iation
Ph ase
IS INW
Ġtechn ic
22 6
Ġent angle
yc in
ĠAd ipic
ĠDO GR
lor oethylene
21 65
amin ophen
Ġselect ing
Ġselect ively
ĠShe lf
ĠProp ylparaben
Ġlight ly
Ġtrans ester
Ġrem ove
Ġcit ric
Ġbro chure
Ġ14 5
tab ly
Ġprevent ing
oll en
Ġass umed
Ġcompar ably
Ġdiff icult
Ġhomogen izing
aff irmed
Ġprodu cing
Ġcent ration
ĠHyd ration
Ġaccording ly
Ġfunction alities
Ġmu cous
ĠNe ither
Ġfollow inc
Ġmult iple
pharmaceutical s
tal ent
ĠCor resp
Ġpe ppermint
und um
Ġset tling
Ġcor undum
Ġcalc ium
lis ation
Ġcre ates
ĠHe avy
13 2
Ġfra gile
Ġcalcul ation
Ġaut om
Ġaut oclave
Ġinstant ly
ĠAb sorptive
ĠInd ometh
Ġneutra lizing
28 647
Ġshell ac
IA DILY
app roved
Ġmisc ibility
Ġlo e
Ġgro up
Ġmet al
Ġmet als
Ġres id
ĠUs Se
ĠOct ober
ĠMeth od
ĠRecommend ations
Ġwor d
ĠMin utes
cor n
Ġconc lusion
ibiot ic
Or dal
Ġ~ ~
95 650
Ġel astic
Ġdisc olor
ĠManufact urability
PC ru
Ġrecept ors
Ġ99 0
Ġinteg rant
Ġchem ica
ĠRic inoleate
apor ation
Ġantibiot ic
Ġhydroph ilize
Ġbip l
Ġoptim al
ĠLa urilsulfate
Ġperson alized
ĠProtect ion
ĠCarb amazep
Ġutiliz e
Ġutiliz ed
Ġsor bitol
Ġref ining
Ġefficient ly
Ġneglig ible
PE O
Ġprefer able
Ġinvol ved
Ġinvol ving
43 55
Ġsuper disin
Ġmir co
Ġcoar ser
Ġ77 2
Ġ77 7
olid iny
ĠAnt ibiotic
ĠPhys icochemical
Ġpres ents
Ġpres cription
Ġcare ful
ĠAct ion
Ġ53 2165
Ġsensit ivity
Ġfo otprint
Ġdec ades
ĠSub sequent
los ure
Ġphen yl
Ġ50348 144
ĠGranul ate
Ġprincip le
Ġmechan ism
ĠTe Ul
ĠImpro vement
Ġ=== =
Poly sorbate
old en
Ġinject ions
Ġinject ables
Ġwound s
Ġrecryst al
Ġ66 131
Ġposs ess
440 1
Sup ersedes
lov aza
Ġnam ed
ĠFunction alities
Ġalter ations
ĠVer apamil
Ġpop corn
ĠPharmacopoe ial
Ġ503479 48
Ġ3003496 4
Ġengraving s
Ġ5034814 5
Acc ela
Inf rared
ĠDec ant
ĠDiffer ential
ĠOS S
Ġcontrib ute
Ġunivers ally
ĠMono oleate
Ġpredic table
Ġpredic tably
Ġmolec ules
ĠCOM p
ĠCOM IP
Ġremar kable
Ġvag inal
Ġsuc ceeding
Ġextrud ed
Ġextrud able
Ġche wable
ĠBe es
ĠBe fore
ĠMal onic
ĠMal vern
Ġtherm od
Ġ5042 4
Ġintens ifies
Ġsw allow
Ġsw ollen
ĠAB A
Ġreve al
ĠlO rece
Ġcoagul ation
Ġcoagul ate
Ġ3027 4400
Ġ3027 4401
Ġammon ium
Ġammon ia
ĠOctadec atri
Ġ50519 57
Ġ50539 226
ĠCarboxy methyl
ĠCarboxy methy
ĠSystem s
ĠSystem atic
âĦ¢ ,
the less
Ġ86 227
ĠMicrob iological
ĠSecond ary
OO s
aphyl actic
no donic
Ġderm al
Ġreco vered
ĠMethyl paraben
ĠMMA IIG
ĠEV OH
ĠLu visk
Ġ5030 62
Ġbloc ks
disinteg rants
Ġjapan ese
ĠAmmon ium
Ġelectroly te
Ġassoci ates
ĠSubst rate
Ġfacilit ate
Ġaz ithrom
organ isms
Ġcir c
ĠPIG so
Ġgener ate
ĠDiaz olidiny
ĠObst et
ĠWil helmy
Ġ3044 4355
Ġ3059 36
Ġatt ention
Ġpolyeth oxylated
ĠHeal th
Ġphosph olipid
ĠExt rusion
Ġconfigur ation
Ġdomin ates
Ġbrief ly
ĠGynec ol
Cr nea
Enter ic
Impro vement
LaV Ordal
Nov ember
Sp ray
aol in
disc losure
sus pend
sos raissc
ĠaCCO oraing
Ġteg rants
Ġtann ins
Ġtrich loroethylene
Ġsali va
Ġperman ent
Ġcul ture
Ġcec sosraissc
Ġomac or
alox ifen
Ġinad equate
Ġdim ethylformamide
Ġdib lock
antic aking
ĠPse ud
ĠPolid ocanol
ĠPinc ers
ĠTim nodonic
ĠSug ar
ĠSha ke
ĠSediment ation
ĠAug ust
ĠAten olol
ĠAVG IADILY
Ġprophyl axis
Ġepid ermis
ĠeBes op
Ġhoriz ontal
lypiCd l
Ġnere in
Ġconven ient
ĠFIO PCru
racon azole
ĠMast ersizer
Ġ525 95650
Ġ519 28647
ersuch ungen
Ġtherape utic
Ġascer tain
Ġvseo a
ĠWIN E
essiO l
Ġcoev aporation
Ġexerc ise
Ġ3057 225
Ġ30499 39
Ġ819 26
ĠGCl Crnea
ĠNever theless
ĠVorher r
Ġphyto pharmaceuticals
ĠrOtal y
Ġsupern atant
rolong ed
ĠJOY ISINW
ĠCetiri zine
Ġsubstanti ate
Ġ500006 95
Ġhydrocarbon s
Ġ13663 6
Ġentangle ment
Ġtransester ification
ĠCorresp onding
ĠIndometh acin
ĠUsSe O
Ġdiscolor ation
Ġ532165 45
ĠTeUl OOs
ĠCOMIP essiOl
ĠOctadecatri en
ĠLuvisk ol
Ġazithrom ycin
Ġphospholipid s
LaVOrdal ory
Ġcecsosraissc rore
ĠFIOPCru es
. /
0 50
0 40
0 80
0 17
2 45
5 19
7 4
A TEC
C H
D isclaimer
E A
E F
E GA
H I
H ome
I nn
J P
M ent
M IG
M MA
N R
P re
R H
S I
S O
S odium
T T
T ST
U IT
W E
b l
b le
b oren
c ols
c aline
c ked
c lohex
d m
d rum
e ad
f at
f ur
f ile
f aint
g ran
h ance
h ren
h oids
i q
i ol
i et
i ency
i pped
i pping
j et
k KN
l en
l ubric
l aced
m un
m atrix
n a
n dering
o o
o jet
p lease
r ub
r ise
s f
s h
s es
s il
s ch
s apon
t es
t ri
t ions
u c
u es
u ide
v ia
v onic
v aginal
w th
x ent
y a
y ro
Ġ ul
Ġ ii
Ġ oleate
Ġ oleic
Ġ ureth
Ġa N
Ġa ce
Ġa im
in ated
in amide
in phosphate
on ation
on ist
Ġt m
Ġt ian
Ġt ren
Ġt urn
Ġt ables
Ġt win
er k
er ature
at i
at en
at ine
ol a
re w
re pt
or ant
he an
en icity
Ġs um
Ġs pp
Ġs ince
Ġp y
Ġp age
Ġp ron
Ġp ath
Ġp arenter
Ġp henol
Ġp orosity
Ġp rolonged
ion ally
Ġc m
Ġc ardboard
Ġo t
Ġf ri
Ġf ace
Ġf all
ic am
ed i
ed ic
ed ite
al gin
it al
it ing
it ch
it utes
it erature
Ġin jection
Ġin lets
Ġin activ
Ġm al
Ġm ot
Ġm illed
Ġm outh
Ġd p
Ġd ent
Ġd os
Ġd est
Ġd ance
Ġd ivid
Ġd ermat
Ġd ynamic
an ges
an oco
ar iz
ĠP a
ĠP b
ĠP o
ĠP yrid
ct um
ation ic
ing redi
Ġw ays
Ġw arm
Ġb w
Ġb ow
Ġb rom
Ġb ak
Ġb lue
Ġb alance
Ġb rid
ent il
ĠK aolin
ĠC ert
ĠC yc
ĠC ii
ĠC inn
ĠC ode
ĠC imetidine
ĠC ationic
ĠT C
ĠT m
ĠT ut
ĠT ributyl
Ġ1 10
Ġ1 19
Ġ1 49
as ionally
ĠS yl
ĠS alicylic
ĠS ind
ĠS weet
us able
om ogen
ĠA L
ĠA queous
ĠA ve
ĠA MU
Ġre ndering
Ġre ctum
am ke
el ar
Ġpro via
Ġe icos
Ġe uropean
ur r
ur able
il a
il ung
Ġg erm
Ġg rin
Ġg reasy
Ġg ta
Ġg olden
ut h
ut ag
ut des
Ġ3 22
um n
um ent
Ġh s
Ġh az
Ġh aem
ly ing
Ġn er
Ġn as
ĠD ried
ĠO L
ĠO e
ĠO pt
ĠF O
ĠF r
ĠF lat
ĠF CC
ra c
ra per
ph an
ith ir
ĠB r
ĠB ac
ĠB AS
ĠB acter
ĠB ism
ĠM w
ĠM ee
ĠM echan
ĠM ason
ĠM asking
Ġst and
Ġst ick
up led
Ġ5 20
Ġ5 31
ĠE I
ĠE a
ĠE t
ĠE sp
ot o
ot inamide
Ġth ro
Ġ4 7
Ġbe i
ub itus
Ġv ul
Ġv acc
tic ul
if ial
sol ubility
ĠR R
ĠR ib
ĠR AR
ĠR ode
ĠR aloxifen
ec ithin
co ater
Ġ6 3
ri ers
ri hi
ĠW ound
ĠW itch
qu er
Ġal sc
Ġal ternatively
st ream
oly tic
Ġcomp oun
Ġcomp lying
Ġl in
Ġl ac
Ġl ast
Ġl ined
Ġl sopropyl
Ġl ayer
Ġdis e
Ġdis infection
est ed
est ant
Ġk eep
Ġk ept
form ance
Ġco upled
end ly
ĠIn hibition
ĠIn activ
ĠL R
ĠL iterature
ĠL ecithin
Ġex ceeds
th s
th al
th rough
ect ant
ma z
ĠG R
ĠG i
ĠG ood
ĠG all
ens it
ĠH IV
ĠH omogen
Ġ50 7
ĠN AR
oc h
oc on
oc ument
ell er
ell ence
ĠPro ceed
ĠPro ceeding
ĠIN G
Ġwh at
Ġwh ithin
Ġ20 10
ĠU MC
ug en
IN N
Ġpar ameter
Ġapplic ability
ĠV ery
ĠV alid
ĠV alsartan
ĠV entil
Ġ25 8
Ġun usable
Ġad v
one xent
dit ional
ĠSt e
ĠSt ress
ĠSt rept
Ġsu fficient
Ġsu ccinic
Ġ10 8
Ġper f
ĠTh yro
isc hen
25 2
Ġ15 3
Ġ15 8
ud iflash
Ġsh if
Ġsh op
Ġsh ipping
com mon
Ġav an
of lav
ment hol
Ġab solute
ad s
ign ed
Ġ18 50
Ġlow ers
Ġim mun
Ġcap ill
fact orial
rox icam
Ġag onist
Ġch ina
Ġint ra
ĠAl low
ĠAl caline
ĠPoly oxyethylene
par ticul
ĠComp action
Ġdo e
nt ersuchungen
Ġup set
Ġ70 5
ĠCo res
ĠCo ffe
® .
oun ced
Ġ5025 15
Ġen orm
Ġrep laced
Ġme q
ĠIt raconazole
ĠDis pensing
ĠDis infection
TH EF
Ġ19 1
Ġkolli tab
ĠAr ch
all er
ĠIP C
cy clohex
Ġmeth y
rect ion
rect al
Ġeth y
Ġeth oxyl
ĠApp ly
Ġ200 8
op alescent
Ġgel atine
Ġcur ves
Ġne uron
20 22
20 21
34 6
poly vinyl
Ġant if
ĠCon ditions
Ġret ard
Ġret arding
Ġdisinteg rate
Ġconsist ently
Ġsur gical
ĠEE E
Ġinst ance
ĠEn hance
Ġmain tained
Ġ24 00
ong estant
.. ..
Ġ11 8
30 7
Ġcol our
Ġcol umn
ĠAn al
ĠRe pose
Ġcar riers
Ġmeas urable
Ġplasticiz ing
Ġ45 00
Ġconcentr atior
Ġinter est
Ġequ al
Ġequ ilib
Ġequ ipped
ne utralized
hex idine
Ġvers ions
Ġstructure s
Ġ13 66
Ġtast es
Ġspec ies
Ġamb er
Ġstabiliz ing
Ġocc asionally
Ġsynt hetically
ĠUn iform
ĠUn sapon
amin ation
amin ated
Ġdepend ence
Ġ33 1
Ġ33 7
Ġ22 4
Ġlower ed
Ġsystem ic
te ilung
osahex aenoate
ĠZ ink
atin n
Ġso on
Ġso ap
18 8
ĠMon ths
Ġ14 2
Ġmol es
Ġsm ell
Ġprevent ion
Ġass igned
ĠNov ember
ĠNov algin
Ġ36 8
ks amke
ĠAcet aminophen
Ġprodu ces
Ġvol atile
Ġsmooth ing
ĠSe lection
16 6
16 7
ĠY ellow
ĠNe a
ĠNe uge
yst ear
ĠCh lor
ĠCh anges
Ġtri al
Ġtri acetin
Ġcor rection
Ġtis sue
ĠForm ation
Ġfilling s
ob acter
ĠHe x
ĠHe ating
ĠBl ood
acet ate
Ġsour ces
Ġ120 1
79 5
Ġtol erated
ĠInd ication
Ġmicro b
Ġmicro organisms
ĠTalc um
Ġremain s
Ġlo zen
Ġgro wth
ĠBlend ing
Ġmet abol
Ġminim izing
Ġeffic iency
hydro fur
MF FT
ĠPhen az
ĠPhen acetin
Ġ23 6
Ġel p
Ġ55 6
ĠManufact ure
ĠCap sules
ĠCap sule
ĠMic elles
Ġlipid s
Ġchem ists
Ġop ening
Ġsilic one
Ġpa per
Ġbas is
pant othen
orr hoids
Ġbi ologic
Ġbi ochemical
ĠLubric ant
Ġissu ed
Ġgen ric
Ġgain s
emuls ions
emuls ification
Ġfe eding
Ġadditive e
ĠPer ugen
Ġgra v
thalm ics
Ad dition
Ġmagn ification
ĠAnt imicrobial
ĠFin ished
Ġcompact ability
Ġmas ks
ĠAct a
Ġu k
Ġdec ubitus
Ġdec ongestant
Ġdown stream
ĠSub coating
Ġprot onation
Ġrob ot
Ġalkali s
Ġtritur ation
Ġsal ts
ĠCit rate
Ġster ilized
Ġatmosph ere
Ġodour s
dissolv es
Ġauxili ary
Ġinject able
ĠDoc osahexaenocic
ĠPhar sil
Ġ50209 110
ĠExper ience
Ġ30531 225
Ġtransp ort
Ġdict rihi
ĠSo ya
Ġvi able
Ġadmin ister
Ġclos ure
Ġpredic ting
ĠKet ocon
ĠCan cer
Ġvag ina
Ġhumect ant
Ġsugg ested
Ġinsert ed
Ġche cked
ĠNot es
ogen icity
Ġintens ively
Ġenvironment ally
Ġ5020910 7
Ġ5020910 8
Ġ5020910 9
Ġ3053122 4
Ġ3053122 6
Ġ3053122 7
Ġip m
Ġtr ue
Ġtr ithir
Ġreve als
Ġjer ric
Ġcam n
Ġcam mn
ĠUp on
ĠJapan ese
aem a
Ġiod ide
Ġiod inated
ĠCer vonic
ureth ral
Ġvom ited
Ġvom iting
Ġdiethylamino ethyl
Ġsuccessful ly
onit rate
Ġsimp ly
Ġpicture s
ĠPot assium
Ġep oxy
Ġ210 46
Ġlod ide
ĠRegX ellence
Ġintest ines
Ġmedi ated
Ġproport ional
Ġ3063 15
Ġdefect s
Sym rise
mel ting
Ġcert ificate
ĠPi roxicam
ĠCy anoco
ĠCalc ium
ĠSm aller
ĠEl ongation
ĠElect ronic
ĠWir ksamke
Ġcohes ion
ĠLoper amide
ĠHem orrhoids
ĠNic otinamide
Ġagit ated
ĠSpec ifically
Ġmetal lic
Ġresid ues
Ġ50424 59
ĠPseud omonas
Inn ojet
Pre paration
boren en
dm f
fat ting
tri ethy
Ġul cers
Ġureth ra
Ġpron ounced
Ġparenter ally
Ġphenol ic
Ġfri endly
Ġmot ion
Ġdent al
Ġdivid ed
ĠPyrid ox
ingredi ents
Ġbow el
Ġbrom ide
Ġbak ter
ĠCii hean
ĠCinn ariz
ĠCode inphosphate
ĠTut s
ĠSyl oid
ĠSind elar
Ġeicos an
Ġgrin ding
utag enicity
Ġhaz el
ĠBism uth
ĠMechan ism
ĠEsp ecially
ifial ble
ĠRib oflav
ĠRAR ER
Ġcompoun c
Ġlac quer
Ġlsopropyl myristate
Ġkeep ing
ĠInactiv ation
through put
ĠGall ate
ĠProceeding s
ĠVentil us
ĠStrept ococcus
ĠThyro id
Ġcapill ary
ĠCoffe in
Ġethoxyl ate
ĠEnhance ment
ĠUniform ity
ĠUnsapon ifialble
ĠNeuge borenen
hydrofur an
ĠPhenaz one
pantothen ate
Ġtrithir atinn
ĠCyanoco bal
ĠRiboflav in
) ),
, ),
- !
. }
/ (
/ )
0 15
0 499
0 307
0 167
1 50
1 34
1 30
1 48
2 31
2 92
3 39
4 55
4 31
4 166
5 10
5 14
6 44
6 278
7 80
7 75
7 197
8 31
9 1
9 27
9 252
? ,
A K
A O
A T
A j
A m
A or
A MA
A www
A MU
B e
B ased
B oth
C omp
C ota
D s
D ow
D eg
D ON
D IN
D BS
E L
E ic
E icosatetraen
F low
F aster
F ilm
G UCTS
H P
H s
H igh
H ib
H CO
H ygroscopicity
I C
I Q
I nt
I ay
I PO
I ner
I IV
J PE
K C
K OH
L O
L U
L udipress
M n
M icrob
N A
N U
N VP
N ew
N IPO
P ent
P ON
P rop
P VP
P ru
Q H
Q Q
R aw
R oller
R ober
S H
S U
S h
S LS
S SC
S EDDS
T h
T acking
U N
V O
V inyl
V Ac
V itamin
W D
W et
W VO
Y E
Y M
Z I
a B
a q
a er
a it
a im
a der
a queous
a hydro
a Hs
b q
b u
b in
b ac
b ank
c ic
c der
c cent
c ale
c astor
d s
d om
d ata
d ll
d ynamic
d etermined
d ecyl
e en
e um
e vid
e ffect
e ys
e parate
e omet
f l
f ram
g l
g n
g o
g ar
g ated
g ov
g illus
h r
h at
h anol
h let
h omenthol
i j
i k
i ph
i qu
i our
i ous
i ality
i ia
i ew
i ans
j os
k p
k en
k ran
l c
l on
l ens
l oc
l ared
l avor
m ma
m ix
m agnesium
m ber
m asking
m Pas
m phatic
n on
n ight
n els
n itol
o an
o yl
o pp
o res
o ver
o hydrate
p ts
p age
p ad
p actor
p almit
p owder
p va
p yrid
r n
r or
r ur
r ations
r ude
r rigation
s en
s kin
s cri
s hor
s elf
s ng
s seo
t el
t ur
t age
t ability
t ose
t ane
t urb
t ilis
t emperature
t len
u i
u ol
u is
u ations
u dit
v it
v eth
v ac
v ha
v irtual
v cols
w ber
x im
x cellence
y us
y ph
z e
z t
z ol
z ij
Ġ ]
Ġ ol
Ġ ion
Ġ id
Ġ ions
Ġ ere
Ġ hem
Ġ ole
Ġa f
Ġa li
Ġa ure
Ġa lic
Ġa part
Ġa Be
Ġa udit
in us
in om
in ium
in osa
in ks
in hydro
in bq
on ia
on vex
on ohydrate
Ġt n
Ġt on
Ġt it
Ġt ip
Ġt ack
Ġt rig
Ġt itan
Ġt max
Ġt rack
Ġt yph
er iv
er ma
er ich
er lan
at r
at ers
at ility
at io
at tle
at iven
ol en
ol lowing
ol vent
ol su
ol veth
re l
re ate
or n
or he
or ly
or ac
or king
or oct
he ating
he lization
he wable
en able
Ġs amp
Ġs ke
Ġs ae
Ġs eld
Ġs imul
Ġs wor
Ġs apon
Ġs inus
li f
li li
Ġp g
Ġp yr
Ġp ay
Ġp ans
Ġp neum
Ġp inbq
Ġc p
Ġc at
Ġc yl
Ġc ess
Ġc ard
Ġc ost
Ġc ee
Ġc umul
Ġc ru
Ġc imetidine
Ġc rac
Ġc rude
Ġo O
Ġo R
Ġo T
Ġo e
Ġo i
Ġo o
Ġo ic
Ġo mp
ro c
ro tin
Ġf un
Ġf ile
Ġf ram
Ġf aced
Ġf acts
is o
is er
is able
is ch
is pers
Ġthe i
Ġthe ophylline
ic ose
ic lens
Ġan g
Ġan aphylactic
ed eral
ed sng
al k
al y
al in
al an
al so
al pha
al ton
it one
it ud
it ator
it teilung
it helization
le ther
le thyl
Ġin g
Ġin su
Ġin let
Ġin vers
Ġin hal
Ġin solubility
Ġm r
Ġm er
Ġm it
Ġm ct
Ġm ers
Ġm illing
Ġm Pas
Ġd l
Ġd ar
Ġd ur
Ġd uct
Ġd ra
Ġd od
Ġd og
Ġd itions
Ġd ye
an i
an y
an os
an der
an ies
an op
an ged
ar ic
ar ing
ar atus
ĠP P
ĠP at
ĠP en
ĠP et
ĠP ra
ĠP ure
ĠP ri
ĠP red
ĠP age
ĠP lat
ĠP UO
ĠP IO
ĠP antopra
ĠP orosity
ĠP edi
ĠP olveth
ing s
Ġw w
Ġw y
Ġw il
Ġw ich
Ġw ae
Ġw armed
Ġw aters
Ġb c
Ġb ul
Ġb and
Ġb ree
Ġb ron
Ġb ond
Ġb onds
Ġb cf
ent le
ent eric
ĠK n
ĠK ra
ĠK ess
ĠK ug
ĠK OR
ĠC z
ĠC lin
ĠC aen
ĠC alorimetry
ĠC WD
ĠC attle
ĠC reate
ĠC hewable
et ically
et ones
ĠT J
ĠT O
ĠT er
ĠT ack
ĠT AN
ĠT ee
ĠT IS
ĠT EC
ĠT rich
ĠT ension
ĠT art
ĠT ables
ĠT max
ĠT EA
ĠT NU
ĠT SH
ĠT YE
Ġfor ma
ul y
ul ation
ul sseo
Ġ1 47
Ġ1 198
Ġ1 1979
as sist
ab l
ab ili
ab out
ab sorb
ab sence
ĠI m
ĠI IG
ĠI ron
ĠI rrigation
ĠS et
ĠS if
ĠS im
ĠS ev
ĠS ER
ĠS low
ĠS ilic
ĠS iev
ĠS DS
ĠS TY
ĠS ym
ĠS ulf
ĠS UL
ĠS imul
ĠS elf
ĠS emi
us ate
us hes
us sa
om yc
ĠA ut
ĠA ES
ĠA TA
ĠA lu
ĠA ft
ĠA TBC
ĠA TEC
Ġ( #
Ġ( >
Ġ( ?
Ġis ot
Ġre d
Ġre tained
Ġre dis
Ġre cip
Ġre heated
Ġre heating
am ents
el man
el coater
Ġpro jects
Ġpro xim
Ġe m
Ġe ut
Ġe aten
Ġe ccent
Ġ2 21
Ġ2 70
Ġ2 75
Ġ2 250
ur g
ur ate
ur itus
il ing
il ter
il ding
il fe
Ġg l
Ġg ly
Ġg ate
Ġg are
Ġg ms
Ġg ras
Ġg uide
Ġg eomet
Ġg entle
os s
os en
os em
Ġ3 19
Ġ3 12
um st
ig hed
ig lycerides
Ġh co
Ġh land
Ġh yg
Ġh lan
Ġh ygroscopicity
Ġn n
Ġn ro
Ġn orm
Ġn oic
Ġn arrow
Ġn anos
ĠD G
ĠD H
ĠD y
ĠD ib
ĠD ust
ĠD ynamic
ĠD BS
ĠD alton
ĠD iglycerides
ĠO H
ĠO f
ĠO o
ĠO TE
ĠO thers
ĠO OO
ĠO THEF
ĠO Iner
yl ated
Ġcon e
Ġcon sul
ĠF R
ĠF ra
ĠF ile
ĠF ee
ĠF aint
ĠF EE
ĠF umed
ĠF SSC
ĠF lavor
ĠF ederal
ĠF ilter
ra x
ra ined
ra hydrofuran
ow s
ce mber
ĠB ran
ĠB AR
ĠB rea
ĠB erk
ĠB Aor
ĠB ulsseo
ĠM c
ĠM ess
ĠM ON
ĠM ia
ĠM ull
ĠM aster
ĠM CO
ĠM FT
ĠM SDS
ĠM utagenicity
ĠM WVO
ĠM YM
ĠM oroct
ĠM itteilung
Ġst ably
Ġst ock
Ġst abili
up olen
up anop
Ġ5 60
ĠE D
ĠE P
ĠE AS
ĠE ER
ĠE NS
ĠE limin
ĠE DMF
ĠE AE
ĠE sters
ers aturated
Ġth ir
Ġth ios
Ġth ough
Ġth orac
Ġ4 10
Ġ4 95
Ġ4 17
iv ap
ub lic
Ġas part
Ġas corbic
Ġas eparate
Ġv p
tic izer
un ts
un saturated
un coated
ĠR P
ĠR Q
ĠR NS
ĠR ay
ĠR ound
ĠR NR
ĠR atio
Ġsol uplus
co polymer
Ġ6 65
ri le
Ġac cent
Ġac ros
ĠW ere
ĠW ee
ĠW ern
ĠW IA
ĠW sch
ĠW orking
qu est
Ġal a
Ġal one
Ġal vcols
st ac
st rength
od erma
oly sis
Ġcomp are
Ġcomp anies
Ġl d
Ġl s
Ġl er
Ġl es
Ġl ce
Ġl ability
Ġl akes
Ġl ining
Ġl udiflash
Ġl aminated
Ġl oss
ag le
Ġ0 3
im ur
im olecular
im eter
Ġdis ting
Ġdis pensing
Ġdis pl
act ed
act am
act osem
per ed
per cent
per gillus
ac cess
ac cept
ac ryl
ain ed
eg en
iz ide
iz och
ess ment
AS Ds
Ġk J
Ġk osher
Ġk etones
form er
form ers
Ġco ax
Ġco unts
ĠIn g
ĠIn is
ĠIn form
ĠIn ste
ĠL E
ĠL e
ĠL s
ĠL is
ĠL ee
ĠL ex
ĠL OD
ĠL ayer
ĠL ipid
ĠL oo
ĠL UN
ĠL actosem
Ġex ch
Ġex ert
Ġex ceed
Ġex ceeding
ON ee
th ym
Ġ8 3
Ġ8 87
ect ics
Ġcan s
Ġsp ot
Ġsp ider
Ġsp rink
Ġsp lit
Ġsp aring
Ġcont ex
ĠG e
ĠG ra
ĠG las
ĠG IT
ĠG old
ĠG luconate
ĠG EI
ĠG eriv
Ġpoly unsaturated
ĠH O
ĠH am
ĠH and
ĠH eight
ĠH ME
ĠH yp
ĠH itt
ĠH ico
ĠH KC
rom ellose
Ġ50 4
Ġ50 44
Ġ50 38
Ġ50 35
Ġ50 131
ir in
ir atory
ir hi
ĠN F
ĠN R
ĠN eg
ĠN AS
ĠN AN
ĠN AL
ĠN ormal
ĠN itrogen
Ġli ver
ap y
ap ed
las er
Ġy d
Ġdr inks
Ġ7 10
Ġ7 000
Ġ7 38
Ġ7 27
Ġ7 98
Ġform ic
Ġform uations
ell en
ĠPro g
ĠPro te
ĠPro file
ĠIN ES
ĠIN UL
Ġ20 7
ĠU K
ĠU PA
ĠU ll
ĠU ntersuchungen
ĠU PON
). .
ug inosa
ress ibility
Ġwe ighed
Ġpar ty
Ġpar achute
cream s
ch itis
Ġnot ifications
Ġapplic abl
Ġsolub ilis
ĠV T
ĠV inyl
ĠV OU
ĠV apor
ĠV ivo
ĠV aginal
ĠV EN
ĠV isco
ĠV ivap
and s
Ġ25 6
Ġun sulf
Ġun lubric
Ġad vers
ost rid
ĠSt ore
ĠSt ay
ĠSt aphyl
Ġsu o
Ġper iph
Ġper turb
Ġmin s
ĠTh a
ĠTh ree
ĠTh orough
ĠTh irhi
isc he
Ġ12 1
Ġ12 39
cent age
pos its
Ġdi e
Ġdi esters
Ġ15 4
Ġ15 7
Ġ15 47
Ġman nitol
Ġsh oe
com m
ĠUS ING
Ġsus cept
coat s
Ġ100 00
ĠPh osphate
Ġprocess ibility
ĠReg istration
Ġpre c
Ġ60 1
Ġ60 131
Ġr ises
), .
ment al
ĠFor ces
Ġab let
ĠProduct s
Ġ40 6
ad ecanol
Ġprovid ing
ov isco
Ġle aving
hem e
Ġmix tur
Ġmon ola
Ġdoc usate
Ġsup ersaturated
Ġam enable
ust ri
Ġim mers
ali s
fact ant
ys ed
Ġsub tilis
ĠSp rink
ĠAl pha
ĠPoly propylene
ĠPoly oxypropylene
io id
ĠComp erlan
Ġfol lc
Ġ70 4
mar nn
rol actam
ĠJ DMF
ĠJ AMA
ĠJ uly
Ġhere it
de aema
10 2
10 59
tain er
Ġse bac
ĠCo ated
ĠCo poly
ĠCo aHs
Ġde posits
Ġdist ill
ort ly
ort ant
ht a
ht m
oun as
Ġfat ting
Ġ< =
Ġen oic
Ġen ough
Ġrep ass
Ġsolid ify
Ġsolid ifies
Ġspray able
Ġsubst ained
ĠDis inf
TH F
Ġ19 4
Ġ19 29
Ġ19 75
que yus
Ġcream y
ĠAr z
ĠAr row
Ġ= ~
Ġsolubiliz ed
ros ive
ĠAc con
ĠPAR E
MP pactor
po int
Ġstear y
spect ra
ĠAs pergillus
Ġbet a
Ġbl ades
Ġrel ati
Ġdispers ec
Ġdispers ibility
Ġdifferent ial
ay ed
Ġreg ions
Ġreg ain
Ġreg ard
Ġreg ards
ĠWh ik
Ġacet onit
king s
Ġ200 4
op ioid
Ġgel ation
ĠRE A
19 78
20 6
20 7
20 8
Ġpack age
Ġrepresent ing
DI E
aen cic
Ġover night
Ġ3055 50
Ġ3055 339
poly sorbate
lam ate
ĠCon tainer
Ġret urn
Ġdisinteg rated
Ġsur ve
lo ad
Ġloc ated
ĠEn thal
Ġ24 60
Ġ24 70
ĠOD EGA
Ġ500 29
Ġimp a
Ġimp ing
Ġimp eller
Ġ11 3
Ġ11 000
Ġ11 44
ĠSolub ilis
ĠEx cipients
ĠEx pl
Ġvar icose
ional d
Ġcol i
ĠTablet tose
ĠAn n
ĠAn aphylactic
ĠRe e
ĠRe ason
ĠRe quest
Ġlipo pro
Ġcar ry
DE AEMA
Ġinspect ior
mon onitrate
Ġla id
Ġla ke
Ġla urilsulfate
Ġvari ation
Ġtheir surface
ĠDi oxide
Ġyellow ing
Ġcount ry
pharma assist
Ġ45 1
Ġlubric ated
Ġmost ly
Ġlipophilic ity
Ġphys icochemical
Ġmic roscopic
Ġbut ylated
Ġet a
Ġet yl
Ġinter act
Ġinter action
Ġinter acting
ĠAR O
Ġmonograph ic
Ġequ als
Ġexp ect
Ġexp and
Ġexp edite
Ġpl op
Ġpl jos
Ġcust om
Ġmat ches
Ġmat orial
Ġaffect ed
Ġcros spolymer
ĠDe cember
cm s
Ġ35 6
Ġ35 10
Ġhydro chloride
Ac id
Kolli tab
Ġchan nel
Ġchan nels
let al
Ġ13 1
Ġ13 2
Ġ13 3
Ġ13 17
Ġprop ane
Ġredu cer
ĠEmuls ification
Ġcopoly vidone
ĠInt raper
ew hat
Ġcle ans
ĠIR N
Ġcool ir
Ġder maz
Ġ16 7
Ġpressure s
ĠDes infek
ĠDes infektion
Ġ305544 37
Ġ305544 36
Ġ305544 90
Ġachiev able
Ġinstruct ion
Ġflow able
Ġtechn iqu
Ġent ers
Ġent rained
ĠSA GE
ĠSA DIE
yc lic
yc ilic
Ġdem ands
ĠAcid s
39 36
39 644
dispers ions
dispers ible
ĠCl ostrid
Ġsom ewhat
amin mononitrate
ĠEth y
ĠEth ocel
Ġdevelop ing
Ġ33 00
Ġ33 37
Ġens ured
Ġ22 00
ĠProp ionald
Ġlower ing
mic elles
te ins
Ġ% )
Ġ% ,
Ġca pping
Ġlight proof
Ġcomb inations
osahex aencic
Ġtrans it
Ġtrans fer
ĠZ O
Ġtox ic
Ġtox icity
Ġhumid ities
ential ly
Ġbehav iour
18 1
Ġcit iia
Ġbro ader
Ġprotect ive
Ġ14 3
27 6
Ġmol ten
Ġrele ases
ĠCetyl pyrid
Ġhydrox y
Ġhydrox ystear
Ġass ures
70 87
Ġmild ness
Ġcarb opol
Ġfoam ing
Ġ21 2
Ġ21 6
Ġcompar atively
Ġpharma copoe
Ġcet earyl
37 43
Ġwet tability
ult ivitamin
12 4
vi ene
Ġlot ion
Ġhomogen ization
ĠAcet aldehyde
Ġcyc lic
Ġcyc ling
Ġcyc les
Ġgelatin ous
rat ia
Ġprodu cers
Ġvol tage
Ġvol atility
ĠProcess ability
ĠProcess sing
Ġresult ant
ĠHyd ro
ĠHyd oxyl
92 4
Ġcl aim
Ġmult ital
Ġmult imolecular
Ġcontrol s
Ġ95 8
Ġ95 10
Ġly oph
Ġly mphatic
Ġ305547 48
Ġ305547 62
Ġpe ag
Ġ68 3
Ġaid s
ĠCh ir
Ġextract ant
Ġtri ester
Ġtri als
Ġtri acetate
Ġcor rosive
ĠNa Cl
ĠNa QH
Ġrat ios
Ġj e
Ġparenteral s
ĠForm aldehyde
ob tained
ĠTri als
ĠTri ethy
Ġthick ens
ester ified
13 3
Ġresp iratory
ĠBl ut
ĠBl ank
Ġcalcul ating
led ge
Ġregul ator
79 1
Ġtol uol
ĠAb rid
ĠAb sence
Ġ69 5
ident iality
Ġlim its
Ġmicro be
Ġneutra li
Ġneutra lize
Ġneutra lisation
ĠInf ection
Ġfaint ly
ĠApprox imate
Ġend ings
Ġcompr ising
Ġmono oleate
Ġgro und
Ġgro wing
Ġstic kiness
Ġ250 86
Ġes h
ĠTG R
Ġres idence
Ġhand le
Ġstrength s
St andard
St earate
nf also
Ġclass ic
08 21
ĠMin imum
Ġconsequ ently
Ġpovidon es
Ġ30034 98
Ġmarket ed
.) _
Ġir on
ĠEnd otox
Ġpetrol eum
SC H
Ġbo iling
ĠOn ly
95 46
Ġdrop s
ĠOver all
Ġantioxid ants
Ġlist ing
Na OH
ĠCol orant
ĠAg ents
ĠAg itator
Ġelimin ation
ĠHigh er
Ġbroad ly
ĠFe u
Sol vent
Ġtend s
Ġsilic on
ĠMore over
Ġkin etic
Ġkin etically
Ġrhe ology
Ġ502538 59
Ġ502538 57
Ġ502538 52
Ġ502538 08
Ġ502538 53
Ġ502538 51
ĠEnter obacter
Ġer ror
Ġconf identiality
Ġaccept ance
ĠLubric ation
Ġ505 487
Ġ505 81
ĠProtect ive
Ġengra ved
Ġscre w
cl ature
Ġz ation
Ġsympt omatic
PE Gs
cap sule
yt rium
art inn
ĠCO MPpactor
ĠRot ation
ĠRot ovisco
Ġprefer ence
Ġprefer ably
Ġprefer entially
ĠMonograph ic
ĠPer forated
ĠPer formance
ĠPer centage
ĠSc he
ĠSc hen
ĠSc rub
ĠSc rew
Ġhal al
Ġessential ly
Ġchallen ges
test ed
Ġ5026 9252
Ġincorpor ation
Ġmoder ately
Ad ditional
get iig
Ġtet rahydrofuran
Ġmagn itud
ĠIS O
ĠRes earch
ĠPhys iological
ĠSolubiliz ing
Ġmacrogolglycerol i
711 206
tin uously
Ġmas k
ĠTrans ition
ĠSur factant
ĠAct ivity
Ġ27 50
Ġstimul ates
Ġenviron ments
Ġheal ing
Ġmicrosco py
Ġ3003497 2
To pical
Ġu ole
Ġu olsu
Ġdig ests
Ġdec yl
Ġdec lared
Ġdown load
Ġ570 7197
Ġrh initis
ĠKollli coat
App lications
Cl upanop
UO TT
ca rot
ca rotin
âĢ Ļ
Ġphen oxyethanol
Ġphen omen
Ġcs l
Ġcs s
ĠMe aning
ĠMe hta
ocol ate
Ġpercent ages
Ġantip rur
ĠGranul ating
ple mentary
Ġbrit tlen
Ġredispers ible
Ġalg ae
imet ric
Ġcoat s
ĠHP LC
Ġblock age
Ġirrit able
Ġirrit ate
ĠSuspens ions
Ġsal ycilic
Ġmil lili
ĠImpro ves
Ġster ile
Ġric in
Ġscient ists
Ġrobust ness
ĠSustain able
Ġinject ed
Ġresist ant
ĠDoc onexent
ĠDoc osahexaenoate
ĠGlycer in
ĠHA AK
Ġchromatograph ie
ĠAss oc
ĠAss essment
ynam ically
Ġauthor ities
ĠSuit ability
Ġsecond s
Ġsecond ary
Ġdigest ed
Ġdigest ive
Ġpr uritus
Ġins ide
ĠPhar marnn
ĠSch izoch
Ġglycer ine
ĠFunction ality
Ġorgan ism
Ġlit any
Ġincompat ibilities
Ġhydroly se
Ġmaxim izing
Ġcolor ants
Pro perties
drug bank
ien ic
oct adecanol
Ġbrea king
ĠAP U
ĠNom eric
Ġ73 2
ĠDissolv ing
Ġacetyl triethy
ĠContin uously
Ġclos er
ĠSurg ical
catal ysed
fa hren
atetra e
Ġpas ticizer
Ġfigure s
Ġmo iet
ĠSh ape
ĠSer ratia
Ġrecent ly
ĠDeterm ine
ĠOph thalmics
ĠBet ween
Ġvag initis
Ġvalid ated
ĠInstant ly
ĠLut ensit
Ġexception ally
ĠHa utdes
Ġprem ise
Ġallerg ic
Ġrepe ated
Ġassess ment
Ġcentr ations
Ġextrud ates
Ġ3056 9546
ĠMeet s
Ġisotherm s
bar rier
cos metic
Ġ.. .
Ġche ck
Ġfavor ite
Ġmill s
ĠChem ie
ĠAsp irin
Ġ29 10
ĠDV S
Ġtherm al
Ġtherm orhe
Ġviscos imeter
Ġformulate c
Ġ5042 45
Ġ5042 3936
ĠNot ation
ĠNot ably
ogen es
Ġintens ifiers
Ġblank et
ĠPart ially
ĠRep ublic
Ġinterpre ted
Ġbrow se
Ġagreem er
Ġagreem ents
Ġpromot es
Ġopport une
Ġip ec
ĠSN A
ĠSN E
ĠAB ZI
Ġactiv ation
Ġactiv ated
Ġactiv ating
Ġactiv ities
Ġmedic aments
Ġestim ating
ĠOctadec atetraen
ĠOctadec atetrae
Ġ50519 927
Ġ50519 924
Ġ50539 225
Ġemploy ed
77 6
Se lect
Ġbic onvex
Ġreason s
ĠFD A
ĠBa uch
ĠBes ides
Ġstra wber
ĠCompound s
ĠSecond ly
%). .
max omega
Ġderm is
ĠCer ne
Ġreco gn
Ġey es
ĠEV O
Ġknow ledge
ĠLu carotin
Ġ5030 510
Ġabsorb s
Ġdistinct ive
Ġbloc ked
Ġ305540 34
ĠAmmon ia
methy lethyl
Ġelectroly tes
Ġassoci ated
Ġdiethylamino ethy
Ġagglomer ation
Ġagglomer ate
Ġagglomer ates
ĠSubst itutes
Ġfacilit ates
ĠDocosapent aen
ĠDocosapent aenoic
ĠDocosapent aenoate
ĠFibre board
ĠHeneicospent a
ĠHeneicospent aenoic
ĠHeneicospent aenoate
Doc osahexaenocic
Doc osahexaencic
comp action
Ġq s
Ġaer obic
Ġaer uginosa
Ġta hlet
Ġbacter ial
Ġbacter ia
ĠSU SE
ĠSU UO
Ġep ithelization
ĠOM Iay
ĠOU F
ĠMI AN
Ġ76 80
ĠRegX xcellence
Ġintest ine
Ġmedi urr
ĠREN AE
Ġproport ions
Ġclean ed
Ġ3063 1059
Ġdefect ive
Ġ50355 16
EI C
Ne utralized
UE d
cf m
me q
Ġtac kiness
Ġpantopra zole
Ġpantopra zol
Ġcos ts
Ġcos olvent
Ġoct a
Ġoper ations
Ġoper ating
rot ating
Ġ138 3
ĠSon tinuously
omet ric
ĠFill er
ĠEicosatetraen oic
ĠEicosatetraen oi
Ġlump s
ĠLev els
Ġ302 39644
ĠThi aminmononitrate
Ġdetect ed
ĠJe zij
ĠJe queyus
ĠCool ing
http s
Ġantisep tic
Ġantisep sis
Ġ502598 00
Ġautom ation
Ġautom ated
Ġelastic ity
Ġbipl ar
Ġbipl ane
ĠCarbamazep in
ĠCarbamazep ine
Ġcareful ly
Ġrecrystal lize
Ġrecrystal lisation
ĠCOMp acted
ĠCOMp ounas
Ġthermod ynamic
Ġthermod ynamically
Ġ5051957 2
Ġ5051957 3
Ġ503062 48
Ġ503062 43
Ġcirc ulation
Ġcirc umst
Spray s
Ġconvenient ly
Ġ3057225 8
Ġ3057225 9
Ġ3049939 5
Ġ3049939 8
ĠOctadecatrien oate
ĠOctadecatrien oi
080 5
017 3
519 20
HI OR
Ment ho
MIG UOTT
SI HIOR
SO p
WE B
iq eys
na ia
tions ver
uc le
Ġtren d
Ġpy oderma
Ġinactiv ating
Ġdermat omyc
ĠPo orly
Ġbrid ges
ĠCert ification
ĠCyc lamate
Ġ119 1
Ġprovia ed
Ġ322 4
Ġhaem olysis
Ġner ve
Ġnas al
ĠFO F
ĠBac illus
ĠBacter icidal
Ġ520 51920
Ġthro at
Ġvul gar
Ġvacc ines
ĠRR O
ĠWound s
Ġlin ked
Ġdise ase
ĠLR AR
ĠGR AS
ĠGi ra
ĠHomogen ize
Ġ507 29
ĠNAR ONee
Ġadv isable
ĠSte phan
Ġshif ts
Ġimmun ogenicity
particul ates
Ġ502515 34
Ġenorm ous
cyclohex anol
Ġmethy acrylic
Ġneuron al
Ġantif oan
ĠAnal ytical
Ġequilib rate
ĠYellow ish
ĠChlor hexidine
Ġmicrob ial
Ġlozen ges
Ġmetabol ite
Ġtransport ation
ĠKetocon azol
Ġjerric ans
Ġcamn artinn
ĠWirksamke it
Ġ5042459 1
ĠPyridox inhydro
Ġbakter izide
ĠCinnariz in
Ġeicosan oids
Ġlacquer ed
ĠCyanocobal amine
0307 48
Aj inom
Am orphous
Deg ussa
Eic osa
Eicosatetraen oate
Flow ability
HP LC
Hib iclens
IQ N
Int roduction
IIV UIT
LO ne
LU ES
Microb iological
New tonian
NIPO SIHIOR
Pent aenoic
Prop ylene
Pru v
Rober ts
Sh ortly
ahydro thym
bu ilding
bin ders
dom inal
evid ent
lon oleic
opp er
pad dle
palmit ic
scri pts
shor ter
tel Ss
tane ously
uis hes
vit ro
vha an
virtual pharmaassist
Ġol der
Ġhem olytic
Ġole yl
Ġali phatic
Ġaure us
Ġalic yclic
ĠaBe SOp
onia e
Ġtip s
Ġtack y
Ġsamp ling
Ġske letal
Ġseld om
Ġsimul taneously
Ġswor d
Ġsinus itis
Ġpneum oniae
Ġcyl inder
Ġcess ing
Ġcumul ative
Ġcru cial
Ġcrac kings
Ġomp ression
Ġfun nel
itone al
Ġinsu fficient
Ġinvers ely
Ġinhal ations
Ġdur ina
Ġdra wn
Ġdod ecyl
Ġdog s
ĠPet ers
ĠPri or
ĠPred ict
ĠPlat ic
ĠPUO IIVUIT
ĠPIO GUCTS
ĠPantopra zole
ĠPedi atr
ĠPolveth viene
Ġwil ful
Ġwaters ensitive
Ġband age
Ġbree ze
Ġbron chitis
ĠKug elcoater
ĠKOR SCH
ĠTart aric
ĠTNU MIGUOTT
Ġforma lize
Ġ1198 18
Ġ11979 8
absorb ing
ĠSev eral
ĠSER A
ĠSlow ly
ĠSilic on
ĠSiev ing
ĠSTY LOne
ĠSym p
ĠSUL UO
ĠSimul ator
ĠAut oclave
ĠATA U
ĠAft ar
Ġisot ropic
Ġredis pered
Ġproxim ity
Ġeut ectics
Ġeccent ric
Ġ270 27
Ġgeomet ry
Ġhland ed
Ġhyg ienic
Ġhlan der
Ġnorm ally
Ġnanos cale
ĠDib utyl
Ġconsul t
ĠBrea king
ĠBerk elman
ĠBulsseo oid
ĠMess er
ĠMull er
ĠMCO al
ĠMoroct ic
ĠElimin ate
Ġthir d
Ġthios ulphate
Ġthorac ic
Ġaspart ame
Ġaccent ed
Ġacros s
ĠWern er
ĠWsch r
Ġdisting uishes
Ġdispl ayed
access data
accept ing
Ġcoax ial
ĠInste ad
ĠLayer ing
ĠLoo king
ĠLactosem onohydrate
Ġexch anged
Ġsprink led
Ġsparing ly
Ġcontex t
ĠGEI telSs
ĠGeriv ery
ĠHyp romellose
ĠHitt lin
ĠHico at
Ġ5044 4166
Ġ5038 06
Ġ5035 6278
Ġ50131 776
ĠNAN A
ĠProte us
ĠINUL EIC
ĠUPA C
ĠUll rich
ĠVOU NIPOSIHIOR
ĠVapor ization
ĠVisco gen
ĠVivap ur
Ġunsulf ated
Ġunlubric ated
Ġadvers e
ĠStaphyl ococcus
Ġperiph eral
Ġperturb ation
ĠThirhi ila
Ġ1239 40
Ġsuscept ible
Ġ60131 775
Ġmonola urate
Ġimmers ion
ĠSprink le
Ġsebac ate
ĠCopoly vidone
Ġdistill ation
ĠDisinf ectant
Ġ1929 202
ĠArrow s
ĠAccon centration
Ġacetonit rile
Ġ3055339 4
Ġsurve y
ĠEnthal py
ĠODEGA DON
Ġ50029 276
ĠSolubilis ation
ĠExpl ore
Ġ1317 75
ĠIntraper itoneal
Ġtechniqu es
ĠSAGE M
ĠClostrid ium
ĠCetylpyrid inium
Ġhydroxystear as
7087 87
Ġpharmacopoe ias
Ġclaim ed
Ġmultital ent
Ġlyoph ilized
ĠAbrid ged
Ġmicrobe ads
Ġ3003498 1
ĠEndotox in
getiig WEB
Ġmagnitud es
Ġuolsu edsng
Ġ5707197 6
Clupanop donic
carot ene
Ġphenomen on
Ġantiprur itic
Ġbrittlen ess
Ġmillili ter
ĠHAAK E
ĠPharmarnn naia
ĠSchizoch ytrium
Ġmoiet ies
ĠHautdes infektion
Ġthermorhe ological
ĠOctadecatetraen oate
Ġstrawber ry
Ġrecogn ized
Ġ5030510 9
ĠJezij iqeys
Ġcircumst ances
Ġdermatomyc osis
Ġvulgar is
ĠPyridoxinhydro chloride
Ajinom oto
ahydrothym ol
virtualpharmaassist ants
! %
! )
' s
, /
- <
. =
. _
. %.
/ <
/ ]
0 13
0 63
0 73
0 217
1 25
1 38
1 47
1 21
1 26
1 250
2 000
2 47
2 35
2 43
3 20
3 38
3 35
3 63
3 29
4 50
4 11
4 38
4 26
5 34
5 65
6 00
6 39
6 79
6 75
7 10
7 34
7 45
8 4
8 97
8 17
8 319
9 14
9 227
? !
@ )
@ -
A V
A b
A s
A IN
A OR
A TA
A nt
A UO
A GI
B D
B O
B w
B et
B est
B ell
B aer
C A
C P
C e
C i
C om
C ase
C ap
C AR
C PR
C MP
C ritical
C leaning
C ST
C SI
C ola
D O
D es
D TA
D rug
D PE
D iffer
D ynamic
D BU
D etails
D ait
D ispers
E r
E NS
E rol
E QG
E TIS
E AA
E thyl
F R
F re
F MC
F orsch
F enofibrate
F DO
G er
G ra
G IN
G SE
G RS
G dol
G Ce
H U
H LB
H OW
H OA
H CSI
I d
I t
I TI
I ER
I IN
I AL
I CL
I mp
I ey
I BC
I IE
J o
K omp
K ITI
L P
L ubric
L IL
L ECTUAL
L actose
L EN
L udiflash
L upolen
M e
M on
M er
M ic
M ar
M el
M isc
M ann
M achine
M ultivitamin
N E
N O
N Y
N i
N s
N os
N Or
N IE
N VG
N mn
O E
O I
O P
O T
O ry
O int
O ral
O IV
O Ss
O SU
P G
P ant
P lastic
P IG
P PI
P yrrolidone
P antothen
Q M
Q aA
Q ui
R E
R U
R Z
R ev
R GA
R AGI
S S
S l
S or
S he
S IN
S ch
S PO
S te
S pect
S urface
S weet
T M
T W
T ur
T ri
T ak
T rans
T iO
T ASA
U r
U al
U SE
U PC
U TU
U lat
U TT
U ntersuchungen
U sen
U IAL
V ir
V erol
V ari
V Cola
W een
X cell
Y P
Y US
Z oomLab
Z ET
_ ]
a h
a al
a est
a ug
a ffect
a ad
a ee
a oll
a erosol
a roma
a hren
a iq
a coater
a iser
b a
b s
b ro
b as
b ur
b ate
b les
b acter
b oth
b urn
b latt
b ottle
b lock
c n
c ol
c ion
c el
c ity
c ens
c alc
c utane
c uron
d h
d n
d r
d w
d ed
d ent
d et
d el
d ec
d res
d est
d lic
d ia
d ensity
d ness
d ynam
d ialysis
d omen
d ds
e a
e as
e pp
e ht
e are
f u
f os
f ig
f un
f oc
f ted
f unction
f eld
f irst
f ellent
f ren
f ume
f ilm
f illed
f ru
f atty
g a
g ent
g st
g ely
g ray
g ery
g ories
g ung
g hor
h h
h k
h v
h is
h om
h ist
h ii
h oper
h Pa
h lb
h ilfe
h dh
i y
i he
i el
i ec
i im
i em
i ere
i ens
i ene
i ov
i ilic
i ole
i ameter
i ert
i ester
i acy
i eti
i Co
i ella
i hi
i acin
i ellen
i ometric
j ant
j ured
k i
k ation
k olli
k et
k ul
k un
k otri
k ung
k ows
k tionsver
l G
l um
l ty
l ong
l lication
l ung
l ogP
l ayer
l OSs
m it
m et
m st
m orph
m illed
m ember
m itt
m ungen
m IP
m ihi
n i
n p
n in
n ed
n an
n ing
n et
n am
n ant
n oc
n av
n ov
n ormal
n ection
n utrition
n ominally
n Nmn
n city
o es
o ul
o os
o ine
o of
o hn
o ole
o owder
o ading
p on
p ow
p ot
p tic
p ite
p lied
p ii
p igment
p edite
p np
q h
r S
r t
r ul
r ater
r ability
r ist
r ard
r one
r ically
r rolid
r ins
r atur
r ushes
s on
s up
s ide
s ace
s ized
s emi
s ungen
s ensit
s lG
t or
t om
t os
t ec
t ac
t em
t ine
t ant
t our
t ight
t rate
t ative
t ak
t ization
t aste
t Ual
t iy
u y
u en
u ar
u um
u ous
u ign
u ros
u hr
u TiO
u Ulat
u kotri
v em
v lic
v ous
v erman
v estig
v omenthol
w an
w as
w end
w art
x per
x ahydrothymol
y li
y co
y res
y per
y ros
y zing
z ul
z os
z ell
z elle
~ -
± )-
 ±)-
Ï ī
Ġ !
Ġ ;
Ġ \
Ġ ig
Ġ lic
Ġ ia
Ġ ients
Ġ urther
Ġ ult
Ġ udipress
Ġa A
Ġa R
Ġa k
Ġa or
Ġa en
Ġa le
Ġa il
Ġa ri
Ġa th
Ġa ter
Ġa OR
Ġa ign
Ġa ha
Ġa ii
Ġa imer
Ġa ila
Ġa ocument
Ġa oes
in in
in or
in et
in one
in ely
in hn
in soluble
in ary
in jection
in ner
in active
in duced
in stant
in bar
in alis
on ate
on ag
on ge
on orrhea
on azole
on ni
on tour
Ġt or
Ġt ion
Ġt um
Ġt ions
Ġt igh
Ġt ile
Ġt ency
Ġt ong
Ġt te
Ġt ise
Ġt ind
Ġt ier
Ġt ex
Ġt urns
Ġt alin
er v
er ing
er ide
er ates
er ides
er ior
er ving
er ger
er apy
at o
at ab
at om
at iv
at form
at af
at olog
at uring
at ically
at ibility
at te
at nn
at ogenicity
ol le
ol our
ol ding
ol ish
ol land
re y
re z
re sol
re ating
re commend
re ased
re cc
re pa
re versible
or a
or b
or an
or ing
or ith
or res
or ated
or ous
or ption
or bic
or gung
or oof
or zelle
he il
he pt
he ld
he een
en es
en ced
en ians
en clature
en ncity
en heil
Ġs n
Ġs il
Ġs lic
Ġs ect
Ġs age
Ġs ides
Ġs art
Ġs acchar
Ġs accharin
Ġs aponification
Ġs onni
li am
li um
li able
li dn
li kation
li mit
Ġp A
Ġp p
Ġp t
Ġp um
Ġp ra
Ġp ac
Ġp end
Ġp erm
Ġp ip
Ġp ad
Ġp ov
Ġp rig
Ġp yrrolid
Ġp ee
Ġp yc
Ġp iec
Ġp olish
Ġp orous
Ġc n
Ġc ab
Ġc ut
Ġc ate
Ġc rom
Ġc ured
Ġc ue
Ġc ale
Ġc St
Ġc yt
Ġc ieve
Ġc rack
Ġc rub
Ġc alin
Ġc erides
Ġo s
Ġo w
Ġo ph
Ġo ress
Ġo osition
Ġo vers
Ġo tal
es feld
ro pm
ro perties
ro duced
ro ck
ro cols
Ġf ro
Ġf it
Ġf ab
Ġf ur
Ġf ig
Ġf ot
Ġf em
Ġf ap
Ġf las
Ġf ee
Ġf lor
Ġf enofibrate
Ġf rul
is d
is ite
is ks
Ġthe t
Ġthe ore
ic on
ic ated
ic ating
ic ely
ic ide
ic ryst
ic eride
Ġan id
Ġan ise
Ġan no
Ġan aer
ed t
ed er
ed it
ed ge
ed les
ed ied
al a
al t
al en
al ing
al one
al hol
al ky
al lit
al lidn
it ate
it ter
it ution
it ition
it ative
it ung
it rac
it ativen
le ed
le ar
le im
le af
le ting
le bs
Ġin e
Ġin et
Ġin ch
Ġin ert
Ġin sensitive
Ġin active
Ġin put
Ġin hom
Ġin jured
Ġin nov
Ġm N
Ġm c
Ġm i
Ġm ar
Ġm id
Ġm ut
Ġm ate
Ġm iv
Ġm ec
Ġm ater
Ġm ma
Ġm ob
Ġm ern
Ġm amali
Ġm rr
Ġm utagenicity
Ġm nin
Ġd u
Ġd an
Ġd as
Ġd ot
Ġd so
Ġd ull
Ġd ans
Ġd umping
Ġd ermatology
Ġd edic
Ġd atab
an il
an orm
an th
an ill
an ak
an ced
an oate
an edi
an edic
ar co
ar se
ar ge
ar rier
ar ison
ar nis
ar rn
ar zt
ar hii
ar nav
ĠP C
ĠP id
ĠP os
ĠP ant
ĠP our
ĠP OR
ĠP ore
ĠP eral
ĠP yrrolidone
ĠP ass
ĠP alm
ĠP rat
ĠP reserv
ĠP Or
ĠP erson
ĠP IV
ĠP rolonged
ĠP MMA
ĠP TW
ĠP fren
ĠP rt
ĠP alhol
Ġand and
ing n
ing os
ing ton
ing ering
Ġw o
Ġw all
Ġw aB
Ġw aiq
Ġw uy
Ġb s
Ġb ur
Ġb il
Ġb ub
Ġb ore
Ġb ile
Ġb ifunctional
Ġb alan
Ġb rushes
Ġb leed
ent e
ent als
ent ie
ent homenthol
ent iometric
ĠK A
ĠK Y
ĠK ur
ĠK od
ĠK ran
ĠK ap
ĠK RI
ĠK out
ĠK all
ĠK idne
ĠK CI
ĠK aiser
ĠK lebs
ĠK arnav
ĠC ent
ĠC and
ĠC one
ĠC are
ĠC te
ĠC yn
ĠC ef
ĠC EE
ĠC rack
ĠC Me
ĠC YP
ĠC lear
ĠKolli tal
ĠKolli ca
ĠKolli ghor
et s
et t
et ri
et hen
et ween
et ta
et tes
et rock
ĠT E
ĠT F
ĠT P
ĠT T
ĠT as
ĠT ra
ĠT og
ĠT IT
ĠT op
ĠT OU
ĠT OM
ĠT itan
ĠT ilm
ĠT romb
ĠT atal
ĠT etra
ĠT ete
ĠT win
ĠT alk
ĠT iere
ĠT tor
ĠT reating
ĠT orres
ul ate
ul ating
ul osis
ul atior
id a
id al
id one
Ġ1 44
Ġ1 250
as in
as is
as ic
as ar
as ure
as ag
as th
as cular
ab i
ab er
ab ove
ab led
ab ilities
ab dominal
ĠI E
ĠI V
ĠI Y
ĠI e
ĠI re
ĠI IT
ĠI se
ĠI RI
ĠI ID
ĠI AO
ĠI Gdol
ĠI OP
ĠI dent
ĠS C
ĠS S
ĠS T
ĠS s
ĠS il
ĠS tic
ĠS st
ĠS ES
ĠS ap
ĠS ING
ĠS af
ĠS ad
ĠS ime
ĠS yr
ĠS ESS
ĠS TE
ĠS eel
ĠS ales
ĠS ult
ĠS ob
ĠS USP
ĠS imil
ĠS Se
ĠS LC
ĠS outh
ĠS HOW
ĠS aug
ĠS ato
us er
us en
us ed
us ions
us lif
us zell
om es
om ov
ĠA E
ĠA H
ĠA V
ĠA e
ĠA ly
ĠA ran
ĠA ver
ĠA av
ĠA ID
ĠA min
ĠA lex
ĠA hear
ĠA EA
ĠA ustri
ĠA ATA
ĠA yli
ĠA zul
Ġ( %),
Ġ( @)
Ġ( _]
Ġ( ±)-
Ġis t
Ġre se
Ġre nal
Ġre view
Ġre fe
Ġre ading
Ġre omov
am y
am id
am ma
am age
am less
am ellar
am aing
am atically
am entals
el ines
el ongation
el mst
el inhn
Ġpro sp
Ġpro ve
Ġpro stac
Ġpro teins
Ġe A
Ġe T
Ġe g
Ġe k
Ġe o
Ġe es
Ġe is
Ġe lic
Ġe ine
Ġe ff
Ġe ines
Ġe iner
Ġe ina
Ġe Iey
Ġ2 44
Ġ2 97
Ġ2 35
Ġ2 78
ur sor
ur izers
ur gical
ur ious
il at
il ed
il ine
il jant
Ġg y
Ġg it
Ġg as
Ġg yl
Ġg un
Ġg lu
Ġg ee
Ġg reas
Ġg ui
Ġg egen
Ġg point
Ġg rater
Ġg rey
Ġg etrock
ut ral
ut inely
os na
os ses
os orb
Ġ3 25
Ġ3 10
Ġ3 21
Ġ3 27
Ġ3 70
um M
um a
ig er
ig ate
ig ella
Ġh a
Ġh u
Ġh orm
Ġh oe
Ġh opper
Ġh yper
Ġh olding
00 5
00 31
00 32
Ġn f
Ġn t
Ġn in
Ġn ar
Ġn ow
Ġn ac
Ġn ran
Ġn ood
Ġn ose
Ġn ach
Ġn ever
Ġn fe
Ġn ied
Ġn omen
Ġn ucle
Ġn aad
Ġn icely
Ġn iger
ĠD t
ĠD er
ĠD up
ĠD ri
ĠD ts
ĠD ip
ĠD ou
ĠD ark
ĠD rop
ĠD rum
ĠD eter
ĠD urn
ĠD IO
ĠD NA
ĠD IIN
ĠD YUS
ĠD uar
ĠD itter
ĠD etween
ĠD amage
ĠO l
ĠO ff
ĠO mg
ĠO Bw
yl meth
Ġcon cept
Ġcon solid
Ġcon nection
ĠF G
ĠF N
ĠF T
ĠF i
ĠF s
ĠF ec
ĠF ir
ĠF IN
ĠF low
ĠF ich
ĠF lor
ĠF und
ĠF amily
ĠF unctional
ĠF alle
ĠF umarate
ĠF rau
ĠF lav
ĠF NA
ĠF ollowing
ĠF isch
ĠF EQG
ĠF USE
ĠF uhr
ĠF enians
ĠF arco
ĠF aber
ra ins
ra ind
ra lizing
ra verman
ow ing
ow ard
ph ore
ph asic
ith ium
ĠB I
ĠB ase
ĠB ax
ĠB ear
ĠB ell
ĠB ox
ĠB ased
ĠB ou
ĠB ak
ĠB ee
ĠB ne
ĠB eur
ĠB enz
ĠB eding
ĠB eh
ĠB ru
ĠB ottle
ĠB uch
ĠB urns
ĠB erich
ĠB RU
ĠB TM
ĠB orzelle
ĠB uszell
ĠB raverman
ĠM D
ĠM E
ĠM od
ĠM IN
ĠM MS
ĠM ethylene
ĠM PA
ĠM ice
ĠM enthol
ĠM EE
ĠM ember
ĠM UU
ĠM organ
ĠM outh
ĠM erk
ĠM ultivitamin
ĠM yco
ĠM enthomenthol
Ġst d
Ġst ation
Ġst ream
Ġst ore
Ġst ances
Ġst ructural
Ġst abilis
Ġst atic
Ġst ead
Ġst ores
Ġst oring
Ġst asis
Ġor ally
ili ll
ili abi
Ġ5 55
Ġ5 30
Ġ5 48
Ġ5 47
Ġ5 15
Ġ5 21
Ġ5 14
Ġ5 65
ĠE F
ĠE N
ĠE s
ĠE ar
ĠE ich
ĠE ign
ĠE ree
ĠE UR
ĠE TE
ĠE ach
ĠE ither
ĠE icosapent
ĠE ERE
ĠE jection
ĠE SC
ĠE RS
ĠE ye
ĠE ico
ĠE urope
ĠE ffervescent
ĠE sch
ĠE uc
ĠE dlic
ot U
ot s
ot yros
Ġth a
Ġth i
Ġth n
Ġth o
Ġth umb
Ġth erapy
Ġ4 47
Ġ4 35
Ġ4 75
Ġ4 96
Ġ4 77
Ġ4 400
Ġ4 71
iv od
Ġbe im
Ġbe ads
ĠThe a
ĠThe ir
ĠThe nn
ub ri
ub iliz
ub ilization
ub erger
omp ose
omp son
Ġas a
Ġas ay
Ġas cor
Ġv o
Ġv ac
Ġv our
Ġv io
Ġv eter
Ġv erv
Ġv idone
tic ular
if ung
sol i
sol ubiliz
ĠR A
ĠR G
ĠR T
ĠR w
ĠR ac
ĠR ON
ĠR te
ĠR ind
ĠR aza
ĠR osen
ĠR SPO
ĠR aee
ĠR iel
ĠR ingn
ec ans
ec alis
ec anoate
Ġsol i
Ġsol utior
co ol
co povidone
co ccus
co vered
Ġ6 19
Ġ6 60
Ġ6 97
Ġ6 27
Ġ6 16
ri y
Ġac ic
Ġac arrier
ĠW ain
ĠW ood
ĠW agn
ĠW IL
ĠW eis
ĠW ew
ĠW ey
ĠW ie
ĠW lod
ĠW ET
ĠW EN
ts hilfe
qu et
qu ency
Ġal tern
Ġal bic
Ġal ba
st est
st ear
st orage
st rop
od in
od en
od der
od ible
od oph
od iester
res is
Ġon an
Ġon ditions
Ġcomp d
Ġcomp res
Ġcomp end
Ġcomp rom
Ġcomp iled
Ġl p
Ġl ed
Ġl ax
Ġl ated
Ġl av
Ġl ack
Ġl ux
Ġl ok
Ġl ingering
Ġl amellar
Ġl ubri
ag ere
ag raph
ag ement
ag Xcell
Ġ0 38
Ġus ec
im per
im su
im ization
im oto
im mungen
Ġdis inf
Ġdis covered
eth icon
eth anedi
per ty
per atur
per formance
per ingos
ac a
ac ia
ac hed
ac ious
ain e
orm ation
ES O
est ions
eg em
eg heeen
iz able
iz ec
iz iens
Ġapp ee
Ġapp aratus
Ġk A
Ġk a
Ġk h
Ġk lin
Ġk aolin
TI G
TI CH
em s
em y
em ia
em inal
em pl
Ġco fact
Ġco coyl
Ġco her
Ġco enzyme
Ġco peia
end ent
ĠIn ject
ĠIn ci
ĠIn cor
ĠIn jury
ĠIn dependent
ĠIn hal
ĠIn side
ĠIn vestig
lic ity
ĠL I
ĠL S
ĠL ir
ĠL ug
ĠL ack
ĠL ally
ĠL ivid
ĠL ong
ĠL alc
ĠL ester
ĠL EE
ĠL ead
ĠL upolen
ĠL BD
ĠL CST
ĠL OE
ĠL oading
ĠL arge
ĠL asin
ĠL osses
ĠL ithium
ĠL ots
ĠL imsu
Ġex eed
Ġex ept
ib ach
Ġ30 60
Ġ30 49
Ġ30 23
Ġ30 77
Ġ30 76
ax el
ON IP
ran olo
th ick
Ġ8 97
Ġ8 80
Ġ8 36
rad ill
rad ecanoate
ect ing
ect ile
Ġformul atior
Ġcan ts
Ġcan cent
ma i
ma zine
ĠOR Ns
ear at
Ġsp ite
Ġsp oiling
Ġsp ores
Ġcont en
Ġcont amination
Ġcont aminated
Ġcont raind
ĠG C
ĠG E
ĠG S
ĠG t
ĠG ray
ĠG LI
ĠG eis
ĠG enet
ĠG ale
ĠG ener
ĠG ef
ĠG ram
ĠG ott
ĠG lobal
ĠG eh
ĠG inn
ĠG olden
ĠG uide
ĠG ocument
ĠG AO
ĠG aB
ĠG egen
ĠG IBC
ĠG uign
ĠG onorrhea
ĠG atte
ĠG amma
ens in
Ġpoly propylene
Ġpoly sorbates
Ġpoly me
Ġpoly morph
ĠH f
ĠH i
ĠH l
ĠH AR
ĠH unt
ĠH CL
ĠH ypoth
ĠH eck
ĠH va
ĠH dll
ĠH orn
ĠH ilfe
ĠH DPE
ĠH UTT
ĠH olland
ĠH arnis
ĠH elmst
ĠH oward
rom e
Ġ50 6
Ġ50 10
Ġ50 47
Ġ50 39
Ġ50 78
Ġ50 89
Ġ50 46
Ġ50 711206
Ġ50 708787
Ġ50 138
ĠN C
ĠN G
ĠN V
ĠN Y
ĠN r
ĠN es
ĠN ces
ĠN ge
ĠN ose
ĠN ish
ĠN agnesium
ĠN atur
ĠN NR
ĠN SS
ĠN iacin
ant itative
der ly
der maz
Ġacid ity
ap ted
ap dle
ution ary
Ġy ure
Ġy oun
Ġy eas
ĠPE C
ĠPE ED
ĠPE EL
ĠPE RE
Ġdr astic
Ġdr amatically
Ġ7 50
Ġ7 40
Ġ7 15
Ġ7 200
Ġ7 89
our s
oc hem
oc yc
oc rin
oc onexent
oc resol
oc aine
ell ant
ell ane
AR A
Ġ9 70
Ġ9 28
ĠPro c
ĠPro vidone
ĠPro phyl
ĠPro perty
yd en
ĠIN UIT
ev alu
Ġwh ic
Ġ20 3
Ġ20 5
Ġ20 15
Ġ20 45
Ġ20 23
Ġit raconazole
ĠU I
ĠU IN
ĠU pm
ĠU lo
ĠU ber
ĠU dll
ĠU NIE
ĠU otU
). ..
ress es
Ġwe ep
mer ely
IN C
erm o
erm al
erm ole
erm inder
pt ol
ist ically
ist rations
ethyl acrylate
Ġpar agraph
og ram
og eneous
og ging
ard i
ch ing
ch man
Ġnot ew
ating s
lastic izer
Ġsolub ilities
ĠV P
ĠV V
ĠV a
ĠV IT
ĠV ME
ĠV ey
ĠV orsch
ĠV Erol
ĠV Id
ĠV anill
ĠV elinhn
ĠV iljant
ĠV erminder
pro mazine
ĠPR EGA
and iol
and iole
and lung
Ġ25 3
Ġ25 7
Ġ25 55
rate c
Ġun ter
Ġun coated
Ġun affect
ular ly
ver gle
Ġad c
Ġad her
Ġad vance
Ġad ipic
Ġad apted
ip ate
ip ulating
ip endent
OR ESO
cess es
Ġfil ing
Ġfil tration
Ġfil trate
ĠSt art
ĠSt ontour
ĠSt rains
Ġ10 9
Ġ10 45
Ġproper tiy
hol s
Ġper ception
Ġper iton
Ġmin d
Ġmin er
Ġmin ty
Ġmin antly
Ġdes orption
ĠTh at
ĠTh oren
ĠTh ompson
ĠTh oden
ĠTh ermo
lig ible
lig nant
25 6
25 9
25 49
Ġ12 3
Ġ12 35
Ġ12 700
int ed
int iziens
Ġtem p
Ġtem peratur
cent er
pos sible
Ġdi ol
Ġdi ethy
Ġob ject
Ġob ta
Ġob stac
Ġ15 2
Ġ15 9
unt on
unt ersuchungen
ud ed
Ġman ner
Ġman agement
Ġman ipulating
ast atin
Ġinc ident
Ġinc lusion
Ġsh amp
Ġsh aker
Ġsh aped
Ġsh oul
ĠUS ed
Ġact er
HA I
HA N
pical S
Ġ100 7
IG S
IG tal
hyd oxy
Ġph ann
Ġph obic
Ġpre ci
Ġpre vi
Ġpre formed
Ġpre tested
Ġ60 6
Ġr E
Ġr way
Ġr ule
Ġr aloxifen
Ġr ollowing
Ġr roperties
Ġr isks
Ġr amaing
of orn
ment hanol
Ġab dominal
Ġab domen
Ġformulations solubiliz
hen ce
Ġavail ab
Ġconcent ated
sul odin
Ġrequ isite
Ġ40 2
Ġ40 4
Ġ40 9
Ġ40 29
ad n
ad ly
ad ine
ad iaz
ad emy
Ġdet erior
sp ecific
sp eed
sp lasticizer
ore versible
Ġ[ /]
Ġprovid ec
ov rrolid
55 22
55 79
Ġle t
Ġle thal
Ġle ukotri
Ġle vomenthol
Ġle ets
Ġle ached
hem ica
Ġmon ome
Ġmon onitrate
Ġind ex
Ġind ipendent
Ġcons is
Ġ- @-
ĠAN L
Ġ18 4
Ġib ility
Ġsuspens io
Ġpo res
Ġpo ured
Ġim possible
Ġbot tom
Ġdocum en
ali t
ali ses
Ġcap rolactam
ual ly
Ġag ocument
Ġsub cutane
Ġwas h
Ġch osen
Ġch ocolate
Ġch opper
Ġch alky
ĠTH T
lu x
Ġint ial
Ġint rins
Ġint roduced
Ġint ormation
ĠSp i
ĠSp ot
ĠSp ick
ĠSp eck
ĠSp onge
ĠSp ataf
hn ert
se a
se quently
se amless
ĠAl so
ĠAl umin
ĠAl fu
AN ICL
ces cens
Ġdrug our
ĠPoly vidon
ĠDA Z
ling en
par ations
par aten
Ġrefer ences
lycer ide
ge aling
ĠComp rehensive
ĠComp ressibility
ĠComp atibility
ting ton
Ġfol owing
Ġgran u
Ġgran ule
Ġdo or
Ġdo phore
prop ane
prop andiole
Ġshow r
Ġdiffer ed
Ġup or
Ġup held
Ġpowder y
mar ket
mar tec
ĠJ HA
ĠJ iameter
ĠJ ohn
ĠJ odoph
Ġgranul ating
Ġqu estions
10 6
10 8
10 50
10 62
10 64
ric s
ric t
Ġplastic iser
Ġse o
Ġse ptic
Ġse ems
Ġcompress ability
Ġcompress ior
ĠCo on
ĠCo hes
ĠCo processed
ĠCo esfeld
ĠCo arse
® ,
Ġde aema
Ġde oconexent
AL NVG
Ġethyl acrylate
ht itung
Ġdeterm ines
ruct ion
,, -
,, /
Ġ5025 47
Ġ5025 16
Ġ5025 148
Ġfat ten
Ġ< -
Ġ< <
Ġen on
Ġen vhaan
Ġen nan
Ġen abled
Ġhyd rates
Ġhe xahydrothymol
Ġhe lium
Ġme ant
50 711206
50 708787
Ġunder go
Ġunder tak
ĠIt aly
Ġsubst rate
Ġsubst itutes
Ġsubst itution
ĠDis soli
Ġtest er
Ġtest ec
we iz
Ġ19 5
Ġ19 50
Ġincre mental
Ġchar ts
Ġchar ged
Ġrecommend er
out let
Ġsoftgel splasticizer
ient en
Ġmanufact urability
Ġro sace
Ġro utinely
Ġforms bro
its vergle
ros omes
Ġperform s
ĠAc ute
ĠAc ademy
ĠQ D
ĠQ e
ĠQ f
ĠQ o
ĠQ ue
ĠQ VG
ĠQ NN
ĠQ martec
Ġsupp orts
Ġsupp resses
Ġstear at
Ġran tant
lin s
lin es
lin ed
lin ked
Ġcharacter istically
ĠAs a
ĠAs h
ĠAs anak
40 8
40 519
ĠLA IGtal
ia ait
Ġmm ation
ĠPar tion
ĠPar ticular
Ġrel ativ
Ġdispers ant
Ġexcip ien
sorb itan
Ġreg ion
Ġreg istration
Ġreg imen
Ġreg istrations
Ġreg ularly
ĠBE T
ĠPROD UCT
ĠWh il
Ġadd a
Ġadd ec
Ġsy resis
Ġacet aminophen
ĠApp ropri
ĠApp aratus
Ġ200 2
ĠEX Ci
Ġpartic ipate
op olymer
ĠRE L
ĠRE T
19 9
19 75
19 86
19 95
19 98
19 90
19 647
19 91
rig en
Ġolli don
Ġcur ren
Ġne pnp
Ġne uen
Ġext ra
Ġext ension
20 20
Ġinf la
Ġinf ection
Ġ17 4
Ġ17 9
Ġ17 400
ole as
34 1
34 8
min s
Ġ3055 403
poly oxyl
Ġpress ion
Ġpress ing
Ġpress ibility
Ġant itus
ach ment
ach lor
ograph s
ĠCon c
ĠCon foc
ĠCon sequently
ĠCon gealing
Ġev ents
ak ed
Ġx anth
Ġret ina
Ġret urns
Ġguid eline
Ġguid elines
Ġparticular y
Ġsur gery
Ġsign ed
pe fru
Ġdesign ing
ĠEE O
lo coat
lo ading
lo zen
lo coccus
IL IC
liz es
Ġloc ally
Ġinst ability
Ġinst ead
Ġinst abilities
Ġconst ants
ĠEn viron
ĠEn gst
Ġcurrent comp
Ġmain hs
Ġ24 9
Ġ24 34
Ġ24 17
Ġ24 74
ĠSE E
ĠSE L
ĠSE N
ĠSE NN
Ġimp rint
.. .
BIL IT
hes iol
Ġ11 4
Ġ11 5
Ġ11 6
ĠIMPLI EC
30 4
30 6
30 207
30 534
ĠEx cess
ĠEx amples
ĠEx cip
ĠEx clusion
ĠEx pedite
ĠEx empl
PA CT
Ġwill ft
Ġblend ers
ĠQu antitative
pend ently
Ġfa ecalis
Ġ300 675
Ġdissolv able
Ġcol ored
paration en
ĠTablet ability
ĠTablet ting
Ġconstit uted
38 0
38 38
38 42
ĠAn ders
ĠAn umber
ĠAn hydrous
ĠAn aest
ĠAn dres
ĠAn wend
ĠMed ica
gan isms
ĠRe a
ĠRe ed
ĠRe cept
ĠRe agXcell
Ġcar bo
ee a
oxy lic
Ġra ae
Ġra ising
Ġinspect io
Ġair y
Ġair ways
Ġair tight
Ġod t
Ġla a
Ġla ury
ĠINCLU DIN
Ġ50259 79
Ġ50259 797
Ġ50259 796
Ġ50259 81
Ġ50259 795
Ġvari ed
cell ular
cell ulose
ĠDi etary
ĠDi agram
ĠDi anorm
ĠDi osna
phar m
Ġbel ov
ĠPharmaco dynam
are n
dis pensing
Ġhard ens
Ġhard ening
Ġsens orial
apent aenoic
lud e
lud es
Ġmic e
Ġmic o
Ġmic rone
Ġmic rosomes
DS P
Ġinter nal
Ġinter particul
ĠAR SE
ĠAR RZ
Ġmonograph y
Ġequ ation
Ġpl atform
Ġpl odder
Ġhom opolymer
ne im
ne utral
Ġmat ch
Ġmat riy
48 0
Ġcros carmellose
Ġox ystearate
Ġ35 1
ĠStear y
Ġcrystal lized
Ġcrystal lize
Ġcrystal lizes
47 7
OU LIL
kinet ic
Ġ13 687
Ġprop anol
Ġprop ranolo
Ġht tos
sw ant
Ġcopoly met
Ġunt ary
Ġethanol ic
97 4
97 817
ĠINTE LP
ĠDESCRIB EL
ym ann
ild dr
Ġspec ially
Ġspec imens
15 7
15 34
15 93
Ġsc raper
Ġsc heme
Ġsc orbic
Ġdev ices
Ġ16 3
Ġ16 80
80 98
ĠDisinteg rations
ĠDes pite
Ġ305544 44
IS OIV
Ġquant itativen
Ġflow s
ĠRI n
Ġimport ar
vers orgung
Ġaccel erates
phen s
Ġent eral
Ġent ero
Ġent hal
Ġar id
Ġar uM
Ġar dness
ĠSA E
ĠSup plementary
Ġpart u
Ġanti hist
yc lins
Ġfin er
Ġfin est
Ġdem anding
ĠAd ding
ĠAd ditional
ĠDO OR
ĠDO WE
Ġstar ted
Ġfluid ised
39 8
mm ing
Ġfish y
Ġanal yzing
Ġbeh ind
ĠEL ORESO
ĠUn like
ĠUn coated
21 2
ep am
Ġsom atogenicity
ĠEth ylene
oxyl ation
Ġ22 3
Ġ22 9
ĠProp anol
ĠProp ellant
ĠProp andiol
ha ush
ha utdes
te blatt
Ġ% .
Ġ% ).
Ġca ihe
Ġlight oroof
Ġcomb ines
26 30
26 29
26 9227
Ġtrans formation
Ġtrans ienten
ĠPre ca
ĠPre parations
acid al
ii inc
ii qh
ii iaait
Ġ@ ~-
ĠZ bl
ĠZ eller
ĠZ epp
Ġrem edied
Ġso e
Ġso aked
Ġlevels we
18 6
18 31
ĠMon if
ĠMon ks
Ġether ified
31 3
yg iene
Ġsem icryst
Ġbro ac
Ġprotect e
Ġprotect ing
Ġless ening
Ġ87 1
Ġ87 3
Ġquick er
Ġ14 35
27 4
ĠHC C
Ġconsider ations
ĠCont amination
Ġsm e
Ġsm dds
Ġfast ed
Ġrele ace
Ġass is
Ġass uring
propanol amine
70 16
Ġpat tern
Ġmild ly
ĠAt trib
Ġ26 7
Ġ26 9
Ġ26 28
Ġcarb amazep
Ġ21 3
Ġ21 4
Ġcompar ative
Ġdiff use
Ġdiff usen
Ġcet anol
Ġcet eare
Ġintend ing
35 62
Ġ96 734
12 9
ci ence
vi ovrrolid
Ġhomogen ised
Ġhomogen isation
Ġformer ly
Table ting
rat able
rat io
Ġstrong est
ice ptive
ĠSe a
ĠSe k
ĠSe en
ĠSe lected
Ġ38 3
Ġfunction alit
ĠMacrogol s
42 82
methyl pyrrolidone
methyl cyclohexanol
ĠY A
ĠY E
ĠY ou
ĠY UU
ĠY aV
ĠY lOSs
ĠY onag
Ġcl ogging
ĠNe xt
ĠNe uros
Ġprepar ing
14 1
bed ded
Ġi id
Ġi his
Ġi was
Ġmacrogol i
Ġ5034 1064
Ġfib re
Ġfib ers
ĠCor rel
ĠCor swant
Ġ800 1
ind ung
Ġpe o
Ġpos es
Ġpos itition
ĠOA IGS
und en
und mann
Ġ68 6
Ġ68 35
ĠCh ines
ĠCh romat
ĠCh ronic
ĠCh romatograph
ĠCh oose
ĠCh ocolate
ĠCh rist
ĠIsopropyl myristate
Ġ34 5
Ġextr ude
Ġextract ed
lex es
lex ed
Ġ306 74
Ġ306 3562
ĠNa C
ĠNa unton
Ġrat s
Ġchlor ophen
Ġchlor hexidine
Ġchlor ocresol
Ġspeed s
ĠGU I
Ġj p
Ġj um
ĠForm ing
iment elle
Ġspect roscopy
reg ular
Ġcre ation
Ġcre ated
Ġcre asing
Ġout let
Ġout lined
Ġ67 1
Ġ67 6
ĠHe eg
ĠHe ptane
ĠHe xane
ĠHe uberger
ĠHe ymann
13 304
oph yt
Ġpalm itate
Ġfra oo
Ġbod ies
ĠSR S
Ġresp ec
acet one
Ġtreat ments
ĠPicture s
ĠAS AE
Ġrest ored
Ġvinyl cap
Ġmelt in
Ġcaus ing
57 43
79 09
ĠAb t
ĠAb out
ĠAb normal
Ġ69 3
ĠInd ustri
ĠInd icating
ĠHum ectant
Ġfoams used
ident ical
Ġmicro bic
Ġrespon se
pre vents
Ġmark ed
Ġdel amination
coating s
ĠInf usion
Ġ97 3
ann a
anti hy
Ġ900 2
Ġdelay ec
EE Y
Ġend ows
Ġlo ose
ĠStud ie
Ġseal ing
ĠQRPI c
Ġimpact s
87 8
ĠMar tine
chain member
Ġlauryl sulfate
Ġinvestig ated
29 8
table ting
Ġmet er
Ġmet acrylic
ĠCar r
ĠCar pent
ĠCar chman
ĠTest ing
Ġres ts
Ġminim ises
gra ined
gra fted
ĠSyn det
Ġeffic acious
Ġ28 6
ĠBio pharm
ĠMeth ode
ĠMeth acryl
Ġmeasure s
Ġhardness es
be k
be agle
oper ative
oper ativen
Ġser um
Ġser ial
Ġser ies
Ġtow er
St ability
St ructural
St earat
edes infektion
propan etri
other apy
08 2
08 25
08 55
08 19
08 39
08 31
08 13
08 93
08 83
onic ation
ĠTurb ule
ĠTurb ala
ĠMin r
hydro stear
ĠPolyvinyl pyrrolid
Ġrot a
MF T
iot ensin
Ġsed ds
Ġpost coating
Ġpost operativen
Ġopt ical
Ġ150 5
Ġagain s
Ġsubject ive
Ġprimar il
.) ;
CE P
CE HU
Ġir rigation
Ġir reversible
Ġir regular
Ġpolar ized
Ġpolar imetric
Ġbio pharma
Ġbio active
Ġ305 855
ĠEnd ocrin
62 33
Ġap reservative
Ġap llication
Ġback ed
ĠOn set
iff usions
Ġlar gely
78 8
Ġel derly
Ġexper ien
Ġexper imental
ĠThio pent
Ġavoid s
Ġdef ine
Ġfre iem
Ġfre quency
ĠCap acity
ĠAv asth
ĠMic roscopic
ĠMic roscopy
ĠMic onazole
Ġ42 3
Ġoxid ative
Ġoxid ized
Ġsynthes is
Ġchem is
ĠCA mn
ĠAg rard
Ġelimin ate
ĠRic inol
ĠRic hard
Ġcontin ous
ĠStabiliz er
198 8
Ġantibiot ischen
Ġhydroph ylic
Ġhydroph iilic
Ġtalc urr
Ġpure ly
Ġpred o
Ġop en
Ġthem oreversible
ĠSci roc
ĠMel astatin
Ġremov al
Ġoptim ize
CO S
Sol ubilization
ner able
sc rew
Ġsimil a
Ġbas eline
Ġ49 0
Ġ49 3
Ġ49 9
Ġdisor der
ĠStir ring
Ġobs erving
Ġrhe ometer
pant oyl
Ġer at
Ġer rr
Ġer odible
Ġer ectile
ĠPalmit inic
Ġbi ologically
Ġbi phasic
Ġneg ative
Ġ48 2
ĠRed ispers
Ġaccept ing
Ġ505 207
Ġ505 30207
Ġload s
ĠCarb onate
36 74
RS PO
RS GRS
meth viovrrolid
Ġz u
Ġz one
Ġpeg s
ĠPract ices
Ġref ers
Ġref lux
Ġelect roc
Ġgen eric
Ġgen ital
ĠLab ras
Ġautomat ic
Ġdiscre te
cap ric
Ġfe aturing
Ġfe eder
ĠOle ic
ĠFit ton
ĠFree zing
ĠRot ter
Ġprefer ences
Ġbiplan a
43 10
inder mann
Ġdam age
ĠPer iton
ĠPer fume
ĠSc heme
Ġhal a
Ġexclud ed
Ġment homenthol
Ġmir abilis
ĠKoll er
ĠKoll wax
ĠKoll pii
ĠCH O
Ġgra iny
ĠLIA BILIT
ĠGlycol e
Ġ5026 0032
Ġ5026 3842
Ġ5026 4282
Ġ5026 3674
ĠUl rich
Ġuniform ly
Ġincorpor ating
Ġ137 110
Ġ137 134
Ġ137 124
Ġ137 243
ĠWHE THEF
ĠARIS INC
58 2
late x
ĠĠ Ġ
Ġtet ani
Ġtet radecanoate
Ġmagn ifications
ĠKOH ISOIV
ĠIS TE
ĠAnt isep
ĠEqu ilib
ĠRes pon
Ġ198 4
rem aining
Ġsand y
ĠcGMP and
Ġmas on
ĠTrans formation
ome promazine
ĠBi w
ĠBi ol
ĠBi ochem
ĠBi RSGRS
Ġstimul ation
Ġstimul atior
Ġ53 269227
ĠCompos itions
sec onds
Ġu um
Ġtre ating
Ġfo i
Ġdig lycerides
Ġdec line
Ġdec omposition
Ġdec olour
ĠKol locoat
ĠTechn ol
Ġju ices
App likation
âĢ Ŀ
hea ver
ĠTa hk
ĠTa ANICL
ĠOr ganisms
ĠMe asure
ĠMe hnert
ĠProcedure s
Ġrub rum
Ġage ing
Ġ502534 86
ĠRefer ence
ĠAcetyl triethy
ĠGranul ates
Ġconcern ing
oar anna
set point
list ed
Ġmechan ically
Ġdys function
Ġbran ches
ĠRev iew
Ġalg inate
Ġalg orith
imet rically
ĠInc reased
ĠInc lude
Ġ180 4
Ġchir urg
ĠDispers ible
Ġblock er
Ġflav or
Ġflav us
Ġirrit ant
Ġirrit ating
Co ater
Co atings
US I
Ġfac es
ĠTe Qui
ĠImpro vem
ela ic
Ġster oids
Ġric er
ĠCompar ative
68 19
Poly mer
Poly vinyl
ĠâĢ ľ
ĠES N
Ġthin ner
Ġvigor ous
Ġatom izing
ĠHA CP
Ġadjust ment
Ġchap ters
Ġhydrogen ation
Ġsupport ive
Ġnew ly
ĠAtom ized
ĠHydroxyl value
Ġdigest ible
Ġflavour s
ĠSuspension stest
Sup plementary
dry er
Ġpr inted
Ġdecre ase
ĠPres urgical
ĠSch oole
ĠSch weiz
ĠSch ilddr
Ġglycer in
Ġglycer ides
Ġalter ing
ĠLi eth
ĠGel ed
ĠGel atin
ĠVer fahren
Ġdeli v
Ġhydroly zed
Ġmaxim al
Ġmaxim izes
Ġcolor it
Ġconstitu ents
ĠPharmacopoe ia
Ġaggreg ation
Ġaggreg ate
Ġtransp orted
Pro cess
Pro cedure
bel ow
drug s
ho fer
ru der
Ġte lease
Ġseg mental
ĠSo ating
ĠMa i
ĠMa ibach
ĠMa lignant
ĠET N
Ġ62 3
Ġll lig
ĠLet ters
ĠGerm icidal
ĠNom enclature
hydrox ystearate
hydrox ystear
Ġabs cesses
ĠContin uous
Ġdeliver ed
73 26
API s
ek tive
lod e
nn ac
pyrrolid inone
Ġpas sea
arb oxylic
ĠCN IS
ĠCOM LEN
ĠCOM CEHU
ĠSh igella
ĠSi egem
ĠDeterm ination
ĠBet a
Ġassist ants
Ġassist allit
Ġvag inalis
ĠRemark s
Ġexception e
ĠHa edic
Ġprem ium
Ġallerg ies
Ġrepe ating
Ġrough ly
ĠAcc la
197 1
Ġevapor ation
Ġevapor ated
Ġevapor ates
Ġassess ed
ĠToxic ol
ĠToxic ity
Ġmarkets long
Ġfeature s
ĠMeet ing
Av icel
Br ushes
wet ting
ĠÎ ±
Ġtinct ure
Ġsulf adiaz
Ġpenet rability
Ġcrosp o
ĠPe ppermint
ĠCU Ne
ĠCU HCSI
ĠCe asar
ĠChem otherapy
ĠSy kes
ĠAer ome
Ġhar sh
Ġham sters
ĠOp thalmics
ĠBe agle
ĠMal inin
ĠMac roscopic
ĠMac rocols
ĠEffic iacy
Ġtherm ally
Ġ5048 7016
Ġ5049 8319
Ġ5042 4310
ĠNot ice
ogen ic
ĠVY UTU
ĠStructure s
Ġpreca ution
Ġrun s
Ġrun ning
Ġamino ester
ĠMedic ine
ĠMedic inal
Ġmicron s
Ġmicron ucle
Ġ5025353 3
ĠAdhes iveness
Ġhydroxyl ation
Ġunderst oc
inn at
Ġtail ored
orth y
Ġom e
Ġfung i
Ġwal t
ĠSter ilization
ĠAB E
Ġreve aled
Ġproof ed
ĠFran ce
ĠMet ab
Ġvent ed
ĠWe ber
Ġlen gth
ĠInter esting
ĠVari ous
ĠThrough put
Ġobtain ec
Ġphot ometric
Ġmonog lyceride
Ġinde pendently
ventil ate
Ġquali tative
Ġassay ed
Ġpharmaco kinetic
Ġcetosteary lether
ĠNeut ralizing
Ġire co
ĠMixture s
Ġelabor ates
Ġexpert ly
Ġexperiment ellen
Ġ50539 897
Ġ50539 398
ĠUlt rez
Ġview ed
Ġspher es
07 79
Man est
Reg ulatory
Ġaff ec
Ġswell able
Ġmoist urizers
ĠFD O
Ġthorough ly
Ġ61 791
Ġ61 788
Ġattrib uted
ĠGr ding
ĠGr undmann
ĠMicrob ial
ĠMicrob icidal
ĠMicrob iol
ĠTRPM B
Con taining
Eicosapent aenoate
LC ST
UU UE
Ġflus h
icid in
Ġdust ing
ĠPelle tization
ĠPantothen y
ĠCa ro
ĠCer a
ĠImp ortant
Ġshort ens
Ġdistinct i
Ġdistinct ly
Ġ305540 50
Ġ305540 47
Ġ305540 46
Ġ305540 51
disinteg rant
disinteg rating
Ġ146 00
Tablet ting
Ġdiethylamino eht
83 38
Doc osahexaenoate
comp ression
comp lexed
sa ure
Ġicosapent ate
Ġaa ah
Ġaa iliabi
Ġaz elaic
Ġaer ogenes
erc ulosis
Ġsimp lif
Ġsimp licity
Ġcir cular
Ġcep acia
ĠPot el
ĠPot entie
ĠPIG SU
Ġbacter ially
ĠSU PPI
Ġ218 19647
Ġgener alises
ĠDiaz epam
ĠOM e
ĠOU I
ĠObst t
ĠMI COS
Ġ59 90
ĠWil liam
Ġlod otyros
Ġdisk ette
hard ening
Ġ3044 6233
Ġ3059 363
Ġatt achment
Ġpolyeth oxylation
ĠHeal ing
Ġ76 31
Ġadsorb s
Ġphosph odiester
ĠWhere as
ĠREN E
ĠExt ruder
Ġclean ers
Ġsupplement ation
Ġconfigur ations
Ġ50355 403
Ġ50355 400
Ġ50355 167
Ġdomin ant
ĠGynec ology
CI ZET
CI TICH
CI EEY
In dia
Ne osorb
Sym p
UE L
des infektion
me able
mel t
Ġtub es
Ġtub ing
Ġtub ular
Ġtub erculosis
lit axel
Ġcert ification
Ġoct anol
Ġoct yldodecanol
ĠPi peringos
ĠParenteral s
ĠCD y
ĠCalc ulate
ĠSm ith
ĠER E
ĠElect ron
ĠWir kung
Ġcohes ive
ĠLev omenthol
ĠLev omepromazine
ĠLoper amid
Ġ302 8098
ĠHem o
ĠNA MEN
ĠNic hols
ĠNee b
ĠNee Ween
ĠThi amine
Ġdetect able
Ġdetect ale
Ġagit ating
Ġantimicrobial s
lohex ane
Ġ502598 12
Ġ502598 17
Ġexplain ed
Ġresid ue
Ġfootprint the
Ġvaginal er
Ġ50424 307
ĠObstet rics
Ġ305936 25
Ġ305936 26
Ġ305936 31
Ġ305936 27
ĠPseud obacter
HI t
Ment hanol
bl um
bl ack
gran ution
gran ces
len versorgung
lubric ation
sh ape
sh aped
tions mitt
Ġaim s
Ġtm ett
Ġtren ding
Ġpy ogenes
Ġpath way
Ġpath ways
Ġpath ogenic
Ġinactiv ated
Ġmal onic
Ġmal nutrition
Ġdos ed
Ġdos ing
Ġdermat ological
ĠPa o
ĠPa ul
ĠPo int
Ġbrid ging
ĠCert ificate
ĠCyc le
ĠSweet eners
ĠAL G
Ġprovia ea
Ġgerm icidal
Ġgerm icide
Ġgerm acidal
Ġhaem olytic
Ġner vous
ĠOpt imal
ĠOpt iCo
ĠOpt imization
ĠFr isch
ĠFr mming
ĠBr EAA
ĠBac itrac
ĠBAS E
ĠBAS I
ĠBacter iological
ĠMee e
Ġstand alone
Ġthro iiqh
Ġvul nerable
Ġvacc um
ĠRode heaver
Ġlin ers
Ġlayer ed
Ġdise ases
ĠGR AIN
ĠGi indermann
ĠHomogen ization
Ġ507 40519
och rome
Ġadv anced
ĠSte phens
Ġsufficient ly
Ġperf ect
Ġperf ume
Ġperf uming
Ġshif ted
Ġimmun ological
Ġintra abdominal
Ġintra cellular
Ġintra operative
ĠAllow ance
Ġ502515 33
Ġenorm ously
cyclohex an
Ġmethy acryl
Ġneuron s
Ġantif oam
Ġretard ation
.... ....
ĠAnal ysis
Ġequilib rium
Ġ1366 19
Ġ1366 81
Ġ1366 83
Ġsmell s
ĠChlor oforn
ĠHex ahydrothymol
ĠHex edit
ĠHex achlor
Ġmicrob iological
Ġlozen ge
Ġmetabol ized
Ġgrav ity
Ġgrav imetric
Ġgrav imetrically
ĠKetocon azole
Ġjerric an
Ġcamn recc
Ġ306315 40
Ġ306315 38
Ġ306315 36
ĠWirksamke itsvergle
Ġ5042459 6
ĠPyridox ine
Ġbakter iellen
ĠCinnariz ine
Ġeicosan oid
ĠThyroid fun
Ġethoxylate c
ĠCyanocobal amin
150 9
AT BO
Comp ressibility
Comp arison
IC OULIL
Th is
Th ermal
effect s
effect ive
fl ake
fl akes
iew s
ians er
ken haush
kran z
kran ken
loc al
loc her
mix ed
mix ing
non ente
rn arhii
sen hofer
temperature s
zt indung
Ġion izable
Ġid antity
Ġid antihy
Ġtit rated
Ġtit ratable
Ġtrig iceride
Ġtrig eminal
Ġtyph osa
Ġtyph imur
erich ia
rel ative
Ġsapon ified
Ġsapon ify
Ġcard iov
ĠoO o
iso propyl
iso propanol
Ġang ular
Ġang iotensin
alk a
aly ptol
alan ine
Ġmer ely
Ġmit igate
Ġdar ned
Ġdar ivod
ĠPat el
ĠPat ients
ĠPen icillin
ĠPra paraten
ĠPra parationen
Ġbul king
ĠKn olle
ĠKra us
ĠKra use
ĠKess el
ĠKess ler
ĠTer atolog
ĠTrich omonas
ĠTrich ophyt
ĠIm age
ĠIm ages
ĠSim ak
ĠSim ethicon
ĠSulf ated
ĠSulf anil
Ġrecip e
Ġrecip es
Ġem uslif
Ġem bedded
urg ische
Ġgl adly
Ġgly co
Ġnn y
Ġnn atnn
Ġnro file
Ġnro ecans
ĠFR ONIP
ĠFra inor
ĠFra grances
ĠBran dw
ĠBAor F
Ġstabili se
Ġstabili lty
ĠED L
ĠED QM
ĠRound table
Ġala ae
Ġala iiiaait
imur a
ĠIng re
ĠIng bar
ĠLe yden
ĠLe bek
ĠLex ington
ĠLex tington
ĠGe bur
ĠGra ft
ĠGra pefru
ĠGold man
ĠGold blum
ĠHam ster
ĠHam sters
ĠHand e
ĠHand edesinfektion
Ġ504 133
Ġ504 30534
ĠNeg liable
ĠNeg ligible
Ġsolubilis er
Ġsolubilis ing
ĠVaginal desinfektion
ĠTha i
comm or
comm ot
Ġprec ursor
Ġprec ludes
Ġablet ting
Ġ<= =
ĠArz neim
ĠArz teblatt
Ġ305550 79
Ġ305550 82
Ġimpa ir
Ġlipopro tein
Ġlipopro teins
Ġexpect ed
Ġexpect orant
Ġcustom ized
Ġcustom izec
Ġchannel ed
Ġcleans ing
Ġcleans ers
ĠDesinfek tionsver
ĠDesinfek tionsmitt
Ġtoxic ologically
ĠHydro stearate
ĠHydro chloride
ĠChir urgische
ĠBlut strop
Ġ505487 67
Ġ505487 71
Ġ50581 346
Ġ50581 348
ĠSche inbar
ĠSche user
ĠSchen k
ĠSchen ck
Ġricin oleic
Ġricin oleas
Ġ504245 18
Ġ504245 92
Ġblanket ec
ĠBauch fellent
ĠBauch hdh
Ġtahlet e
Ġ5035516 8
Ġ5035516 9
Ġ50729 134
Ġ50729 133
Ġhemolytic us
ĠPeters en
Ġ503806 85
Ġ503806 83
073 2
247 8
329 0
AV IE
Ab stract
Ant i
AUO T
Bet adine
Best immungen
Baer locher
Com m
Cap acity
Des infektion
Differ ential
Dait o
Dispers ant
Er hh
ENS iO
ETIS IIE
FR G
Fre und
Forsch ung
Ger ia
Gra in
GIN aoll
GCe NY
HOA MIG
Imp ortant
Jo int
Komp lexes
KITI E
Lubric ant
Mon ographs
Mer ck
Mic ro
Mar Comm
Mel t
Misc ellane
Mann itol
Ni ater
Oint ment
Oral s
Pant oyl
Plastic izers
PIG UUUE
Pantothen ic
QaA nNmn
Rev iews
RAGI HAN
Sor bitol
She lf
Sch leim
Ste phan
Spect ra
Tur rax
Tak asag
Trans ient
TASA KITIE
Ur l
UPC ILIC
Usen kranken
UIAL Ory
Vir us
Verol Url
Vari ous
bas ec
bacter ium
calc ium
curon ide
dec ompose
dest ruction
fos se
film s
hv iline
hoper iert
ieti ans
kolli don
kul aren
kun de
kows ki
ktionsver htitung
logP ow
mihi ulatior
net en
nam ely
noc iceptive
pow del
pot entiometric
pigment ary
ratur rax
sup plied
sensit ve
tac kin
tem p
uTiO Sl
uUlat igor
xper imentelle
yres oe
zos in
Ġlic enced
Ġult raturrax
Ġaor und
Ġaen vhaan
Ġath y
Ġaign es
Ġaha ave
Ġaila allidn
Ġtigh ter
Ġtong ue
Ġtier arzt
Ġtex ture
Ġtalin iim
atom izing
recommend ed
repa iring
oran ge
hept anedic
enheil kunde
Ġslic k
Ġsect ior
Ġsart ie
Ġsacchar ine
Ġpac litaxel
Ġpend ant
Ġperm orated
Ġpip ettes
Ġpad ale
Ġpov egheeen
Ġprig oine
Ġpyrrolid on
Ġpyc no
Ġpiec es
Ġpolish ing
Ġcab inet
Ġcut ting
Ġcate gories
Ġcrom nonente
Ġcyt ochrome
Ġcrub bing
Ġcalin vlic
Ġoph thalmic
Ġovers aturated
Ġfab iet
Ġfem ale
Ġfap leting
Ġflas k
Ġflor a
Ġfrul hoperiert
Ġtheore tically
Ġanno oaranna
Ġanaer obic
Ġinhom ogeneous
Ġinnov ative
Ġmar cescens
Ġmid dle
Ġmut ually
Ġmiv ed
Ġmec h
Ġmater ia
Ġmob ile
Ġmern rnarhii
Ġmamali an
Ġmnin h
Ġdan azole
Ġdot ted
Ġdedic ated
Ġdatab ase
ĠPid slG
ĠPos sible
ĠPant henol
ĠPOR T
ĠPeral ta
ĠPass agere
ĠPrat ap
ĠPreserv atives
ĠPOr mihiulatior
ĠPerson nel
ĠPIV UPCILIC
ĠPfren gle
ĠPrt ifung
ĠwaB rigen
Ġwaiq ht
Ġwuy arrn
Ġbur st
Ġbil ayer
Ġbub bles
Ġbalan cing
ĠKur imura
ĠKod y
ĠKran kenhaush
ĠKap lan
ĠKRI ARA
ĠKout ras
ĠKall innat
ĠKidne y
ĠKlebs iella
ĠKarnav ati
ĠCand ida
ĠCyn res
ĠCef sulodin
ĠKollital b
ĠKollica ot
ethen yl
ĠTra uma
ĠTog ether
ĠTIT CIEEY
ĠTOU P
ĠTOM ICOULIL
ĠTitan um
ĠTromb etta
ĠTetra hydrofuran
ĠTiere xperimentelle
ĠTtor mulation
ĠTorres ani
ĠIse li
ĠIRI AT
ĠIAO E
ĠIOP uUlatigor
ĠIdent ity
ĠSil ver
ĠStic king
ĠSap onication
ĠSING H
ĠSaf ran
ĠSime on
ĠSyr ups
ĠSeel ander
ĠSult apdle
ĠSob radill
ĠSUSP ENSiO
ĠSimil ar
ĠSSe S
ĠSaug lingen
ĠAran go
ĠAver aged
ĠAav UIU
ĠAID S
ĠAmin ophylline
ĠAlex ander
ĠAhear n
ĠAustri aca
ĠAATA NE
ĠAyli ffe
ĠAzul ene
Ġrese al
Ġreading s
Ġreomov ed
Ġprosp ektive
Ġprostac yclins
Ġelic its
Ġeff ort
Ġeina i
Ġgyl col
Ġglu curonide
Ġgreas iness
Ġgetrock neten
Ġhorm ones
Ġhyper pigmentary
0031 6
Ġnac ced
Ġnran iiinc
Ġnood les
Ġnfe ktionsverhtitung
Ġnied ermole
Ġnomen clature
Ġnucle i
ĠDup re
ĠDri acoater
ĠDts ch
ĠDip lococcus
ĠDou ching
ĠDark ening
ĠDrop s
ĠDeter gent
ĠDurn y
ĠDIIN O
ĠDuar te
ĠOff set
ĠOBw ald
ylmeth acrylate
Ġconsolid ated
ĠFec al
ĠFir min
ĠFlor al
ĠFund amentals
ĠFrau enheilkunde
ĠFlav ours
ĠFNA ME
ĠFisch er
ĠFEQG UIALOry
ĠFuhr t
ĠBax ter
ĠBell amy
ĠBou quet
ĠBak t
ĠBne i
ĠBeur teilung
ĠBenz ocaine
ĠBeding ungen
ĠBeh andlung
ĠBru hn
ĠBuch er
ĠBerich t
ĠBRU GINaoll
ĠBorzelle ca
ĠBuszell o
ĠMod ified
ĠMPA TASAKITIE
ĠMerk le
ĠMyco bacterium
Ġstream lines
Ġstabilis er
Ġstead ily
Ġ515 97817
Ġ521 5522
Ġ565 13304
ĠEign ung
ĠEicosapent aenoate
ĠESC M
ĠERS TE
ĠEico apentaenoic
ĠEsch erichia
ĠEuc alyptol
ĠEdlic h
ĠThenn hviline
Ġascor bate
Ġvac uum
Ġvio enncity
Ġveter inary
ĠRac es
ĠRosen kranz
ĠRaee uTiOSl
ĠWain ht
ĠWood burn
ĠWagn er
ĠWIL ETISIIE
ĠWeis senhofer
ĠWew alka
ĠWey ers
ĠWlod kowski
ĠWET TIG
ĠWEN A
Ġaltern ating
Ġalbic ans
Ġcompend ium
Ġcomprom ise
Ġlax ative
Ġlav age
Ġlux urious
Ġlok alen
imper meable
Ġdisinf ecting
ethanedi yl
Ġklin ischen
Ġcofact or
Ġcoher ent
ĠInject ables
ĠInci uded
ĠIncor poration
ĠInhal ation
ĠInvestig ations
ĠLir rigation
ĠLug ols
ĠLivid as
ĠLalc lum
ĠLBD DS
ĠLimsu wan
Ġexept ed
Ġ3060 7326
Ġ3049 2630
Ġ3023 5579
Ġ3077 6819
Ġ3076 5743
thick ness
Ġcancent ratec
Ġcontraind icated
ĠGLI UEL
ĠGeis mai
ĠGenet ic
ĠGale otti
ĠGener ig
ĠGef ahren
ĠGram icidin
ĠGott ardi
ĠGeh alt
ĠGinn y
ĠGolden hem
ĠGAO L
ĠGaB ar
ĠGegen wart
ĠGIBC IER
ĠGuign ier
ĠGatte fosse
Ġpolymorph ism
ĠHAR SIN
ĠHypoth yresoe
ĠHva q
ĠHdll er
ĠHarnis ch
ĠHelmst edt
Ġ5010 1050
Ġ5047 7909
Ġ5039 1593
Ġ5089 3290
Ġ5046 1831
Ġ50138 477
ĠNces eea
ĠNge e
ĠNish imoto
ĠNatur al
Ġyoun g
Ġyeas ts
ĠPEEL E
ocyc lohexane
ĠProphyl actic
evalu ate
ĠUIN AVIE
ĠUlo VerolUrl
ĠUNIE T
Ġnotew orthy
ĠVIT tUal
ĠVorsch lag
ĠVErol orl
ĠVId GCeNY
ĠVanill a
ĠVelinhn ce
ĠViljant o
ĠVerminder te
Ġunaffect ed
Ġadher ed
ĠStontour is
Ġperiton ites
Ġdiethy lether
Ġobject ive
Ġobta ir
Ġobstac les
Ġshamp oos
hydoxy stearate
Ġphann ga
Ġpreci ous
Ġprevi ously
Ġramaing adn
Ġformulationssolubiliz ing
Ġ4029 32
Ġdeterior ation
Ġleukotri enes
Ġsubcutane ous
Ġintrins ic
ĠSpick er
ĠSpataf ora
ĠAlumin um
ĠAlfu zosin
ĠJodoph ore
Ġseptic um
ĠCohes ion
Ġ502547 56
Ġ502516 95
Ġ5025148 0
Ġfatten ing
Ġennan cers
Ġrosace a
Ġformsbro ad
ĠQVG HOAMIG
ĠQmartec aal
ĠAsanak a
ĠLAIGtal Y
ĠPartion ing
ĠAppropri ate
ĠEXCi PACT
Ġcurren ts
Ġnepnp nnac
Ġ3055403 2
Ġantitus sive
ĠConfoc al
Ġxanth an
lozen ges
ĠEngst r
Ġcurrentcomp endial
ĠSENN A
Ġimprint ed
ĠExcip ient
ĠExempl ary
Ġ300675 41
ĠAnders on
ĠAnaest hesiol
ĠAndres en
ĠAnwend ung
ĠRecept or
ĠReagXcell ance
Ġraae ietians
ĠINCLUDIN C
Ġ5025979 9
ĠDiagram mm
ĠPharmacodynam ics
Ġmicrone edles
Ġinterparticul ate
Ġ13687 4
ĠINTELP LECTUAL
Ġenthal py
Ġantihist amine
hautdes intiziens
Ġcaihe tained
ĠPreca utionary
ĠZepp a
Ġsemicryst alline
ĠAttrib uted
Ġcarbamazep ine
Ġceteare th
ĠYaV ilill
ĠYonag a
ĠNeuros cience
ĠCorrel ation
Ġpositition ed
ĠChines e
ĠChromat ogram
ĠChromatograph y
ĠChrist ianser
Ġ30674 274
Ġ3063562 4
Ġchlorophen ols
Ġchlorocresol s
Ġfraoo a
Ġvinylcap rolactam
ĠIndustri al
Ġmicrobic idal
ĠMartine z
ĠCarpent ier
ĠMethacryl saure
propanetri ol
hydrostear ic
ĠPolyvinylpyrrolid on
Ġ305855 59
ĠEndocrin ol
iffusions untersuchungen
Ġexperien ced
ĠThiopent al
ĠAvasth i
ĠCAmn RAGIHAN
ĠAgrard iffusionsuntersuchungen
ĠRicinol ic
ĠSciroc co
ĠRedispers ion
Ġ505207 86
methviovrrolid one
Ġelectroc hemica
ĠLabras ol
ĠPeriton itis
ĠKollpii at
ĠAntisep sis
ĠEquilib rium
ĠRespon ses
Ġdecolour ised
ĠTahk ilat
Ġalgorith m
Ġchirurg ischen
ĠTeQui rea
ĠImprovem ents
ĠHACP P
ĠSchoole y
ĠSchilddr Usenkranken
hydroxystear ic
ĠCOMLEN t
ĠCOMCEHU AUOT
ĠSiegem und
ĠHaedic ke
Ġsulfadiaz in
ĠCUNe HIt
ĠCUHCSI IU
ĠVYUTU PIGUUUE
Ġmicronucle us
Ġphotometric ly
Ġdiethylaminoeht ylmethacrylate
Ġsimplif ies
ĠPIGSU CIZET
ĠSUPPI CITICH
Ġlodotyros ine
Ġ3059363 3
Ġphosphodiester ase
Ġ3028098 8
ĠPseudobacter emia
ĠOptiCo at
ĠBrEAA GSE
ĠBacitrac in
ĠHexedit ine
ĠHexachlor ocyclohexane
Ġcamnrecc ion
ĠWirksamkeitsvergle ich
ĠThyroidfun cion
Ġtyphimur ium
Ġcardiov ascular
ĠTeratolog ische
ĠTrichophyt on
ĠSulfanil amide
Ġemuslif ier
Ġnroecans at
ĠFRONIP NOr
ĠBrandw unden
Ġalaiiiaait l
ĠGebur tshilfe
ĠGrapefru it
Ġ504133 34
Ġprecursor s
ĠDesinfektionsver fahren
ĠDesinfektionsmitt el
ĠBlutstrop fen
ĠBauchfellent ztindung
ĠBauchhdh lenversorgung
Erhh ung
Miscellane ous
Schleim hautdesintiziens
Takasag o
Ġailaallidn es
Ġtierarzt l
heptanedic arboxylic
Ġpovegheeen ig
Ġfrulhoperiert en
Ġmernrnarhii ac
ĠPOrmihiulatior r
ĠPIVUPCILIC S
ĠKrankenhaush ygiene
ĠTOMICOULIL ALNVG
ĠSobradill o
Ġniedermole kularen
Ġ5215522 2
ĠWILETISIIE rS
ĠVYUTUPIGUUUE IL
ĠPIGSUCIZET S